 EXHIBIT 2.1      

Exhibit 2.1

  



  



  

  



  



  



  

AGREEMENT AND PLAN OF MERGER

  



  

BY AND AMONG

  



  

OPKO HEALTH, INC.,

  



  

BAMBOO ACQUISITION, INC.

  



  

AND

  



  

BIO-REFERENCE LABORATORIES, INC.

  



  



  



  

Dated as of June 3, 2015

  



  



  



  



  



    


--- 

 


--- 

    



  

TABLE OF CONTENTS

  



  

Page

  

    

    



  

    

     Article 1 Transactions and Terms of Merger   | 2 
---|--- 
     | 
   1.1  | Merger  | 2 
   1.2  | Time and Place of Closing  | 2 
   1.3  | Effective Time  | 2 
   1.4  | Charter and Bylaws  | 3 
   1.5  | Directors and Officers  | 3 
   1.6  | Conversion of Shares  | 3 
   1.7  | Anti-Dilution Provisions  | 4 
   1.8  | Stock Options  | 4 
   1.9  | Exchange Procedures  | 6 
   1.10  | Rights of Former Company Shareholders  | 8 
     |   | 
   Article 2 Representations and Warranties of the Company   | 8 
     | 
   2.1  | Organization, Standing, and Corporate Power  | 9 
   2.2  | Articles of Incorporation and Bylaws  | 9 
   2.3  | Capitalization  | 9 
   2.4  | Authority; Noncontravention; Voting Requirements  | 11 
   2.5  | Governmental Approvals  | 12 
   2.6  | Company SEC Documents; Undisclosed Liabilities  | 12 
   2.7  | Absence of Certain Changes  | 15 
   2.8  | Litigation  | 15 
   2.9  | Compliance with Laws; Permits  | 15 
   2.10  | Information Supplied  | 16 
   2.11  | Tax Matters  | 16 
   2.12  | Labor Relations  | 18 
   2.13  | Employee Benefits Plans  | 20 
   2.14  | Environmental Matters  | 22 
   2.15  | Intellectual Property  | 23 
   2.16  | Healthcare Regulatory and Related Matters  | 25 
   2.17  | Real Property  | 27 
   2.18  | Material Contracts  | 28 
   2.19  | Accounts Receivable  | 28 
   2.20  | Insurance  | 29 
   2.21  | Related Party Transactions  | 29 
   2.22  | Questionable Payments  | 29 
   2.23  | Anti-Takeover Provisions  | 29 
   2.24  | Opinion of Financial Advisor  | 30 
   2.25  | Brokers and Finders  | 30 
   2.26  | Tax and Regulatory Matters  | 30 
      

   

i 
--- 

 


--- 

    



  

   



     Article 3 Representations and Warranties of Parent and Sub   | 30 
---|--- 
     | 
   3.1  | Organization, Standing, and Power  | 31 
   3.2  | Authority; Noncontravention; Voting Requirements  | 31 
   3.3  | Required Filings and Consents  | 32 
   3.4  | Capital Stock  | 32 
   3.5  | Parent Subsidiaries  | 33 
   3.6  | SEC Filings; Financial Statements  | 33 
   3.7  | Absence of Undisclosed Liabilities  | 34 
   3.8  | Absence of Certain Changes or Events  | 35 
   3.9  | Tax Matters  | 35 
   3.10  | Environmental Matters  | 36 
   3.11  | Intellectual Property  | 36 
   3.12  | Regulatory and Related Matters  | 38 
   3.13  | Compliance with Laws  | 38 
   3.14  | Material Contracts  | 39 
   3.15  | Tax and Regulatory Matters  | 39 
   3.16  | Litigation  | 39 
   3.17  | Information Supplied  | 39 
   3.18  | Brokers and Finders  | 40 
   3.19  | Ownership and Operations of Sub  | 40 
   3.20  | Ownership of Company Common Stock  | 40 
     |   | 
   Article 4 Conduct of Business Pending Consummation   | 41 
     | 
   4.1  | Affirmative Covenants of the Company  | 41 
   4.2  | Negative Covenants of the Company  | 41 
   4.3  | Covenants of Parent  | 44 
   4.4  | Notification of Certain Matters  | 45 
   4.5  | No Control of Other Party's Business; Other Actions  | 46 
   4.6  | Preparation of Proxy Statement/Prospectus and Registration
Statement; Company  Shareholders' Meeting  | 46 
   4.7  | No Solicitation  | 49 
   4.8  | Access to Information  | 53 
   4.9  | Antitrust Notification; Consents; Reasonable Best Efforts  | 53 
   4.10  | Filing with State Office  | 55 
   4.11  | Directors' and Officers' Indemnification and Insurance  | 55 
   4.12  | Press Releases  | 57 
   4.13  | State Takeover Laws; Charter Provisions; No Rights Plan  | 57 
   4.14  | Employee Benefits and Contracts  | 58 
   4.15  | Shareholder Litigation  | 59 
   4.16  | NASDAQ; Post-Closing SEC Reports  | 60 
   4.17  | FIRPTA Company Certificate  | 60 
   4.18  | Conduct of Parent and Sub  | 60 
   4.19  | Section 16 Matters  | 60 
   4.20  | Governance Matters  | 61 
   4.21  | SEC Reports  | 61 
    

  

    

  

  

    

  

   

ii 
--- 

 


--- 

    



  

     4.22  | Post-Closing Restructuring  | 61 
---|---|--- 
     |   | 
   Article 5 Conditions Precedent to Obligations to Consummate  | 62 
     | 
   5.1  | Conditions to Obligations of Each Party  | 62 
   5.2  | Conditions to Obligations of Parent and Sub  | 63 
   5.3  | Conditions to Obligations of the Company  | 64 
     |   | 
   Article 6 Termination  | 65 
     | 
   6.1  | Termination  | 65 
   6.2  | Effect of Termination  | 67 
   6.3  | Expenses  | 68 
     |   | 
   Article 7 Miscellaneous  | 69 
     | 
   7.1  | Definitions  | 69 
   7.2  | Non-Survival of Representations, Warranties and Agreements  | 81 
   7.3  | Disclosure Schedules  | 81 
   7.4  | Governing Law; Jurisdiction  | 81 
   7.5  | WAIVER OF JURY TRIAL  | 81 
   7.6  | Severability; Construction  | 82 
   7.7  | Specific Performance  | 82 
   7.8  | Entire Agreement  | 82 
   7.9  | Amendments  | 83 
   7.10  | Extension; Waivers  | 83 
   7.11  | Parties in Interest  | 83 
   7.12  | Assignment  | 83 
   7.13  | Notices  | 84 
   7.14  | Counterparts  | 85 
   7.15  | Captions; Articles and Sections  | 85 
   7.16  | Interpretations  | 85 
    

  



  

    

iii 
--- 

 


--- 

    



  

AGREEMENT AND PLAN OF MERGER

  



  

THIS AGREEMENT AND PLAN OF MERGER (this " _Agreement_ ") is made and entered
into as of June 3, 2015, by and among OPKO HEALTH, INC., a Delaware
corporation (" _Parent_ "); BAMBOO ACQUISITION, INC., a New Jersey
corporation (" _Sub_ "); and BIO-REFERENCE LABORATORIES, INC., a New Jersey
corporation (the " _Company_ "). Certain capitalized terms used in this
Agreement are defined in _Section 7.1_.

  



  

 _Recitals_

  



  

WHEREAS, the board of directors of the Company (the " _Board_ ") has
determined that a merger of the Company and Sub, on the terms and subject to
the conditions set forth herein, is fair to, and in the best interests of the
Company and its shareholders, and declared it advisable to enter into this
Agreement with Parent and Sub and consummate the transactions described
herein;

  



  

WHEREAS, the board of directors of Parent and the board of directors of Sub
have determined that a merger of the Company and Sub, on the terms and
subject to the conditions set forth herein, is fair to, and in the best
interests of the Parent, Sub and their stockholders and sole shareholder,
respectively, and have determined that it is in the best interests of Parent
and Sub and their stockholders and sole shareholder, respectively, and
declared it advisable, to enter into this Agreement and consummate the
transactions described herein;

  



  

WHEREAS, the Board has (a) approved and adopted this Agreement and the
transactions contemplated hereby, including the Merger, and (b) recommended
approval and adoption of this Agreement by the shareholders of the Company;

  



  

WHEREAS, the board of directors of Sub, has (a) approved and adopted this
Agreement and the transactions contemplated hereby, including the Merger, and
(b) recommended approval of this Agreement and the transactions contemplated
hereby by the sole shareholder of Sub;

  



  

WHEREAS, it is the intention of the Parties to this Agreement that the Merger
for federal income tax purposes shall qualify as a "reorganization" within
the meaning of Section 368(a) of the Internal Revenue Code of 1986, as
amended, and the rules and regulations promulgated thereunder (the " _Code_
"), and this Agreement is intended to be, and is hereby, adopted as a plan of
reorganization within the meaning of Section 368(a) of the Code; and

  



  

WHEREAS, at the Effective Time, Sub shall merge with and into the Company,
with the Company surviving such merger, and the outstanding shares of Company
Common Stock shall be converted into the right to receive shares of Parent
Common Stock (except as provided herein) and, upon the terms and subject to
the conditions of this Agreement, the Company shall continue to conduct its
business and operations as a wholly owned subsidiary of Parent.

  



  

NOW, THEREFORE, in consideration of the above and the mutual warranties,
representations, covenants, and agreements set forth herein, the Parties
hereby agree as follows:

  



   


--- 

 


--- 

    

  



  

Article 1 
  _Transactions and Terms of Merger_

  



  

1.1 _Merger_.

  



  

On the terms and subject to the conditions set forth in this Agreement, at
the Effective Time, Sub shall be merged with and into the Company in
accordance with the provisions of the New Jersey Business Corporation Act (as
amended, the " _NJBCA_ ") and with the effects provided in the NJBCA (the "
_Merger_ "). At the Effective Time, the separate existence of Sub shall cease
and the Company shall continue as the Surviving Corporation in the Merger and
shall be a wholly owned Subsidiary of Parent and shall continue to be
governed by the Laws of the State of New Jersey. From and after the Effective
Time, the Surviving Corporation shall possess all the rights, privileges,
powers, immunities, purposes and franchises, both public and private, of each
of the Company and Sub, all real property and personal property, tangible and
intangible, of every kind and description, belonging to each of the Company
and Sub shall be vested in the Surviving Corporation without further act or
deed, and the title to any real estate, or any interest therein, vested in
each of the Company and Sub shall not revert or be in any way impaired by
reason of such Merger, the Surviving Corporation shall be liable for all the
obligations and liabilities of each of the Company and Sub and any claim
existing or action or proceeding pending by or against each of the Company and
Sub may be enforced as if such Merger had not taken place, and neither the
rights of creditors nor any liens upon, or security interests in, the
property of each the Company and Sub shall be impaired by such merger or
consolidation.

  



  

1.2 _Time and Place of Closing_.

  



  

The closing of the transactions contemplated hereby (the " _Closing_ ") will
take place at 9:00 a.m., New York City time, or such other time as the
Parties, acting through their authorized officers, may mutually agree, on a
date to be specified by the parties hereto, but no later than the third (3rd)
Business Day following the satisfaction or waiver of the conditions
(excluding the conditions that, by their nature, cannot be satisfied until
the Closing, but subject to the satisfaction or waiver of those conditions at
Closing) set forth in _Article 5_ , unless this Agreement has been theretofore
terminated pursuant to its terms or unless another time or date is agreed to
in writing by the Parties. The Closing shall be held at the offices of
Greenberg Traurig, P.A., 333 S.E. Second Avenue, Suite 4400, Miami, FL 33131
(or pursuant to the electronic or other remote exchange of documents and
closing deliverables required by this Agreement), unless another place is
agreed to in writing by the Parties. The date on which the Closing occurs is
referred to in this Agreement as the " _Closing Date._ "

  



  

1.3 _Effective Time_.

  



  

Concurrently with the Closing, the Company, Parent and Sub shall cause a
certificate of merger relating to the Merger substantially in the form
attached hereto as Exhibit A (the " _Certificate of Merger_ ") and a plan of
merger substantially in the form attached hereto as Exhibit B, to each be
duly executed and filed with the office of the Department of the Treasury of
New Jersey as provided under the NJBCA. The Merger shall become effective on
the date and time at which the Certificate of Merger have been properly filed
with the Department of the Treasury of

  



    

2 
--- 

 


--- 

    



  

the State of New Jersey or at such later date and time as is agreed between
the Parties and specified in the Certificate of Merger, but in no event more
than ninety (90) days after the date of filing the Certificate of Merger with
the Department of the Treasury of the State of New Jersey, and such date and
time is hereinafter referred to as the " _Effective Time._ " The Merger shall
have the effects set forth in this Agreement and the NJBCA.

  



  

1.4 _Charter and Bylaws_.

  



  

At the Effective Time, the certificate of incorporation of the Surviving
Corporation shall be the certificate of incorporation of Sub in effect
immediately prior to the Effective Time, and the bylaws of the Surviving
Corporation shall be the bylaws of Sub in effect immediately prior to the
Effective Time, in each case until thereafter amended in accordance with their
respective terms and the NJBCA, provided that each shall be amended to change
the name of the Company therein to "BIO-REFERENCE LABORATORIES, INC.".

  



  

1.5 _Directors and Officers_.

  



  

The directors of Sub in office immediately prior to the Effective Time
(together with such additional persons as may be appointed or elected to
become directors of the Surviving Corporation effective as of the Effective
Time), shall be the directors of the Surviving Corporation at the Effective
Time and shall serve in such capacity until the earlier of their resignation
or removal or until their successors are duly elected and qualified in
accordance with the applicable provisions of the certificate of
incorporation and bylaws of the Surviving Corporation and the NJBCA. The
officers of Sub in office immediately prior to the Effective Time
(together with such additional persons as may be elected to become officers
of the Surviving Corporation effective as of the Effective Time) shall be the
officers of the Surviving Corporation at the Effective Time and shall serve in
such capacity until the earlier of their resignation or removal or until
their successors are duly elected and qualified in accordance with the
applicable provisions of the certificate of incorporation and bylaws of the
Surviving Corporation and the NJBCA.

  



  

1.6 _Conversion of Shares_.

  



  

Subject to the terms and conditions of this Agreement, including, but not
limited to, the provisions of this _Article 1_ , at the Effective Time, by
virtue of the Merger and without any action on the part of Parent, the
Company, Sub or any holder of Company Common Stock:

  



  

(a)   _Conversion of Sub Common Stock_. Each share of Sub
Common Stock issued and outstanding immediately prior to the Effective Time
shall be converted into one fully paid and nonassessable share of common
stock, par value $0.01 per share, of the Surviving Corporation (the "
_Converted Shares_ "). The Converted Shares shall constitute the only
outstanding shares of capital stock of the Surviving Corporation at the
Effective Time. From and after the Effective Time, all certificates
representing shares of Sub Common Stock shall be deemed for all purposes to
represent the Converted Shares until the board of directors of the Surviving
Corporation issues new certificates in respect of such shares.

  

   

3 
--- 

 


--- 

    



  

(b)   _Shares Held by the Company or Parent_. Each of the shares
of Company Common Stock held by any Company Entity (including shares of
Company Common Stock held in treasury by the Company) or by any Parent Entity
shall be canceled and retired at the Effective Time and no consideration
shall be issued in exchange therefor.

  



  

(c)   _Conversion of Company Common Stock_. Each share of
Company Common Stock (excluding shares cancelled pursuant to _Section
1.6(b)_) issued and outstanding at the Effective Time shall cease to be
outstanding and shall be converted into and exchanged for the right to
receive Parent Common Stock in the ratio of 2.75 (the " _Exchange Ratio_ ")
shares of Parent Common Stock for such share of Company Common Stock (the "
_Merger Consideration_ "). From and after the Effective Time, all such shares
of Company Common Stock shall no longer be outstanding and shall automatically
be cancelled and retired and shall cease to exist, and each holder of a
certificate (a " _Company Certificate_ ") or book-entry share (a " _Book-
Entry Share_ ") representing any such shares of Company Common Stock shall
cease to have any rights with respect thereto, except the right to receive
the Merger Consideration therefor, without interest thereon, upon the
surrender of such Company Certificate or Book-Entry Share in accordance with
_Section 1.9_.

  



  

(d)   _Fractional Shares_. Notwithstanding any other provision
of this Agreement, each holder of shares of Company Common Stock exchanged
pursuant to the Merger who would otherwise have been entitled to receive a
fraction of a share of Parent Common Stock (after taking into account all
Company Certificates and Book-Entry Shares delivered by such holder) shall
receive, in lieu of such fraction of a share of Parent Common Stock, one
share of Parent Common Stock.

  



  

1.7 _Anti-Dilution Provisions_.

  



  

If, between the date of this Agreement and the Effective Time, the
outstanding shares of Company Common Stock shall have been changed into, or
exchanged for, a different number of shares or a different class, by reason of
any stock dividend, subdivision, reclassification, reorganization,
recapitalization, split, combination, contribution or exchange of shares, the
Merger Consideration and any payments to be made under _Section 1.6_ and any
other number or amount contained herein which is based upon the number
of shares of Company Common Stock shall be correspondingly adjusted to
provide the holders of Company Common Stock, Company Options and other awards
under the Company Option Plan, the same economic effect as contemplated by
this Agreement prior to such event. Nothing in this _Section 1.7_ shall be
construed to permit any Party to take any action that is otherwise
prohibited or restricted by any other provision in this Agreement.

  



  

1.8 _Stock Options_.

  



  

(a)  Prior to the Effective Time, the Board shall take all
necessary actions so that each option to purchase shares of Company Common
Stock granted by the Company, whether granted pursuant to the Company Option
Plan (individually, a " _Company Plan Option_ ") or otherwise (collectively,
including all Company Plan Options, the " _Company Options_ ") that is
outstanding immediately prior to the Effective Time, whether vested or
unvested, shall be

  



    

4 
--- 

 


--- 

    

converted into and become rights with respect to Parent Common Stock, and
Parent shall assume each Company Option, in accordance with the terms of the
Company Option Plan and/or stock option agreement by which it is evidenced,
except that from and after the Effective Time, (i) Parent and its
compensation committee shall be substituted for the Company and the
compensation committee of the Board (including, if applicable, the Board)
administering such Company Option Plan, (ii) each Company Option assumed by
Parent may be exercised solely for shares of Parent Common Stock (or cash, if
so provided under the terms of such Company Option), (iii) the number of
shares of Parent Common Stock subject to such Company Options shall be equal
to the number of shares of Company Common Stock subject to such Company
Options immediately prior to the Effective Time multiplied by the Exchange
Ratio, rounded down to the nearest whole share, and (iv) the per share
exercise price under each such Company Option shall be adjusted by
dividing the per share exercise price under each such Company Option by the
Exchange Ratio and rounding up to the nearest cent. In
addition, notwithstanding the provisions of clauses (iii) and (iv) of the
first sentence of this _Section 1.8(a)_, each Company Option that is an
"incentive stock option" or a nonqualified stock option held by a U.S.
taxpayer shall be adjusted as required by Section 424 of the Code and Section
409A of the Code and the Treasury Regulations thereunder, so as not to
constitute a modification, extension or renewal of the option, within the
meaning of Section 424(h) of the Code and the Treasury Regulations under
Section 409A of the Code, or otherwise result in negative Tax treatment or
penalties under Section 424 of the Code or Section 409A of the Code. Each of
the Company and Parent shall adopt any and all resolutions and take all
necessary steps to effectuate the foregoing provisions of this _Section
1.8(a)_.

  



  

(b)  As soon as practicable after the Effective Time, Parent
shall deliver to the participants in each Company Option Plan an appropriate
notice setting forth such participant's rights pursuant thereto and the grants
subject to such Company Option Plan shall continue in effect on the same
terms and conditions (subject to the adjustments required by _Section
1.8(a) _after giving effect to the Merger), and Parent shall comply with the
terms of each Company Option Plan to ensure, to the extent required by, and
subject to the provisions of, such Company Option Plan, that Company Options
that qualified as incentive stock options prior to the Effective Time
continue to qualify as incentive stock options after the Effective Time and
Company Options that qualified for exemption from application of Section 409A
of the Code prior to the Effective Time continue to remain so exempt. At or
prior to the Effective Time, Parent shall take all corporate action necessary
to reserve for issuance sufficient shares of Parent Common Stock for delivery
upon exercise of Company Options assumed by it in accordance with this
_Section 1.8_. As soon as practicable after the Effective Time, Parent shall
file a registration statement on Form S-3 or Form S-8, as the case may be (or
any successor or other appropriate forms), with respect to the shares of
Parent Common Stock subject to such options and shall use its reasonable
efforts to maintain the effectiveness of such registration statements (and
maintain the current status of the prospectus or prospectuses contained
therein) for so long as such options remain outstanding.

  



    

5 
--- 

 


--- 

    

1.9 _Exchange Procedures_.

  



  

(a)  On the Closing Date, Parent shall make available to
Parent's transfer agent or another exchange agent selected by Parent and
which is reasonably acceptable to the Company (the " _Exchange Agent_ "), for
exchange in accordance with this _Section 1.9_, the shares of the Parent
Common Stock issuable pursuant to this Agreement. Promptly after the
Effective Time, the Surviving Corporation shall instruct the Exchange Agent to
mail (or in the case of the Depository Trust Company on behalf of " _Street_
" holders, deliver) to each holder of record of a Company Certificate or Book-
Entry Shares immediately prior to the Effective Time, appropriate transmittal
materials and instructions (which shall specify that delivery shall be
effected, and risk of loss and title to such Company Certificates or Book-
Entry Shares shall pass, only upon proper delivery of such Company
Certificates or Book-Entry Shares to the Exchange Agent). Each holder of
shares of Company Common Stock that have been converted into the right to
receive Merger Consideration shall be entitled to receive the Merger
Consideration in respect of (i) any share of Company Common Stock
represented by a Company Certificate upon surrender to the Exchange Agent of
such Company Certificate, together with a duly completed and validly executed
letter of transmittal and duly endorsed as the Exchange Agent may require or
(ii) any Book-Entry Share upon receipt of an "agent's message" by the Exchange
Agent, together with such other evidence, if any, of the transfer as the
Exchange Agent may reasonably request. In the event of a transfer of
ownership of shares of Company Common Stock represented by Company
Certificates or Book-Entry Shares that are not registered in the transfer
records of the Company, the consideration provided in _Section 1.6_ may be
issued to a transferee if the Company Certificates representing such shares
or Book-Entry Shares are delivered to the Exchange Agent, accompanied by all
documents required to evidence such transfer and by evidence satisfactory to
the Exchange Agent that any applicable stock transfer Taxes have been paid.
If any Company Certificate shall have been lost, stolen, mislaid or destroyed,
upon receipt of (i) an affidavit of that fact from the holder claiming such
Company Certificate to be lost, mislaid, stolen or destroyed, (ii) such bond,
security or indemnity as Parent and the Exchange Agent may reasonably require,
and (iii) any other documents necessary to evidence and effect the bona fide
exchange thereof, the Exchange Agent shall issue to such holder the
consideration into which the shares represented by such lost, stolen, mislaid
or destroyed Company Certificate shall have been converted. The
Exchange Agent may establish such other reasonable and customary rules and
procedures in connection with its duties as it may deem appropriate. Parent
shall pay all charges and expenses, including those of the Exchange Agent, in
connection with the distribution of the consideration provided in _Section
1.6_. No interest will accrue or be paid to any holder of Company Common
Stock.

  



  

(b)  After the Effective Time, each holder of shares of Company
Common Stock (other than shares to be canceled pursuant to _Section
1.6(b)_) shall submit a duly completed and validly executed letter of
transmittal, duly endorsed as the Exchange Agent may require (or, in the case
of Book-Entry Shares, such other evidence, if any, of the transfer as the
Exchange Agent may reasonably request) together with (except in the case of a
holder of Book-Entry Shares) the Company Certificate or Company Certificates
representing such shares and shall promptly upon surrender thereof receive in
exchange therefor the consideration provided in _Section 1.6 _in one or more
shares of Parent Common Stock which shall be in uncertificated book

  



    

6 
--- 

 


--- 

    

entry form unless a physical certificate is requested, together with all
undelivered dividends or distributions in respect of such shares (without
interest thereon) pursuant to _Section 1.6_. Parent shall not be obligated
to deliver the Merger Consideration to which any former holder of Company
Common Stock is entitled as a result of the Merger until such holder
surrenders or transfers such holder's Company Certificate or Company
Certificates or Book-Entry Shares for exchange as provided in this _Section
1.9_.

  



  

(c)  Each of Parent, the Surviving Corporation and the Exchange
Agent shall be entitled to deduct and withhold from the Merger Consideration
otherwise payable pursuant to this Agreement to any holder of shares of
Company Common Stock such amounts, if any, as it is required to deduct and
withhold with respect to the making of such payment under the Code or any
provision of any state, local, or foreign Tax Law, unless they have been
presented with documentation that eliminates the requirement to withhold,
and to request any necessary Tax forms, as applicable, or any other proof of
exemption from withholding or similar information, from the shareholders of
the Company or other recipient of payments in respect of which such deduction
and withholding was made. To the extent that any amounts are so withheld by
Parent, the Surviving Corporation or the Exchange Agent, as the case may be,
such withheld amounts shall be treated for all purposes of this Agreement as
having been paid to the holder of the shares of Company Common Stock in
respect of which such deduction and withholding was made by Parent, the
Surviving Corporation or the Exchange Agent, as the case may be. Each of
Parent, the Surviving Corporation and the Exchange Agent shall provide any
documentation of such deduction or withholding as reasonably requested by the
shareholders of the Company or other recipient of payments in respect of
which such deduction and withholding was made.

  



  

(d)  Any portion of the aggregate Merger Consideration that
remains unclaimed by the holders of Company Common Stock for one year after
the Effective Time shall be returned to Parent (together with any dividends or
earnings in respect thereof). Any holders of Company Common Stock who have
not theretofore complied with this _Article 1_ shall thereafter be entitled to
look only to Parent, and only as a general creditor thereof, for payment of
the consideration deliverable in respect of each share of Company Common
Stock such holder holds as determined pursuant to this Agreement, in each
case, without any interest thereon.

  



  

(e)  Any other provision of this Agreement notwithstanding,
none of Parent, the Surviving Corporation or the Exchange Agent shall be
liable to a holder of Company Common Stock for any amounts paid or property
delivered in good faith to a public official pursuant to any applicable
abandoned property, escheat or similar Law. Any amounts of consideration
remaining unclaimed by holders of shares of Company Common Stock immediately
prior to such time when the amounts would otherwise escheat to or become
property of any Governmental Entity shall become, to the extent permitted by
Law, the property of Parent free and clear of any claims or interest of any
Person previously entitled thereto.

  



  

(f)  If, at any time after the Effective Time, any further
action is necessary or desirable to carry out the purposes or intent of this
Agreement and to vest the Surviving Corporation with full right, title and
possession to all Assets, property, rights, privileges, powers and franchises
of the Company and Sub, the directors and officers of Parent and the Surviving
Corporation shall have the authority to take all such lawful and necessary
action.

  



  

   

7 
--- 

 


--- 

    



  

1.10 _Rights of Former Company Shareholders_.

  



  

At the Effective Time, the stock transfer books of the Company shall be
closed as to holders of Company Common Stock immediately prior to the
Effective Time and no transfer of Company Common Stock by any such holder
shall thereafter be made or recognized. If, after the Effective Time, Company
Certificates and Book-Entry Shares representing shares of Company Common Stock
are presented to the Surviving Corporation for transfer, they shall be
canceled and exchanged for the Merger Consideration as provided in this 
_Article 1_. Until surrendered for exchange in accordance with the provisions
of _Section 1.9_, each Company Certificate theretofore representing shares
of Company Common Stock and each Book-Entry Share (other than shares to
be canceled pursuant to _Section 1.6(b)_) shall from and after the Effective
Time represent for all purposes only the right to receive the consideration
provided in _Section 1.6_ in exchange therefor, subject, however, to
the Surviving Corporation's obligation to pay any dividends or make any other
distributions with a record date prior to the Effective Time which have been
declared or made by the Company in respect of such shares of Company Common
Stock in accordance with the terms of this Agreement and which remain unpaid
at the Effective Time. To the extent required by Law, former shareholders of
record of the Company shall be entitled to vote after the Effective Time at
any meeting of Parent stockholders the number of whole shares of Parent
Common Stock into which their respective shares of Company Common Stock are
converted, regardless of whether such holders have exchanged their Company
Certificates or Book-Entry Shares for Parent Common Stock in accordance with
the provisions of this Agreement. Whenever a dividend or other distribution
is declared by Parent on the Parent Common Stock, the record date for which
is at or after the Effective Time, the declaration shall include dividends or
other distributions on all shares of Parent Common Stock issuable pursuant to
this Agreement, no dividend or other distribution payable to the holders of
record of Parent Common Stock as of any time subsequent to the Effective Time
shall be delivered to the holder of any Company Certificates or Book-
Entry Shares until such holder surrenders such Company Certificates or Book-
Entry Shares for exchange as provided in _Section 1.9_. However, upon
surrender of such Company Certificates or Book-Entry Shares, both the Parent
Common Stock (together with all such undelivered dividends or other
distributions without interest) and any undelivered dividends and cash
payments payable hereunder (without interest) shall be delivered and paid
with respect to each share represented by such Company Certificates or Book-
Entry Shares.

  



  

Article 2 
  _Representations and Warranties of the Company_

  



  

The Company represents and warrants to Parent and Sub that, except as
disclosed in the Company Disclosure Schedule or as disclosed in the Company's
Proxy Statement on Schedule 14A filed with the SEC on May 28, 2014, the Annual
Report on Form 10-K for the fiscal year ended October 31, 2014 (including the
exhibits thereto), as amended, or in any Company SEC Document filed
subsequent to such Form 10-K but prior to the date of this Agreement, but
without giving effect to any amendment to any such Company SEC Document filed
on or after the date of this Agreement and excluding any disclosures set forth
in any section entitled "risk factors" or constituting "forward-looking
statements" or any other statements that are similarly

  



    

8 
--- 

 


--- 

    

cautionary, predictive or forward-looking in nature, except, in each case,
other than historical information contained therein (the " _Filed Company SEC
Documents_ "): 
  

  

2.1 _Organization, Standing, and Corporate Power_.

  



  

(a)  The Company is a corporation duly organized, validly
existing and in good standing under the Laws of the State of New Jersey and
has all requisite corporate power and authority necessary to own or lease all
of its Assets and to carry on its business as it is now being conducted. The
Company is duly qualified to do business and is in good standing in each
jurisdiction in which the nature of the business conducted by it or the
character or location of the Assets owned or leased by it makes such
qualification necessary, except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material Adverse Effect.

  



  

(b)  Each Company Subsidiary is duly organized, validly existing
and in good standing under the Laws of the jurisdiction of its organization
and has all requisite corporate power and authority necessary to own or lease
all of its Assets and to carry on its business as it is now being conducted.
Each Company Subsidiary is duly qualified to do business and is in good
standing in each jurisdiction in which the nature of the business conducted
by it or the character or location of the Assets owned or leased by it makes
such qualification necessary except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material Adverse Effect.

  



  

2.2 _Articles of Incorporation and Bylaws_.

  



  

The Company has heretofore made available to Parent true, correct and
complete copies of the Organizational Documents, in each case as amended to
the date of this Agreement, of the Company and each Company Subsidiary
(collectively, the " _Company Organizational Documents_ "). The Company
Organizational Documents are in full force and effect. The Company and the
Company Subsidiaries are in compliance with the material terms of the Company
Organizational Documents.

  



  

2.3 _Capitalization_.

  



  

(a)  The authorized capital of the Company consists of
35,000,000 shares of Company Common Stock and 1,666,667 shares of
Company Preferred Stock, 3,000 of which are designated as Series A Junior
Participating Preferred Stock. At the close of business on June 1, 2015, (i)
27,802,976 shares of Company Common Stock were issued and outstanding, (ii) no
shares of Company Common Stock were held by the Company in its treasury,
(iii) 138,000 shares of Company Common Stock were reserved for issuance
pursuant to outstanding Company Options, and (iv) no shares of Company
Preferred Stock were issued or outstanding. All outstanding shares of Company
Common Stock have been duly authorized and validly issued and are fully paid,
nonassessable and free of preemptive rights. _Section 2.3_ of the Company
Disclosure Schedule sets forth a true, complete and correct list, as of the
close of business on June 1, 2015, of all Company Options, the number of
shares of Company Common Stock subject thereto, the grant dates, expiration
dates and the exercise or base prices. With respect to

  



  

   

9 
--- 

 


--- 

    



  

the Company Options, (i) each grant of a Company Option was duly authorized
no later than the date on which the grant of such Company Option was by its
terms to be effective (the " _Grant Date_ ") by all necessary corporate
action, including, as applicable, approval by the Board, or a committee
thereof, (ii) each such grant was made in accordance with the terms of the
applicable Company Option Plan, the Exchange Act and all other applicable
Law, (iii) the per share exercise price of each Company Option was not less
than the fair market value of a share of Company Common Stock on the
applicable Grant Date, and (iv) each such grant was properly accounted for in
all material respects in accordance with GAAP in the financial statements
(including the related notes) of the Company.

  



  

(b)  Except for the Company Options, there are on the date
hereof no outstanding (i) securities of the Company convertible into or
exchangeable for shares of capital stock or voting securities or ownership
interests in the Company, (ii) options, warrants, rights or other agreements
or commitments requiring the Company to issue, or other obligations of the
Company to issue, any capital stock, voting securities or other ownership
interests in (or securities convertible into or exchangeable for
capital stock or voting securities or other ownership interests in) the
Company (or, in each case, the economic equivalent thereof), (iii)
obligations of the Company to grant, extend or enter into any subscription,
warrant, right, convertible or exchangeable security or other similar
agreement or commitment relating to any capital stock, voting securities or
other ownership interests in the Company (the items in clauses (i), (ii) and
(iii), together with the capital stock of the Company, being referred to
collectively as " _Company Securities_ "), or (iv) obligations by the Company
or any Company Subsidiary to make any payments based on the price or value of
the shares of Company Common Stock. Other than pursuant to the Company Option
Plan, there are no outstanding obligations of the Company or any Company
Subsidiary to purchase, redeem or otherwise acquire any Company
Securities. There are no voting trusts or other agreements or understandings
to which the Company or any Company Subsidiary is a party with respect to the
voting of capital stock of the Company. All outstanding securities of the
Company have been offered and issued in compliance in all material respects
with all applicable Securities Laws and any applicable U.S. state securities
and "blue sky" laws.

  



  

(c)  Except as set forth in _Section 2.3(c)_ of the Company
Disclosure Schedule, the Company or a Company Subsidiary is the record and
beneficial owner of all of the outstanding shares of capital stock (or other
equity interests) of each Company Subsidiary, free and clear of any Lien, and
there are no irrevocable proxies with respect to any such shares. There are no
outstanding (i) securities of the Company or any Company Subsidiary
convertible into or exchangeable for shares of capital stock or other voting
securities or ownership interests in any Company Subsidiary, (ii) options,
restricted stock, warrants, rights or other agreements or commitments to
acquire from the Company or any Company Subsidiary, or obligations of the
Company or any Company Subsidiary to issue, any capital stock, voting
securities or other ownership interests in (or securities convertible into or
exchangeable for capital stock or voting securities or other ownership
interests in) any Company Subsidiary, (iii) obligations of the Company or any
Company Subsidiary to grant, extend or enter into any subscription, warrant,
right, convertible or exchangeable security or other similar agreement or
commitment relating to any capital stock, voting securities or other ownership
interests in any Company Subsidiary (the

  



  

   

10 
--- 

 


--- 

    



  

  

items in clauses (i), (ii) and (iii), together with the capital stock of such
Subsidiaries, being referred to collectively as " _Subsidiary Securities_ "),
or (iv) obligations of the Company or any Company Subsidiary to make any
payment based on the value of any shares of any Company Subsidiary. There are
no outstanding obligations of the Company or any Company Subsidiary to
purchase, redeem or otherwise acquire any outstanding Subsidiary Securities.
There are no voting trusts or other Contracts to which the Company or any
Company Subsidiary is a party with respect to the voting of capital stock (or
other equity interests) of any Company Subsidiary. All Subsidiary Securities
of any Company Subsidiary incorporated or formed in a jurisdiction located
within the United States of America are duly authorized, validly issued, fully
paid and nonassessable.

  



  

2.4 _Authority; Noncontravention; Voting Requirements_.

  



  

(a)  The Company has all necessary corporate power and
authority to execute and deliver this Agreement subject to obtaining the
Required Company Vote, to perform its obligations hereunder and to consummate
the Merger and the other transactions contemplated hereby. The execution,
delivery and performance by the Company of this Agreement, and the
consummation of the Merger and the other transactions contemplated hereby,
have been duly and validly authorized and approved by the Board, and except
for obtaining the Required Company Vote, no other corporate action on the
part of the Company or its shareholders is necessary to authorize
the execution, delivery and performance by the Company of this Agreement and
the consummation by the Company of the Merger and the other transactions
contemplated hereby. This Agreement has been duly and validly executed and
delivered by the Company and, assuming due authorization, execution and
delivery hereof by the other Parties hereto, constitutes legal, valid and
binding obligations of the Company, enforceable against the Company in
accordance with their respective terms, except that such enforceability (i)
may be limited by bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and other laws of general application affecting or
relating to the enforcement of creditors' rights generally and (ii) is subject
to general principles of equity (the " _Bankruptcy and Equity Exception_ ").

  



  

(b)  Neither the execution and delivery of this Agreement by the
Company nor the consummation by the Company of the Merger and the other
transactions contemplated hereby, nor compliance by the Company with any of
the terms or provisions hereof or thereof, will (i) assuming the Required
Company Vote is obtained, conflict with or violate any provision of the
Company Organizational Documents or (ii) assuming that each of the consents,
authorizations and approvals referred to in _Section 2.5 _and _Section 3.2_
and the Required Company Vote is obtained (and any condition precedent to any
such consent, authorization or approval has been satisfied) and each of the
filings referred to in _Section 2.5_ and _Section 3.2 _are made and any
applicable waiting periods referred to therein have expired, conflict with or
violate in any material respect any Law, judgment, writ or injunction of any
Governmental Entity applicable to the Company or any Company Subsidiary or by
which any property or Asset of the Company or any Company Subsidiary is bound
or affected, or (iii) result in any breach of, or constitute a Default under,
result in the loss of a benefit under or give rise to any right of
termination, amendment, acceleration, payment or cancellation of, any
Contract or Lease to which any Company Entity is a party, or result in the
creation of a Lien upon any of the Assets of

  



  

   

11 
--- 

 


--- 

    

    



  

  

the Company or any Company Subsidiary other than, in the case of clause (iii),
as would not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect.

  



  

(c)  The Board, at a meeting duly called and held, at which all
directors of the Company were present, duly and unanimously adopted
resolutions (i) declaring that the terms of this Agreement, the Merger and the
other transactions contemplated hereby are fair to, and in the best interests
of the Company and its shareholders, (ii) approving, adopting and authorizing
this Agreement, the Merger and the other transactions contemplated hereby,
(iii) directing that the approval of this Agreement and the Merger be
submitted to a vote at a meeting of the shareholders of the Company, and (iv)
recommending that the shareholders of the Company approve this Agreement,
subject to the terms and conditions hereof (the " _Company Board
Recommendation_ ").

  



  

(d)  The Required Company Vote constitutes the only vote or
approval of the holders of any class or series of capital stock of the
Company necessary to approve this Agreement and the Merger and the other
transactions contemplated hereby.

  



  

2.5 _Governmental Approvals_.

  



  

Except for (i) the filing with the SEC of the Proxy Statement/Prospectus, the
Registration Statement and other filings required under, and compliance with
other applicable requirements of, the Exchange Act, the rules of the NASDAQ
and state securities and "blue sky" laws, (ii) the filing of the Certificate
of Merger with the Department of the Treasury of the State of New Jersey as
provided under the NJBCA, (iii) the filing of all applications, consents,
approvals, authorizations and notices, as required by CMS, FDA, federally
recognized but privately operating accrediting organizations, or any other
federal, state, local or foreign Governmental Entity, including such entities
that are concerned with or regulate clinical laboratories, or is concerned
with or regulates public health care programs (each, a " _Healthcare
Regulatory Authority_ "), each as set forth in _Section 2.5_ of the Company
Disclosure Schedule, and (iv) filings required under, and compliance with
other applicable requirements of, the Antitrust Laws, including filings
required under the HSR Act and the Foreign Antitrust Filings (the items
listed in _Section 2.5_ of the Company Disclosure Schedule and the
requirements referenced in clauses (i)-(iv) of this _Section 2.5_ being
referred to collectively as the " _Governmental Approvals_ "), no consents or
approvals of, Permits from or filings, declarations or registrations with, any
Governmental Entity are necessary for the execution and delivery of this
Agreement by the Company and the consummation by the Company of the Merger and
the other transactions contemplated hereby.

  



  

2.6 _Company SEC Documents; Undisclosed Liabilities_.

  



  

(a)  Since November 1, 2011, the Company has timely filed with
or furnished to the SEC all Company SEC Documents. As of their respective
effective dates (in the case of Company SEC Documents that are registration
statements filed pursuant to the requirements of the Securities Act) and as
of their respective SEC filing dates (in the case of all other Company SEC
Documents), the Company SEC Documents complied in all material respects with
the

  



  

   

12 
--- 

 


--- 

    



  

  

applicable requirements of the Securities Laws and the Sarbanes-Oxley Act of
2002 (the " _Sarbanes-Oxley Act_ ") and the rules and regulations of the SEC
thereunder, applicable to such Company SEC Documents and none of the Company
SEC Documents as of such respective dates (or, if amended prior to the date
of this Agreement, the date of the filing of such amendment, with respect
to the disclosures that are amended) contained any untrue statement of a
material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading. As of the date of
this Agreement, there are no outstanding or unresolved comments in comment
letters received from the SEC staff with respect to the Company SEC Documents
and (ii) to the Knowledge of the Company, none of the Company SEC
Documents is the subject of ongoing SEC review, outstanding SEC comment or
outstanding SEC investigation. No Company Subsidiary is required to file
periodic reports with the SEC pursuant to the Exchange Act.

  



  

(b)  As of their respective dates of filing with the SEC, the
consolidated financial statements of the Company and the Company Subsidiaries
included in the Company SEC Documents (i) complied as to form in all material
respects with all applicable accounting requirements and with the published
rules and regulations of the SEC with respect thereto (except, in the case of
unaudited statements, as permitted by Form 10-Q of the SEC and Regulation
S-X), (ii) have been prepared in accordance with GAAP applied on a
consistent basis for the periods presented (except (A) as may be indicated in
the notes thereto or (B) as permitted by Regulation S-X) and (iii) present
fairly, in all material respects, the consolidated financial position of the
Company and the Company Subsidiaries, and the results of their operations and
cash flows, as of the dates and for the periods shown, in conformity
with GAAP.

  



  

(c)  The Company and the Company Subsidiaries have implemented
and maintain a system of internal control over financial reporting (as
required by Rule 13a15(a) under the Exchange Act) that is reasonably designed
to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of consolidated financial statements in
accordance with GAAP for external purposes and includes policies and
procedures that (i) pertain to the maintenance of records that in reasonable
detail accurately and fairly reflect the transactions and dispositions of the
Assets of the Company, (ii) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial statements in
accordance with GAAP, and that receipts and expenditures of the Company are
being made only in accordance with authorizations of management and directors
of the Company, and (iii) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use or disposition of the
Company's Assets that could have a material effect on its financial
statements, and such system of internal control over financial reporting is
reasonably effective. The Company's management has completed an assessment of
the effectiveness of the Company's internal controls over financial reporting
in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act
for the year ended October 31, 2014 and the description of such assessment set
forth in the Company's Annual Report on Form 10-K for the fiscal year ended
October 31, 2014 is accurate in all material respects. The Company has
implemented and maintains disclosure controls and procedures (as defined in
Rule 13a15(d) of the Exchange Act) that are designed to ensure that
information required to be disclosed by the Company in the

  



  

   

13 
--- 

 


--- 

    



  

  

reports it files or submits under the Exchange Act is recorded, processed,
summarized and reported within the time frames specified by the SEC's rules
and forms (and such disclosure controls and procedures are effective), and has
disclosed, based on its most recent evaluation of its system of internal
control over financial reporting prior to the date of this Agreement, to the
Company's outside auditors and the audit committee of the Board (i) any
significant deficiencies and material weaknesses known to it in the design or
operation of its internal control over financial reporting (as defined in Rule
13a15(f) of the Exchange Act) that would reasonably be expected to adversely
affect the Company's ability to record, process, summarize and
report financial information and (ii) any fraud known to it, that involves
management or other employees who have a significant role in the Company's
internal control over financial reporting.

  



  

(d)  To the Knowledge of the Company, as of the date hereof, no
employee of the Company or the Company Subsidiaries has provided or is
providing information to any law enforcement agency regarding the violation of
any applicable Law of the type described in Section 806 of the Sarbanes-Oxley
Act by the Company or the Company Subsidiaries. Neither the Company nor the
Company Subsidiaries nor, to the Knowledge of the Company, any director,
officer, employee, contractor, subcontractor or agent of the Company or the
Company Subsidiaries has discharged, demoted or suspended an employee of the
Company or the Company Subsidiaries in the terms and conditions of employment
because of any lawful act of such employee described in Section 806 of the
Sarbanes-Oxley Act.

  



  

(e)  Since November 1, 2011, each of the principal executive
officer of the Company and the principal financial officer of the Company has
made all certifications required by Rule 13a-14 or 15d-14 under the Exchange
Act and Sections 302 and 906 of the Sarbanes-Oxley Act, in each case, with
respect to the Company SEC Documents, and the statements contained in such
certifications were complete, correct and accurate on the date such
certifications were made. For purposes of this Agreement,
"principal executive officer" and "principal financial officer" shall have
the meanings given to such terms in the Sarbanes-Oxley Act.

  



  

(f)  Neither the Company nor any of the Company Subsidiaries is
a party to, or has any commitment to become a party to, any joint venture,
off-balance sheet partnership or any similar Contract (including any Contract
relating to any transaction or relationship between or among the Company or
any Company Subsidiary, on the one hand, and any unconsolidated Affiliate,
including any structured finance, special purpose or limited purpose entity
or Person, on the other hand), or any "off-balance sheet arrangements" (as
defined in Item 303(a) of Regulation S-K of the SEC), where the result,
purpose or intended effect of such Contract is to avoid disclosure of any
material transaction involving, or material liabilities of, the Company or any
Company Subsidiary in the Company SEC Documents.

  



  

(g)  Neither the Company nor any of the Company Subsidiaries has
any Liabilities, including those arising under any Law and those arising
under any Contract or Lease, except for Liabilities (i) reflected or reserved
against on the balance sheet of the Company and the Company Subsidiaries as
of October 31, 2014 (the " _Balance Sheet Date_ ") (including the notes
thereto) included in the Filed Company SEC Documents, (ii) incurred after the
Balance

  



   

14 
--- 

 


--- 

    

  



  

Sheet Date in the ordinary course of business consistent with past practice,
(iii) as contemplated by this Agreement or otherwise in connection with the
Merger and the other transactions contemplated hereby or (iv) as is not
reasonably likely to be material to the Company's financial condition or
liquidity.

  



  

2.7 _Absence of Certain Changes_.

  



  

(a)  Except as set forth in _Section 2.7(a)_ of the Company
Disclosure Schedule, since the Balance Sheet Date through the date of this
Agreement, the Company and the Company Subsidiaries have conducted their
respective businesses in all material respects only in the ordinary course
consistent with past practice, as provided in or contemplated by this
Agreement, or as required by applicable Law. Neither the Company nor any of
the Company Subsidiaries has taken any action since the Balance Sheet Date
that, if taken after the date of this Agreement without the prior written
consent of Parent, would constitute a breach of _Section 4.2_.

  



  

(b)  Since the Balance Sheet Date, there has not been any state
of facts, change, event, effect or occurrence that has had, or that would
reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect.

  



  

2.8 _Litigation_.

  



  

As of the date hereof and at any time since January 1, 2012, except as set
forth in _Section 2.8_ of the Company Disclosure Schedule, (i) there is no
and has not been any Litigation instituted by or pending or, to the Knowledge
of the Company, threatened against the Company or the Company Subsidiaries or
any of its or their Assets and (ii) neither the Company nor the Company
Subsidiaries nor any of their respective Assets is or has been subject, or,
to the Knowledge of the Company, threatened to be subject, to any outstanding
Order.

  



  

2.9 _Compliance with Laws; Permits_.

  



  

Except as set forth in _Section 2.9_ of the Company Disclosure Schedule,
since January 1, 2012, the Company and the Company Subsidiaries have been and
currently are in compliance in all material respects with all Laws and all
Orders, in each case applicable to the Company or any Company Subsidiary.
Since January 1, 2012, the Company and each of the Company Subsidiaries have
held and currently hold all Permits material to the conduct of their
respective businesses as they are now being conducted and such Permits are
valid and in full force and effect. (i) No revocation or cancellation of any
such material Permit is pending, and (ii) since January 1, 2012, neither the
Company nor any of the Company Subsidiaries has received any written, or to
the Knowledge of the Company, oral, notice from any Governmental Entity
threatening to revoke or cancel any such Permit or threatening any
adverse action with respect to any such Permit. The Company and the Company
Subsidiaries are in compliance in all material respects with the terms of all
such Permits.

  



   

15 
--- 

 


--- 

    

  

2.10   _Information Supplied_.

  



  

(a)  None of the information to be supplied by the Company and
included in the Registration Statement to be filed by Parent with the SEC in
connection with the Parent Common Stock, will, when the Registration Statement
becomes effective, contain an untrue statement of a material fact, or omit to
state any material fact necessary to make the statements therein not
misleading.

  



  

(b)  None of the information to be included in the Proxy
Statement/Prospectus to be mailed to the Company's shareholders, and any
other documents to be filed by the Company or any of its Affiliates with the
SEC or any other Regulatory Authority in connection with the transactions
contemplated hereby (including the Required Filings) that is supplied by the
Company or any of its Affiliates for inclusion therein, will, at the
respective time such documents are filed, and with respect to the Proxy
Statement/Prospectus, when first mailed to the shareholders of the Company,
contain an untrue statement of a material fact, or omit to state any
material fact necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading, or, in the case of
the Proxy Statement/Prospectus or any amendment thereof or supplement thereto,
at the time of the Company shareholder meeting to consider the Merger,
contain an untrue statement of a material fact, or omit to state any material
fact necessary to make the statements therein not misleading.

  



  

(c)  All documents that the Company or its Affiliates are
responsible for filing with any Regulatory Authority in connection with the
transactions contemplated hereby will comply as to form in all material
respects with the provisions of applicable Law.

  



  

2.11 _Tax Matters_.

  



  

Except as set forth in the applicable subsection of _Section 2.11_ of the
Company Disclosure Schedule:

  



  

(a)  The Company and each Company Subsidiary have filed when
due (taking into account valid extensions): (i) all material Tax Returns
required by applicable Law to be filed with respect to it; (ii) all such Tax
Returns were true, correct and complete in all material respects as of the
time of such filing; (iii) all material Taxes (whether or not reflected on any
Tax Return) owed by the Company and the Company Subsidiaries, if required to
have been paid, have been paid (except for Taxes that are being contested in
good faith or reserved for on the financial statements of the Company and the
Company Subsidiaries); and (iv) as of the date of the latest financial
statements of the Company, any Liability of the Company or any Company
Subsidiary for accrued Taxes not yet due and payable, or which are being
contested, has been provided for on the financial statements of the
Company to the extent required by and in accordance with GAAP.

  



  

(b)  There is no outstanding request for any extension of time
for any of the Company or the Company Subsidiaries to pay any Taxes or file
any Tax Returns, other than any such request made in the ordinary course of
business consistent with past practice, and there has

  



   

16 
--- 

 


--- 

    

  



  

been no waiver or extension of any applicable statute of limitations for the
assessment or collection of any Taxes of any of the Company or the Company
Subsidiaries.

  



  

(c)  There are no Liens for any Taxes (other than a Lien for
Taxes not yet due and payable) on any of the Assets of the Company and the
Company Subsidiaries.

  



  

(d)  No written claim has been made that is currently pending by
an authority in a jurisdiction where the Company or any Company Subsidiary
does not file a Tax Return that such entity may be subject to Taxes by that
jurisdiction, and to the Knowledge of the Company no other such claim has
been made.

  



  

(e)  No Audits are presently pending with regard to any Taxes
or Tax Returns of the Company or any Company Subsidiary. No
written notification has been received by the Company or any Company
Subsidiary that an Audit is pending or threatened with respect to any Taxes
due from or with respect to or attributable to the Company or any Company
Subsidiary or any Tax Return filed by or with respect to the Company or any
Company Subsidiary, and to the Knowledge of the Company, no other such
notification has been received by the Company or any Company Subsidiary.

  



  

(f)  All Tax deficiencies that have been claimed, proposed,
assessed or asserted against the Company or any Company Subsidiary have been
fully paid or finally settled.

  



  

(g)  The Company and each Company Subsidiary has complied in all
material respects with all applicable Laws relating to the withholding of
Taxes and the payment thereof to appropriate authorities, including Taxes
required to have been withheld and paid in connection with amounts paid or
owing to any employee, independent contractor, creditor, shareholder, or other
party (including, without limitation, withholding of Taxes pursuant to
Sections 1441 and 1442 of the Code or similar provisions under any
state, local, and foreign Laws) and have, within the time and the manner
prescribed by Law, withheld and paid over to the proper Governmental Entities
all amounts required to be so withheld and paid over under the applicable Tax
Laws.

  



  

(h)  The Company and each Company Subsidiary have collected all
material sales, use, value added and other Taxes required to be collected,
have remitted, or will remit within the time and in the manner prescribed by
law, all such amounts to the appropriate Governmental Entity, and have paid
all material sales, use, value added and other Taxes to the appropriate
Governmental Entity in cases where collection from another party was not
required.

  



  

(i)  Neither the Company nor any Company Subsidiary (i) is a
party to any Tax sharing, Tax indemnification, or Tax allocation Contract,
(ii) has been a member of an affiliated group filing a consolidated federal
income Tax Return (other than a group the common parent of which was the
Company), or (iii) is liable or responsible for the Tax Liability of any other
Person under Treasury Regulation Section 1.1502-6 or any corresponding or
similar provision of state, local or foreign Tax Law (other than the
liability of other members of the consolidated group of which the Company is
parent), as a withholding agent or collection agent, or as a transferee or
successor (other than customary indemnifications for Taxes contained in credit
or other commercial agreements the primary purposes of which do not relate to
Taxes).

  



   

17 
--- 

 


--- 

    

  

(j)  During the two-year period ending on the date hereof,
neither the Company nor any Company Subsidiary was a distributing corporation
or a controlled corporation in a transaction intended to be governed by
Section 355 of the Code.

  



  

(k)  To the Knowledge of the Company, neither the Company nor
any Company Subsidiary will be required to include any adjustment in taxable
income for any Tax period (or portion thereof) beginning after the Closing
Date pursuant to Section 481 of the Code (or any corresponding or similar
provision of state, local or foreign Tax Law).

  



  

2.12 _Labor Relations_.

  



  

(a)  The Company and each Company Subsidiary have complied in
all material respects with all Laws relating to the hiring of employees and
the employment of labor, including provisions thereof relating to wages,
hours, collective bargaining, employment discrimination, civil rights, safety
and health, workers' compensation, pay equity, classification of employees,
and the collection and payment of withholding and/or Social Security payments
and/or Taxes. To the Knowledge of the Company, neither the Company nor any
Company Subsidiary currently employs any Person who is not permitted to work
in the jurisdiction in which such Person is employed. The Company and each
Company Subsidiary have complied in all material respects with all Laws that
could require overtime to be paid to any current employee of the Company
and/or Company Subsidiaries. Since January 1, 2012, no current employee has
brought or threatened in writing or, to the Knowledge of the Company,
threatened orally to bring a material claim for unpaid compensation or
employee benefits, including overtime amounts, and no former employee has any
claim pending or threatened in writing or, to the Knowledge of the Company,
threatened orally to bring a material claim for unpaid compensation or
employee benefits, including, without limitation, overtime amounts.

  



  

(b)  Neither the Company nor any Company Subsidiary is
delinquent in payments to any of its current employees for any
material amount of wages, salaries, commissions, bonuses or other direct
compensation for any services performed by them or amounts required to be
reimbursed to such employees or in payments owed upon any termination of the
employment of any such employees.

  



  

(c)  Since January 1, 2012, there has not been an unfair labor
practice complaint made against the Company or any Company Subsidiary before
any Governmental Entity and no such complaint is pending.

  



  

(d)  Since January 1, 2012, there has not been a labor strike,
material dispute, slowdown or stoppage actually pending or, to the Knowledge
of the Company, threatened in writing against the Company or any Company
Subsidiary.

  



  

(e)  No labor union represents any employees of the Company or
any Company Subsidiary. To the Knowledge of the Company, no labor union has
taken any material action with respect to organizing the employees of the
Company or any Company Subsidiary. Neither the Company nor any Company
Subsidiary is party to or bound by any collective bargaining agreement or
union contract.

  



   

18 
--- 

 


--- 

    

  

(f)  All material sums due for employee compensation and
benefits have been duly and adequately accrued on the financial statements of
the Company to the extent required by GAAP applied on a consistent basis.

  



  

(g)  To the Knowledge of the Company, any individual who
performs or performed services for the Company or any Company Subsidiary and
who is not treated as an employee for U.S. federal income Tax purposes by the
Company or for income Tax purposes of the relevant jurisdiction of such
Company Subsidiary, is not an employee under applicable Laws.

  



  

(h)  To the Knowledge of the Company, as of the date hereof, no
officer or key employee presently intends to terminate their respective
employment with the Company or any Company Subsidiary, nor does the Company or
any Company Subsidiary have a present intention to terminate the employment
of any of the foregoing.

  



  

(i)  Except as set forth in _Section 2.12(i)_ of the Company
Disclosure Schedule, the employment of all Persons and officers currently
employed by the Company and any Company Subsidiary is terminable at will. All
material sums due for employee compensation and benefits and all accrued
vacation time owing to any employees of the Company or any Company Subsidiary
have been duly and adequately accrued on the accounting records of the
Company, in each case in accordance with GAAP applied on a consistent basis.

  



  

(j)  Except as set forth in _Section 2.12(j)_ of the Company
Disclosure Schedule, (i) each current or former employee, officer and
consultant of the Company and of each Company Subsidiary has executed a
proprietary information and inventions assignment agreement or similar
agreement whereby all Intellectual Property created by them in the scope of
their employment or other relationship with the Company or any Company
Subsidiary is assigned to the Company, and (ii) to the Knowledge of the
Company, none of the Company's or any Company Subsidiaries' current or former
employees, officers or consultants are in material violation thereof.

  



  

(k)  Since November 1, 2014, none of the Company or any Company
Subsidiary has taken any material action that would trigger notice or
liability under any state, local or foreign plant closing notice Law.

  



  

(l)  Prior to the date of this Agreement, each officer or
employee of the Company and of each Company Subsidiary listed in
_Section 2.12(l)_ of the Company Disclosure Schedule has entered into an
amendment to his or her employment agreement with the Company or such Company
Subsidiary, as applicable, substantially in the form attached hereto as
_Exhibit B_ , and each such employment agreement, as amended, is in full
force and effect.

  



  

2.13 _Employee Benefits Plans_.

  



  

(a)   _Section 2.13(a)_ of the Company Disclosure Schedule sets
forth an accurate and complete list of all "employee benefit plans" (as
defined in Section 3(3) of the Employee Retirement Income Security Act of
1974, as amended (" _ERISA_ "), including multiemployer plans within the
meaning of Section 3(37) of ERISA, each a " _Multiemployer Plan_ ")), whether
or not

  



  

   

19 
--- 

 


--- 

    



  

  

subject to ERISA, and any other bonus, profit sharing, compensation, pension,
severance, savings, deferred compensation, fringe benefit, insurance,
welfare, post-retirement health or welfare benefit, health, life, stock
option, restricted stock, company car, scholarship, relocation, disability,
accident, sick pay, sick leave, accrued leave, vacation, holiday, termination,
unemployment, individual employment, consulting, executive compensation,
incentive, commission, retention, change in control, non-competition, or
other plan, agreement, policy, trust fund, or arrangement (whether written or
unwritten, insured or self-insured) (i) currently established, maintained,
sponsored, or contributed to (or with respect to which any obligation to
contribute has been undertaken and currently exists) by the Company or any
Company Subsidiary on behalf of any employee, officer, director, consultant,
stockholder or other individual service provider of the Company or any
Company Subsidiary (in each case, whether current, former or retired) or
their dependents, spouses, or beneficiaries, or (ii) under which the Company
or any ERISA Affiliate has or may have any Liability, contingent or
otherwise, other than legally mandated benefit plans or arrangements. All such
plans, agreements, programs, policies, commitments and arrangements are
collectively referred to as the " _Plans_ ". For purposes of this _Section
2.13_, the term " _ERISA Affiliate_ " means any entity, including but not
limited to any corporation, partnership, limited liability company, sole
proprietorship, or other legal entity that, together with the Company, is
treated as a single employer under Sections 414(b), (c), (m) or (o) of the
Code or Section 4001(b)(1) of ERISA.

  



  

(b)  With respect to each Plan, the Company has provided or made
available to Parent complete and correct copies of (i) all plan documents,
trust agreements, insurance contracts or other funding arrangements, (ii) all
current summary plan descriptions, (iii) the most recent determination
letter, if applicable, (iv) for the three (3) most recent years (A) the Form
5500 and attached schedules, (B) any non-discrimination testing results and
(C) audited financial statements and actuarial valuation reports to the
extent applicable (v) material communications received from or sent to any
Governmental Entity relating to any ongoing compliance matter, and (vi) all
amendments to any such Plan.

  



  

(c)  With respect to each Plan: (i) each Plan has been
established, maintained and administered in all material respects
in accordance with its express terms and with the requirements of applicable
Law; (ii) each Plan which is intended to be qualified within the meaning of
Section 401(a) of the Code is so qualified and has received a favorable
determination letter, opinion letter, or advisory letter from the Internal
Revenue Service upon which it may rely as to its qualification, and nothing
has occurred, whether by action or failure to act, that could reasonably be
expected to cause the loss of such qualification; (iii) no event has occurred
and no condition exists that would subject the Company, either directly or by
reason of its affiliation with any ERISA Affiliate, to any material Tax,
fine, Lien, penalty or other Liability imposed by ERISA, the Code or other
applicable Laws; (iv) for each Plan with respect to which a Form 5500 has
been filed, no material change has occurred with respect to the
matters covered by the most recent Form since the date thereof; (v) except as
set forth in _Section 2.13(c)_ of the Company Disclosure Schedule, no Plan is
a split-dollar life insurance program; (vi) no Plan provides for loans to
executive officers (within the meaning of the Sarbanes Oxley Act of 2002);
(vii) no Plan is a "multiple employer welfare arrangement" (within the
meaning of Section 3(40)(A) of ERISA), or is funded through a trust intended
to be exempt from federal income Tax pursuant to

  



   

20 
--- 

 


--- 

    

  



  

Section 501(c)(9) of the Code; (viii) no Plan is maintained outside the
United States; (ix) there are no pending or, to the Company's Knowledge,
threatened actions, claims or lawsuits against or relating to the Plans, the
assets of any of the trusts under such arrangements or the sponsor or the
administrator, or against any fiduciary of the Plans with respect to the
operation of such arrangements (other than routine benefit claims); (x) no
Plan is under audit or, to the Company's Knowledge, investigation by any
Governmental Entity; (xi) all payments required to be made by the Company
under any Plan, any Contract, or by Law (including all contributions
(including all employer contributions and employee salary reduction
contributions), insurance premiums or intercompany charges) with respect to
all prior periods have been timely made or properly accrued and reflected in
the most recent consolidated balance sheet prior to the date hereof, in
accordance with the provisions of each Plan, applicable Law and GAAP; (xii)
there has been no amendment to, announcement by the Company relating to, or
change in employee participation or coverage under, any Plan which would
increase materially the expense of maintaining such Plan above the level of
the expense incurred therefor for the most recent fiscal year; (xiii) the
Company may amend or terminate each Plan (other than individual arrangements
or Plans required by applicable Law) at any time without incurring any
Liability thereunder other than in respect of claims incurred prior to such
amendment or termination and administrative expenses associated with such
termination; and (xiv) no Plan is a self-insured arrangement and no event has
occurred and no condition exists that could reasonably be expected to result
in a material increase in the premium costs of Plans that are fully-insured.

  



  

(d)  None of the Plans provide retiree health or life insurance
benefits except as may be required by Section 4980B of the Code and Section
601 of ERISA, any other applicable Law or at the expense of the participant or
the participant's beneficiary.

  



  

(e)  No Plan is (i) a Multiemployer Plan or other "employee
pension benefit plan" (within the meaning of Section 3(2) of ERISA) subject
to Title IV of ERISA; (ii) subject to the funding standards of Section 302 of
ERISA or Section 412 of the Code; or (iii) a multiple employer plan (within
the meaning of Section 413(c) of the Code), and neither the Company nor any
ERISA Affiliate has any obligation to contribute to, or has any actual or
contingent liability or obligation (including any obligation to make any
contribution) to or in respect of any such plan or any Multiemployer Plan.

  



  

(f)  Neither the execution and delivery of this Agreement nor
the consummation of the transactions contemplated hereby will (either alone
or in combination with another event): (i) result in any payment becoming due,
or increase the amount of any compensation or benefits due, to any current or
former employee, consultant or other service provider of the Company and the
Company Subsidiaries or with respect to any Plan; (ii) increase any benefits
otherwise payable under any Plan; (iii) result in the acceleration of the
time of payment or vesting, or result in any payment or funding (through a
grantor trust or otherwise), of any such compensation or benefits; or (iv)
result in the payment of any amount that would, individually or in
combination with any other such payment, be an "excess parachute payment"
within the meaning of Section 280G of the Code. No Person is entitled to
receive any additional payment (including any tax gross-up or other payment)
from the Company as a result of the

  



  

   

21 
--- 

 


--- 

    



  

  

imposition of the excise taxes required by Section 4999 of the Code, any
Taxes required by Section 409A of the Code, or as part of
severance arrangements.

  



  

(g)  With respect to each group health plan benefiting any
current or former employee of the Company or any ERISA Affiliate that is
subject to Section 4980B of the Code, the Company has substantially complied
with the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended,
and all other applicable Laws in all material respects.

  



  

2.14 _Environmental Matters_.

  



  

(a)  (i) The Company and the Company Subsidiaries comply, and
have complied in all material respects since January 1, 2012, with all
applicable Environmental Laws, which compliance includes the possession,
maintenance of, compliance with, and application for, all Environmental
Permits required under applicable Environmental Laws for the operation of the
business of the Company and the Company Subsidiaries; (ii) except as set
forth in _Section 2.14_ of the Company Disclosure Schedule, there have been
no Releases of Materials of Environmental Concern at any of the properties at
which the Company or any Company Subsidiary owns, leases or operates under
circumstances that are reasonably likely to result in liability of the Company
or the Company Subsidiaries under any applicable Environmental Law; (iii)
except as set forth in _Section 2.14_ of the Company Disclosure
Schedule, neither the Company nor any of the Company Subsidiaries have
produced, processed, manufactured, generated, transported, treated, handled,
used, stored, disposed of or Released any Materials of Environmental Concern;
(iv) except as set forth in _Section 2.14 _of the Company Disclosure
Schedule, neither the Company nor the Company Subsidiaries has received any
written notification alleging that it is liable for, or any written request
for information pursuant to Section 104(e) of the Comprehensive
Environmental Response, Compensation and Liability Act or similar U.S. state
statute concerning, any Release or threatened Release of Materials of
Environmental Concern at any location except, with respect to any such
notification or request for information concerning any such Release or
threatened Release, to the extent such notification or request for information
has been resolved with the appropriate Governmental Entity or otherwise; and
(v) except as set forth in _Section 2.14_ of the Company
Disclosure Schedule, neither the Company nor the Company Subsidiaries has
received any written claim, notice or complaint, and no Litigation is
pending, in each case that alleges a violation by or a liability of the
Company or the Company Subsidiaries of or under any Environmental Laws, and
to the Knowledge of the Company no such Litigation is threatened.

  



  

(b)  The representations and warranties contained in this
_Section 2.14_ are the sole representations of the Company relating to
Environmental Laws, Environmental Permits and Materials of Environmental
Concern.

  



  

2.15 _Intellectual Property_.

  



  

(a)  The Company and each of the Company Subsidiaries (i) own
all right, title and interest in and to the Owned Intellectual Property, a
true and complete list of which is set forth in _Section 2.15(a)_ of the
Company Disclosure Schedule or (ii) are licensed or otherwise possess
sufficient right to use and enforce all Owned Intellectual Property. All
trademarks,

  



  

   

22 
--- 

 


--- 

    



  

Copyrights, and Patents that are the subject of an application for
registration or a registration issued, filed with or recorded by any
Governmental Entity and included in the Owned Intellectual Property
(collectively, " _Company Registered Intellectual Property_ ") are set forth
in _Section 2.15(a)_ of the Company Disclosure Schedule. The Company
Registered Intellectual Property is valid, subsisting and enforceable (or in
the case of applications for registration thereof, properly applied for) and
held in the name of the Company or the Company Subsidiaries, and there has
been no final and unappealable decision from a court, patent office, or other
regulatory agency rendering any Company Registered Intellectual Property
invalid or unenforceable. For purposes of this Agreement, " _Intellectual
Property_ " shall mean: (i) patents, patent applications of any kind
(including, without limitation, provisional, utility, design, divisionals,
continuations, continuations in part and reissue applications and foreign
counterparts thereof), inventions, discoveries, inventor's certificates, and
invention disclosures (whether or not patented), and any renewals,
extensions, re-examinations, supplementary protection certificates or reissues
thereof, in any jurisdiction (" _Patents_ "); (ii) rights in registered and
unregistered trademarks, trade names, service marks, brand names,
certification marks, trade dress, logos, and other indications of origin, the
goodwill associated with the foregoing and registrations in any jurisdiction
of, and applications in any jurisdiction to register, the foregoing, including
any extension, modification or renewal of any such registration or
application; (iii) domain names, uniform resource locators and other names
and locators associated with the Internet, and any and all applications or
registrations therefor; (iv) all trade secrets, and other confidential
information, including, to the extent held as a trade secret or as
confidential information: technology, know how, data, processes, schematics,
business methods, formulae, drawings, designs, compositions of matter,
techniques, improvements, methods (including manufacturing methods), clinical
and regulatory strategies, formulations, manufacturing data and
processes specifications, manuals, research and development/clinical
proposals and proprietary customer and supplier lists, and all
documentation relating to any of the foregoing (" _Trade Secrets_ "); (v)
copyrighted and copyrightable writings, published and unpublished writings
and other works, whether copyrightable or not, in any jurisdiction,
registrations or applications for registration of copyrights in any
jurisdiction, designs, specifications, derivative works in any jurisdiction
for the foregoing, and any renewals or extensions thereof (" _Copyrights_ ");
(vi) claims or causes of action arising out of or related to past, present or
future infringement or misappropriation of the foregoing; and (vii) any and
all other intellectual property or similar type of proprietary rights
relating to any of the foregoing.

  



  

(b)  (i) To the Knowledge of the Company, there is no
unauthorized use, disclosure, infringement or misappropriation by any third
party of any of the Owned Intellectual Property, including by any employee or
former employee of any of the Company or any Company Subsidiary, (ii) to the
Knowledge of the Company, the conduct of the business of the Company and the
Company Subsidiaries (including the provision of the Company Services) as
currently conducted does not violate, infringe or misappropriate any
Intellectual Property of, or violate any Company Material Contract with, any
third party, (iii) there is no pending or, to the Knowledge of the Company,
threatened, claim or litigation against the Company or any Company Subsidiary,
contesting the validity, enforceability or ownership of the Owned
Intellectual Property or right of the Company or any Company Subsidiary to
exercise the rights therein, and (iv) is no claim or proceeding pending
against the Company, or to the Knowledge of

  



  

   

23 
--- 

 


--- 

    



  

the Company threatened, alleging that the Company or any Company Subsidiary
have infringed or misappropriated any Intellectual Property of any third
party.

  



  

(c)  Other than agreements between the Company and any Company
Subsidiary and their respective employees and consultants, non-
disclosure agreements entered into in the ordinary course of business
consistent with past practice, agreements for the use of
commercially available software, and service, support and maintenance
agreements entered into in the ordinary course of business consistent with
past practice, _Section 2.15(c)_ of the Company Disclosure Schedule sets
forth a complete list of all (i) material licenses, sublicenses and other
agreements in which the Company or any Company Subsidiary have granted to any
Person the right to make, use, sell, offer for sale, have made or import the
Owned Intellectual Property, (ii) material agreements, contracts or licenses
under which any of the Company or any Company Subsidiary is obligated to pay
fees or royalties to any Person in connection with the use of any
Intellectual Property, and (iii) all other material indemnifications,
forbearances to sue, settlement agreements and licensing or cross-licensing
arrangements to which the Company or any Company Subsidiary is a party
relating to the Intellectual Property.

  



  

(d)  To the Knowledge of the Company, no employee, independent
contractor, consultant or agent of the Company or any Company Subsidiary has
misappropriated any Trade Secrets of any other Person in the course of the
performance of his or her duties as an employee, independent contractor,
consultant or agent of the Company or any Company Subsidiary.

  



  

(e)  To the Knowledge of the Company, each employee of, or
consultant to, the Company Entities, that has performed services relevant to
the Owned Intellectual Property for the Company or any Company Subsidiary that
is material to the Company's or any Company Subsidiary's operations has
assigned to the Company or a Company Subsidiary any and all rights, title
and interest in and to such Intellectual Property.

  



  

(f)  To the Knowledge of the Company, the Company has taken
reasonable precautions customary in the territory and industry in which the
Company operates to protect the secrecy, confidentiality, and value of its
material Trade Secrets, that it intends to maintain as trade secrets under
applicable Laws and, to the Knowledge of the Company, such Trade Secrets have
not been divulged to any third party except pursuant to a properly executed
standard confidentiality and non-disclosure agreement or other
similar written obligations of confidentiality and, to the Knowledge of the
Company, no Person has breached such agreement.

  



  

(g)  No Owned Intellectual Property right will terminate or
cease to be a valid right of the Company by reason of the execution and
delivery of this Agreement by the Company, the performance of the Company of
its obligations hereunder, or the consummation by the Company of the
transactions contemplated by this Agreement.

  



  

(h)  Except as would not, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect, the Owned
Intellectual Property was not developed using any federal or university
funding, resources or staff and no government entity or university has any
rights to any of the Owned Intellectual Property.

  



   

24 
--- 

 


--- 

    

  

2.16 _Healthcare Regulatory and Related Matters_.

  



  

(a)  The Company and the Company Subsidiaries are and have
been, since January 1, 2010, in compliance in all material respects with (i)
all Laws (including all rules, regulations and policies) of CMS, FDA, OIG,
Drug Enforcement Administration (" _DEA_ ") and other Healthcare Regulatory
Authorities, including by way of example only, the Food, Drug, and Cosmetic
Act, the Public Health Service Act, the Health Insurance Portability and
Accountability Act of 1996, the Health Information Technology for Economic
and Clinical Health (HITECH) Act, the Federal Health Care Program Anti-
Kickback Act (Social Security Act  1128B(b)), the Anti-Inducement Act
(Social Security Act  1128A(a)(5)), the Ethics in Patient Referrals Act of
1989, as amended (Social Security Act  1877), the other provisions of the
Social Security Act and all implementing regulations, and (ii) all Healthcare
Regulatory Authorizations, including all requirements of CMS, FDA, DEA and
all other Healthcare Regulatory Authorities, that are applicable to the
Company and the Company Subsidiaries, or by which any property, product (if
any), service or other Asset of the Company and the Company Subsidiaries is
bound or affected.

  



  

(b)  Since January 1, 2010, neither the Company nor the Company
Subsidiaries has received any written notification of any pending or, to the
Knowledge of the Company, threatened, claim, suit, proceeding, hearing,
enforcement, audit, investigation, revocation of CLIA certification, any
certificate of accreditation issued by a CMS recognized accrediting
organization, revocation of any State or Federal license or permit,
suspension, exclusion, suspension of payments, imposition of prepayment
review, corrective action plan, civil money penalties, arbitration or other
action from any Healthcare Regulatory Authority.

  



  

(c)  Since January 1, 2013, the Company and the Company
Subsidiaries have held all material Healthcare Regulatory
Authorizations required for the conduct of their respective businesses, and
all such Healthcare Regulatory Authorizations are in full force and effect.
No event has occurred which allows, or after notice or lapse of time would
allow, revocation or termination thereof or results in any other impairment
of the material rights of the holder of any such Healthcare Regulatory
Authorization.

  



  

(d)  Section 2.16(d) of the Company Disclosure Schedule contains
a complete and accurate list of the top twenty (20) Laboratory Developed
Tests ("LDT"), as that term has been defined by the FDA in its 2014 Guidance
entitled "Framework for Regulatory Oversight of Laboratory Developed Tests,"
of the Company, based on the net consolidated revenue generated by each such
LDT during the Company's most recently completed fiscal year.

  



  

(e)  No notification has been received by any Company Entity
from any Regulatory Authority that would reasonably be expected to preclude
the Company from continuing to use such LDTs. No applications or notifications
made or other materials submitted by the Company Entities to any Regulatory
Authority contained an untrue statement of material fact, or omitted to state
a material fact required to be stated therein or necessary in order to make
the statements contained therein, in light of the circumstances under which
they were made, not misleading on a material matter.

  



  

   

25 
--- 

 


--- 

    



  

(f)  Neither the Company nor the Company Subsidiaries
manufacture, distribute, or use any medical device, drug or biologic
is required to be, but which has not been approved, cleared or waived by the
FDA and none of the Company's LDTs or any Company Service is the subject of
any clinical investigation under 21 C.F.R. pt. 312 or 21 C.F.R. pt. 812, or
otherwise.

  



  

(g)  Neither the Company nor any of the Company Subsidiaries has
received any material written information since January 1, 2010 from any
Healthcare Regulatory Authority with jurisdiction over the marketing, sale,
use, handling and control, safety, efficacy, reliability, manufacturing or
provision of Company Services or products offered or to be offered by the
Company, if any, which would reasonably be expected to lead to the
revocation, withdrawal, or denial of any application for marketing approval
before such Healthcare Regulatory Authority.

  



  

(h)  The Company has made available to Parent all material
reports, documents, claims, notices, filings, minutes,
transcripts, recordings and other material correspondence between the Company
and any of the Company Subsidiaries, on the one hand, and any Healthcare
Regulatory Authority, on the other hand, since January 1, 2013.

  



  

(i)  All material reports, documents, claims, applicable
registration files and dossiers, notices and similar filings required to be
filed, maintained, or furnished to any Healthcare Regulatory Authority by the
Company and the Company Subsidiaries since January 1, 2010 have been so
filed, maintained or furnished and, to the Knowledge of the Company, were
complete and correct in all material respects on the date filed (or were
corrected in or supplemented by a subsequent filing).

  



  

(j)  All clinical testing conducted by or on behalf of the
Company Entities is being conducted in material compliance with
requirements of CLIA and, as applicable, in accordance with Good Laboratory
Practices as set forth in 21 C.F.R. pt. 58.

  



  

(k)  (i) Neither the Company nor any of the Company Subsidiaries
has received any FDA Form 483, notice of adverse finding, warning letters,
untitled letters or other notices alleging a lack of safety from any
Healthcare Regulatory Authority, and (ii) there is no action or proceeding
pending or, to the Knowledge of the Company, threatened by any such Healthcare
Regulatory Authority, contesting the approval of, the uses of, or the
labeling (if any) or promotion of, or otherwise alleging any violation of
Law with respect to, a product if any, manufactured, distributed or marketed
by or on behalf of the Company or the Company Subsidiaries.

  



  

(l)  Neither the Company nor any of the Company Subsidiaries
is the subject of any pending or, to the Knowledge of the Company, threatened
investigation regarding the Company, the Company Subsidiaries, any Company
Services or products, if any, by the FDA pursuant to its " _Fraud, Untrue
Statements of Material Facts, Bribery, and Illegal Gratuities_ " Final
Policy set forth in 56 Fed. Reg. 46191 (Sept. 10, 1991) and any amendments
thereto, or otherwise. Neither the Company nor any of the Company
Subsidiaries, nor, to the Knowledge of the Company, any officer, employee,
agent or distributor of the Company or any Company

  



  

   

26 
--- 

 


--- 

    



  

  

Subsidiary, has committed or been convicted of any crime or engaged in any
conduct for which debarment is mandated by 21 U.S.C.  335a(a) or any similar
Law or authorized by 21 U.S.C.  335a(b) or any similar Law. Neither the
Company nor any of the Company Subsidiaries, nor, to the Knowledge of the
Company, any officer, employee, agent or distributor of the Company or any
Company Subsidiary, has been convicted of any crime or engaged in any conduct
for which such Person could be excluded from participating in the
federal health care programs under Section 1128 of the Social Security Act or
any similar Law. As of the date hereof, no claims, actions, proceedings or
investigations that would reasonably be expected to result in a material
debarment or exclusion of the Company is pending or, to the Knowledge of the
Company, threatened, against the Company or, to the Knowledge of the Company,
any of its directors, officers, employees or agents.

  



  

(m)  No Company Entity or any Affiliate thereof has taken or
agreed to take any action or has any Knowledge of any fact or
circumstance that the Company believes is reasonably likely to materially
impede or delay receipt of any Governmental Approvals necessary to consummate
the Merger or the other transactions contemplated by this Agreement.

  



  

(n)  Since January 1, 2010, neither the Company nor any of its
Subsidiaries nor any of their respective laboratories has been on "pre-
payment review" by any Medicare Administrative Contractor or by CMS, or a
corrective action plan with CMS or corporate integrity agreement with OIG.
Since January 1, 2010, except as listed in _Section 2.16(n)_ of the Company
Disclosure Schedule, no claim that has been submitted by or on behalf of the
Company or any of its Subsidiaries or any of their respective laboratories
is, to the knowledge of the Company, under or has been under reconsideration
pursuant to Social Security Act  1869(b). For any calendar year since 2009,
neither the Company nor any of its Subsidiaries nor any of their respective
laboratories has had total Medicare or Medicaid rates of disallowance of
claims or parts thereof that exceeded five percent of the total dollar value
of claims submitted to any payor.

  



  

(o)  Since January 1, 2008, neither the Company nor any of its
Subsidiaries nor any of their respective laboratories has received any Civil
Investigative Demand or subpoena from the Department of Justice or any OIG
subpoena or demand, nor does the Company have reason to suspect that it has
been named as a defendant in a False Claims Act case, whether sealed or
unsealed.

  



  

2.17 _Real Property_.

  



  

The Company has no Owned Real Property and the Company or a Company
Subsidiary has a valid leasehold interest in all of its Leased Real
Properties, free and clear of all Liens. Such Leased Real Property is
sufficient to conduct the Company's and the Company's Subsidiaries'
respective businesses as currently conducted in all material respects. The
Company has delivered to Parent a true and complete copy of each Lease to
each material Leased Real Property of the Company and the Company's
subsidiaries, and each amendment thereto, a true and complete list of which
is set forth in _Section 2.17_ of the Company Disclosure Schedule. Except as
may be limited by the Bankruptcy and Equity Exception, all such Leases are
valid and in full force and effect against the Company or any Company
Subsidiary party

  



   

27 
--- 

 


--- 

    

  



  

thereto and, to the Company's Knowledge, the counterparties thereto, in
accordance with their respective terms, and there is not, to the Company's
Knowledge, under any of such Leases, any existing Default by the Company or
any Company Subsidiary which would result in the termination of such Leases.

  



  

2.18 _Material Contracts_.

  



  

Each Company Material Contract is valid and binding on the Company and any of
the Company Subsidiaries to the extent the Company or such Subsidiary is a
party thereto, as applicable, and to the Knowledge of the Company, each other
party thereto, and is in full force and effect and enforceable in accordance
with its terms (subject to the Bankruptcy and Equity Exception), except those
which are cancelled, rescinded or terminated after the date of this Agreement
in accordance with their terms (and not as a result of a default by the
Company). The Company and each Company Subsidiary, and, to the Knowledge of
the Company, any other party thereto, has in all material respects performed
all obligations required to be performed by it under each Company Material
Contract. There is no Default under any Company Material Contract by the
Company or any Company Subsidiary with respect to its material
obligations thereunder, or, to the Knowledge of the Company, by any other
party thereto, and no event has occurred that with the lapse of time or the
giving of notice or both would constitute a material Default thereunder by the
Company or any Company Subsidiary or to the Knowledge of the Company, by any
other party thereto.

  



  

2.19 _Accounts Receivable_.

  



  

All accounts receivable and other amounts due the Company or any of its
Subsidiaries (" _Receivables_ ") are fairly reflected on its consolidated
balance sheet (the " _Most Recent Balance Sheet_ ") as of January 31, 2015
(the " _Most Recent Balance Sheet Date_ ") and in the records and books of
account of the Company or any of its Subsidiaries since the Most Recent
Balance Sheet Date have arisen in the ordinary course of business consistent
with past practice, represent enforceable obligations to the Company or its
Subsidiaries arising from sales actually made or services actually performed
and, subject only to consistently recorded contractual adjustments and
reserves for bad debts established in a manner consistent with past
practice, have been, or will be, current and collected or are, or will be,
collectible in the aggregate recorded amounts thereof in accordance with
their terms and are not and will not, be subject to any contests, claims,
counterclaims or setoffs. Since the Most Recent Balance Sheet Date there has
been no materially adverse change in the amount or collectability of the
Receivables or the related provisions or reserves from that reflected in the
Most Recent Balance Sheet. _Section 2.19_ of the Company Disclosure
Schedule contains a complete and accurate aging of all Receivables of the
Company and its Subsidiaries as of the Most Recent Balance Sheet Date setting
forth the (i) customer or third party payor names and (ii) the amounts owed by
each. Except as set forth in _Section 2.19_ of the Company Disclosure
Schedule, to the Knowledge of the Company, no account debtor has refused or
threatened to refuse to pay any material obligations to the Company or its
Subsidiaries, as applicable, for any reason, or has otherwise made a
material claim to set off or similar claim.

  



  

   

28 
--- 

 


--- 

    



  

2.20   _Insurance_.

  



  

The Company maintains for itself and the Company Subsidiaries insurance
policies covering the Company's property and equipment and director and
officer liability in such amounts, with such deductibles and against such
risks and losses as, in its judgment, are reasonable for the material
business and assets of the Company and the Company Subsidiaries. All of such
insurance policies are in full force and effect and neither the Company nor
any Company Subsidiary is in material default with respect to its
obligations under any of such insurance policies. Excluding insurance
policies that have expired and been replaced in the ordinary course of
business consistent with past practice, as of the date hereof, no threat in
writing has been made to cancel (excluding cancellation upon expiration or
failure to renew) any insurance policy of the Company and the Company
Subsidiaries during the period of one year prior to the date hereof, which
policy was not or could not be replaced without a material increase in premium
or reduction in coverage.

  



  

2.21   _Related Party Transactions_.

  



  

No current officer, director or Affiliate of the Company is a party to any
material agreement, contract, commitment or transaction with the Company or
the Company Subsidiaries or has any material interest in any material property
used by the Company or the Company Subsidiaries or is a Person that is a
party to any Contract or any Lease, in each case, that would be required to be
disclosed under Item 404 of regulation S-K of the Securities Act.

  



  

2.22   _Questionable Payments_.

  



  

Since January 1, 2010, neither the Company nor any of the Company
Subsidiaries nor, to the Knowledge of the Company, any director,
officer, agent, employee or other person associated with or acting on behalf
of the Company or any Company Subsidiary has (i) used any corporate funds for
any unlawful contribution, gift, entertainment, or other unlawful expense
relating to political activity; (ii) made any direct or indirect unlawful
payment to any foreign or domestic government official or employee from
corporate funds; (iii) violated or is in violation of any provision of the
Foreign Corrupt Practices Act of 1977, as amended, or any similar Law; or
(iv) made any bribe, rebate, payoff, influence payment, kickback or other
unlawful payment.

  



  

2.23   _Anti-Takeover Provisions_.

  



  

There is no shareholder rights plan, "poison pill" anti-takeover plan or
other similar device in effect to which the Company is a party or otherwise
bound. The Company has taken all actions necessary to render inapplicable to
this Agreement and the transactions contemplated hereby, including the
Merger, and inapplicable to Parent, Sub and the Company's capital stock in
connection with this Agreement and the transactions contemplated hereby,
including the Merger, any and all "fair price," "moratorium," "control share
acquisition," "business combination" and other similar Laws of the State of
New Jersey or any other state or jurisdiction, including the " _New Jersey
Shareholders ' Protection Act_" statutes set forth in Section 14A:10A-1 et
seq. of the NJBCA (collectively, the " _Anti-takeover Laws_ "), and no such
Anti-takeover Laws apply or will apply to this Agreement and the transactions
contemplated hereby, including the Merger.

  



   

29 
--- 

 


--- 

    

  

2.24   _Opinion of Financial Advisor_.

  



  

The Board has received the opinion of Allen and Company LLC (the " _Company
Financial Advisor_ "), to the effect that, as of the date of such opinion and
based on, and subject to the various assumptions, qualifications and
limitations set forth therein, the Exchange Ratio to be received by holders
of Company Common Stock pursuant to this Agreement is fair, from a financial
point of view, to such holders (other than any Parent Entity or any of their
respective Affiliates), and such opinion has not been modified or withdrawn
as of the date of this Agreement.

  



  

2.25   _Brokers and Finders_.

  



  

Except for the Company Financial Advisor, the fees of which will be paid by
the Company, no broker, investment banker, financial advisor or other Person
is entitled to any broker's, finder's, financial advisor's or other similar
fee in connection with the Merger and the other transactions contemplated
hereby based upon arrangements made by or on behalf of the Company or any
Company Subsidiary or Affiliate. The Company has made available to Parent a
true and complete copy of the engagement letter (including any amendments
thereto) with the Company Financial Advisor, which engagement letter (as so
amended, if applicable) sets forth all of the fees of the Company Financial
Advisor payable by the Company in connection with the Merger and the
other transactions contemplated hereby.

  



  

2.26   _Tax and Regulatory Matters_.

  



  

No Company Entity or, to the Knowledge of Company, any Affiliate thereof has
taken or agreed to take any action, and the Company does not have any
Knowledge of any agreement, plan or other circumstance that is reasonably
likely to (a) prevent the Merger from qualifying as a "reorganization" within
the meaning of Section 368(a) of the Code, or (b) to materially impede or
delay receipt of any of the Governmental Approvals which are conditions
precedents under _Section 5.1(c)_ of this Agreement.

  



  

Article 3 
  _Representations and Warranties of Parent and Sub_

  



  

Parent and Sub represent and warrant to the Company that, except as disclosed
in the Parent Disclosure Schedule or as disclosed in Parent's Annual Report
on Form 10-K for the fiscal year ended December 31, 2014 (including the
exhibits thereto) or in any Parent SEC Document filed subsequent to such Form
10-K but prior to the date of this Agreement, but without giving effect to any
amendment to any such Parent SEC Document filed on or after the date of this
Agreement and excluding any disclosures set forth in any section
entitled "risk factors" or constituting "forward-looking statements" or any
other statements that are similarly cautionary, predictive or forward-looking
in nature, except, in each case, other than historical information contained
therein:

  



   

30 
--- 

 


--- 

    

  

3.1 _Organization, Standing, and Power_.

  



  

(a)  Parent is a corporation duly incorporated and validly
existing under the laws of the State of Delaware and has all
requisite corporate power and authority necessary to own or lease all of its
Assets and to carry on its business as it is now being conducted. Parent is
duly qualified to do business and is in good standing in each jurisdiction in
which the nature of the business conducted by it or the character or location
of the Assets owned or leased by it makes such qualification necessary, except
as would not, individually or in the aggregate, reasonably be expected to
have a Parent Material Adverse Effect.

  



  

(b)  Each Parent Subsidiary is duly organized and validly
existing under the Laws of the jurisdiction of its organization and has all
requisite corporate power and authority necessary to own or lease all of its
Assets and to carry on its business as it is now being conducted. Each Parent
Subsidiary is duly qualified to do business and is in good standing in each
jurisdiction in which the nature of the business conducted by it or the
character or location of the Assets owned or leased by it makes such
qualification necessary, except as would not, individually or in the
aggregate, reasonably be expected to have a Parent Material Adverse Effect.

  



  

3.2 _Authority; Noncontravention; Voting Requirements_

  



  

(a)  Each of Parent and Sub has all necessary corporate right,
power and authority to execute and deliver this Agreement and, subject to the
adoption of this Agreement by Parent as the sole shareholder of Sub, to
perform its obligations hereunder and thereunder and to consummate the Merger
and the other transactions contemplated hereby. The execution, delivery and
performance by each of Parent and Sub of this Agreement and the consummation
of the Merger and the other transactions contemplated hereby by Parent
and Sub have been duly and validly authorized by their respective boards of
directors and, other than Parent's adoption of this Agreement in its capacity
as the sole shareholder of Sub, no other corporate proceedings or approvals on
the part of Parent or Sub are necessary to authorize the execution, delivery
and performance by each of Parent and Sub of this Agreement or the
consummation by Parent and Sub of the transactions contemplated hereby (other
than, with respect to the Merger, the filing of the Certificate of Merger).
Each of Parent and Sub has duly and validly executed and delivered this
Agreement and, assuming the due authorization, execution and delivery by the
other parties thereto, such agreements constitute valid and binding
obligations of each of Parent and Sub, as applicable, enforceable against
each of them in accordance with their respective terms, subject, in each case,
to the Bankruptcy and Equity Exception.

  



  

(b)  Neither the execution and delivery of this Agreement by
Parent and Sub nor the consummation of the Merger and the other transactions
contemplated hereby by Parent and Sub, as applicable, nor compliance by each
of Parent and Sub, as applicable, with any of the terms or provisions hereof,
as applicable, will (i) conflict with or violate any provision of the
Organizational Documents of Parent or Sub, (ii) assuming that each of the
consents, authorizations and approvals referred to in _Section 2.5_, 
_Section 3.2_ and the Required Company Vote is obtained (and any condition
precedent to any such consent, authorization or approval has been satisfied)
and each of the filings referred to in _Section 2.5_ and _Section 3.2 _are
made and any

  



  

   

31 
--- 

 


--- 

    



  

  

applicable waiting periods referred to therein have expired, conflict with or
violate any Law, judgment, writ or injunction of any Governmental Entity
applicable to Parent or Sub or by which any of their Assets are bound or
affected, or (iii) result in any breach of or constitute a Default under,
result in the loss of a benefit under or give rise to any right of
termination, amendment, acceleration, payment or cancellation of any Contract
to which any Parent Entity is a party, or result in the creation of a Lien on
any of the Assets of Parent or Sub, other than, in the case of clauses (ii)
or (iii), as would not, individually or in the aggregate, reasonably be
expected to have a Parent Material Adverse Effect.

  



  

3.3 _Required Filings and Consents_.

  



  

Except for the Governmental Approvals, no consents or approvals of, Permits
from or filings, declarations or registrations with, any Governmental Entity
are necessary for the execution and delivery of this Agreement by Parent and
Sub and the consummation by Parent and Sub of the Merger and the other
transactions contemplated hereby, other than as would not, individually or in
the aggregate, have or reasonably be expected to have a Parent Material
Adverse Effect or materially delay or materially impair the ability of Parent
or Sub to consummate the transactions contemplated hereby.

  



  

3.4 _Capital Stock_.

  



  

(a) The authorized capital stock of Parent consists of (i)
750,000,000 shares of Parent Common Stock, of which 464,411,844 shares were
issued and 463,291,477 shares were outstanding at the close of business on
June 2, 2015, and (ii) 10,000,000 shares of preferred stock of Parent, of
which no shares were issued and outstanding at the close of business on June
2, 2015. As of the date of this Agreement, no more than 24,970,984 shares of
Parent Common Stock are subject to Parent Options in respect of Parent Common
Stock and no more than 10,353,181 shares of Parent Common Stock are reserved
for future grants under the Parent Stock Plan. Upon any issuance of any shares
of Parent Common Stock in accordance with the terms of the Parent Stock Plan,
such shares will be duly and validly issued and fully paid and nonassessable.
As of the date of this Agreement, no more than 2,253,902 shares of Parent
Common Stock are issuable upon the exercise of Parent Warrants. As of the
date of this Agreement, no more than 6,680,773 shares of Parent Common Stock
are issuable upon the conversion of Parent's 3.00% convertible senior notes
due 2033 (the " _Parent Notes_ "). Except for Parent Options, Parent Warrants
and the Parent Notes, there are on the date hereof no outstanding (i)
securities of Parent convertible into, exercisable or exchangeable for shares
of capital stock or voting securities or ownership interests in Parent, and
(ii) options, warrants, rights or other agreements or commitments requiring
Parent to issue, or other obligations of Parent to issue, any capital stock,
voting securities or other ownership interests in (or securities convertible
into or exchangeable for capital stock or voting securities or other
ownership interests in) Parent (or, in each case, the economic equivalent
thereof). No Parent Entity owns any capital stock of Parent.

  



  

(b)  All of the issued and outstanding shares of Parent Common
Stock are, and all of the shares of Parent Common Stock to be issued in
exchange for shares of Company Common Stock upon consummation of the Merger,
when issued in accordance with the terms of this Agreement, will be duly and
validly issued and outstanding and fully paid and nonassessable

  



  

   

32 
--- 

 


--- 

    



  

  

under the General Corporation Law of the State of Delaware. None of the
shares of Parent Common Stock to be issued in exchange for shares of Company
Common Stock upon consummation of the Merger will be issued in violation of
any preemptive rights.

  



  

3.5 _Parent Subsidiaries_.

  



  

Parent or one of its wholly owned Subsidiaries owns all of the issued and
outstanding shares of capital stock (or other equity interests) of each
Parent Subsidiary, free and clear of any Lien, and there are no irrevocable
proxies with respect to any such shares. There are no outstanding (i)
securities of Parent or any Parent Subsidiary convertible into or exchangeable
for shares of capital stock or other voting securities or ownership interests
in any Parent Subsidiary, (ii) options, restricted stock, warrants, rights or
other agreements or commitments to acquire from Parent or any Parent
Subsidiary, or obligations of Parent or any Parent Subsidiary to issue, any
capital stock, voting securities or other ownership interests in (or
securities convertible into or exchangeable for capital stock or voting
securities or other ownership interests in) any Parent Subsidiary, (iii)
obligations of Parent or any Parent Subsidiary to grant, extend or enter into
any subscription, warrant, right, convertible or exchangeable security or
other similar agreement or commitment relating to any capital stock, voting
securities or other ownership interests in any Parent Subsidiary (the items
in clauses (i), (ii) and (iii), together with the capital stock of such Parent
Subsidiaries, being referred to collectively as " _Parent Securities_ "), or
(iv) obligations of Parent or any Parent Subsidiary to make any payment based
on the value of any shares of any Parent Subsidiary. There are no outstanding
obligations of Parent or any Parent Subsidiary to purchase, redeem or
otherwise acquire any outstanding Parent Securities. There are no voting
trusts or other Contracts to which Parent or any Parent Subsidiary is a party
with respect to the voting of capital stock (or other equity interests) of
any Company Subsidiary. All Parent Securities of any Parent Subsidiary
incorporated or formed in a jurisdiction located within the United States of
America are duly authorized, validly issued, fully paid and nonassessable.

  



  

3.6 _SEC Filings; Financial Statements_.

  



  

(a)  Parent has timely filed all SEC Documents required to be
filed by Parent since January 1, 2012 (the " _Parent SEC Reports_ "). The
Parent SEC Reports (i) at the time filed, complied in all material respects
with the applicable requirements of the Securities Laws and other applicable
Laws, except to the extent updated, amended, restated or corrected by a
subsequent SEC Document filed or furnished to the SEC by Parent and (ii) did
not, at the time they were filed (or, if amended or superseded by a filing
prior to the date of this Agreement, then on the date of such filing or, in
the case of registration statements, at the effective date thereof, and in
the case of proxy statements, at the date of the mailing of such proxy
statement) contain any untrue statement of a material fact or omit to state a
material fact required to be stated in such Parent SEC Reports or necessary
in order to make the statements in such Parent SEC Reports, in light of the
circumstances under which they were made, not misleading. As of the date of
this Agreement, there are no outstanding or unresolved comments in comment
letters received from the SEC staff with respect to the Parent SEC Reports and
(ii) to the Knowledge of Parent, none of the Parent SEC Reports is the
subject of ongoing SEC review, outstanding SEC comment or outstanding SEC
investigation. No Parent Subsidiary is required to file any SEC Documents.

  



  

   

33 
--- 

 


--- 

    



  

(b)  Each of the Parent Financial Statements (including, in each
case, any related notes) contained in the Parent SEC Reports, including any
Parent SEC Reports filed after the date of this Agreement until the Effective
Time, complied as to form in all material respects with the applicable
published rules and regulations of the SEC with respect thereto, was prepared
in accordance with GAAP applied on a consistent basis for the periods
presented (except as may be indicated in the notes to such financial
statements or as permitted by Regulation S-X), and presented fairly in all
material respects the consolidated financial position of Parent and its
consolidated Subsidiaries as of the respective dates thereof and the
consolidated results of operations and cash flows for the periods indicated.

  



  

(c)  Since January 1, 2012, Parent and each Parent Entity has
had in place "disclosure controls and procedures" (as defined in Rules
13a-15(e) and 15d-15(e) of the Exchange Act) reasonably designed and
maintained to ensure that all information (both financial and non-financial)
required to be disclosed by Parent in the Parent SEC Reports is recorded,
processed, summarized and reported within the time periods specified in the
rules and forms of the SEC, and that such information is accumulated
and communicated to Parent's management as appropriate to allow timely
decisions regarding required disclosure and to make the certifications of the
chief executive officer and chief financial officer of Parent required under
the Exchange Act with respect to such reports.

  



  

(d)  Parent has designed and maintains a system of "internal
control over financial reporting" (as defined in Rules 13a-15(f) and
15d-15(f) of the Exchange Act) sufficient to provide reasonable assurances
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP.

  



  

(e)  Neither Parent nor any of the Parent Subsidiaries is a
party to, or has any commitment to become a party to, any joint venture, off-
balance sheet partnership or any similar Contract (including any Contract
relating to any transaction or relationship between or among Parent or any
Parent Subsidiary, on the one hand, and any unconsolidated
Affiliate, including any structured finance, special purpose or limited
purpose entity or Person, on the other hand), or any "off-balance sheet
arrangements" (as defined in Item 303(a) of Regulation S-K of the SEC), where
the result, purpose or intended effect of such Contract is to avoid
disclosure of any material transaction involving, or material liabilities of,
Parent or any Parent Subsidiary in the Parent SEC Reports.

  



  

3.7   _Absence of Undisclosed Liabilities_.

  



  

No Parent Entity has incurred any Liability, including those arising under
any Law and those arising under any Contract, except (i) such Liabilities
incurred after December 31, 2014 in the ordinary course of business consistent
with past practice, (ii) in connection with this Agreement and the
transactions contemplated hereby, (iii) such Liabilities that are reflected or
reserved against in the consolidated balance sheets of Parent as of December
31, 2014, included in the Parent SEC Reports, or (iv) as is not
reasonably likely to have a Parent Material Adverse Effect.

  



   

34 
--- 

 


--- 

    

  

3.8   _Absence of Certain Changes or Events_.

  



  

(a)  Since December 31, 2014, there has not been any state of
facts, change, event, effect or occurrence that has had, or that would
reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect.

  



  

(b)  Since December 31, 2014, Parent has carried on its
businesses only in the ordinary course consistent with past practice.

  



  

3.9   _Tax Matters_.

  



  

Except as set forth in the applicable subsection of _Section 3.9_ of the
Parent Disclosure Schedule:

  



  

(a)  The Parent Entities have timely filed with the appropriate
taxing authorities all material Tax Returns in all jurisdictions in which
such Tax Returns are required to be filed and such Tax Returns are correct and
complete in all material respects. The Parent Entities are not the
beneficiary of any extension of time within which to file any Tax Return
(other than any extensions to file Tax Returns obtained in the ordinary
course consistent with past practice). All material Taxes of the Parent
Entities (whether or not shown on any Tax Return) if required to have been
paid, have been paid (except for Taxes which are being contested in good
faith) or reserved for on the Parent's financial statements. Any Liability of
the Parent Entities for accrued Taxes not yet due and payable, or which are
being contested in good faith, has been provided for in the financial
statements of the Parent Entities to the extent required by and in accordance
with GAAP. There are no Liens for any material amount of Taxes (other than a
Lien for Taxes not yet due and payable or for which are being contested in
appropriate proceedings) on any of the Assets of the Parent Entities. No
claim has ever been made in writing which is currently pending by an authority
in a jurisdiction where any Parent Entity does not file a Tax Return that
such Parent Entity may be subject to Taxes by that jurisdiction.

  



  

(b)  None of the Parent Entities has received any written notice
of assessment or proposed assessment in connection with any material amount
of Taxes which is currently pending, and there are no threatened in writing or
pending disputes, claims, audits or examinations regarding any Taxes of any
Parent Entity. None of the Parent Entities has waived any statute of
limitations in respect of any Taxes which are currently pending.

  



  

(c)  Except as would not, individually or in the aggregate,
reasonably be expected to have a Parent Material Adverse Effect, all Tax
deficiencies that have been claimed, proposed, assessed or asserted against
the Parent Entities have been fully paid or finally settled.

  



  

(d)  Each Parent Entity has complied in all material respects
with all applicable Laws relating to the withholding of Taxes and the payment
thereof to appropriate authorities, including Taxes required to have been
withheld and paid in connection with amounts paid or owing to any employee,
independent contractor, creditor, stockholder, or other party (including,
without limitation, withholding of Taxes pursuant to Sections 1441 and 1442
of the Code or similar

  



  

   

35 
--- 

 


--- 

    



  



  

provisions under any state, local, and foreign Laws) and have, within the
time and the manner prescribed by law, withheld and paid over to the proper
Governmental Entities all amounts required to be so withheld and paid over
under the applicable Tax Laws.

  



  

3.10   _Environmental Matters_.

  



  

(a)  (i) Each Parent Entity complies, and has complied in all
material respects since January 1, 2012, with all applicable
Environmental Laws, which compliance includes the possession, maintenance of,
compliance with, and application for, all Environmental Permits required
under applicable Environmental Laws for the operation of the business of the
Parent Entities; (ii) except as set forth in _Section 3.10_ of the Parent
Disclosure Schedule, there have been no Releases of Materials of Environmental
Concern at any of the properties which any Parent Entity owns, leases or
operates under circumstances that are reasonably likely to result in
liability of any Parent Entity under any applicable Environmental Law; (iii),
except as set forth in _Section 3.10_ of the Parent Disclosure Schedule no
Parent Entity has produced, processed, manufactured, generated, transported,
treated, handled, used, stored, disposed of or Released any Materials of
Environmental Concern; (iv) except as set forth in _Section 3.10 _of the
Parent Disclosure Schedule, no Parent Entity has received any written
notification alleging that it is liable for, or any written request for
information pursuant to Section 104(e) of the Comprehensive Environmental
Response, Compensation and Liability Act or similar U.S. state statute
concerning, any Release or threatened Release of Materials of Environmental
Concern at any location except, with respect to any such notification or
request for information concerning any such Release or threatened Release, to
the extent such notification or request for information has been resolved with
the appropriate Governmental Entity or otherwise; and (v) except as set forth
in _Section 3.10_ of the Parent Disclosure Schedule, no Parent Entity has
received any written claim, notice or complaint, and no Litigation is pending,
in each case that alleges a violation by or a liability of any Parent Entity
of or under any Environmental Laws, and to the Knowledge of the Parent no such
Litigation is threatened.

  



  

(b)  The representations and warranties contained in this
_Section 3.10_ are the sole representations of the Parent relating to
Environmental Laws, Environmental Permits and Materials of Environmental
Concern.

  



  

3.11   _Intellectual Property_.

  



  

(a)  Parent and the Parent Subsidiaries (i) own all right,
title and interest in and to the Parent Owned Intellectual Property material
to the conduct of their respective businesses or (ii) are licensed or
otherwise possess sufficient right to use and enforce all Parent Owned
Intellectual Property. The Parent Registered Intellectual Property is valid,
subsisting and enforceable (or in the case of applications for registration
thereof, properly applied for) and held in the name of Parent or the Parent
Subsidiaries, and there has been no final and unappealable decision from a
court, patent office, or other regulatory agency rendering any
Parent Registered Intellectual Property invalid or unenforceable other than
exceptions that would not materially affect the business of Parent and the
Parent Subsidiaries taken as a whole.

  



  

   

36 
--- 

 


--- 

    



  



  

(b)  Except as set forth in _Section 3.11(b)_ of the Parent
Disclosure Schedule, (i) to the Knowledge of Parent, there is no unauthorized
use, disclosure, infringement or misappropriation by any third party of any of
the Parent Owned Intellectual Property, including by any employee or former
employee of any of Parent or any Parent Subsidiary; (ii) to the Knowledge of
the Parent, neither Parent's use, development, manufacture, marketing,
license, or sale of any Parent Product/Service currently licensed, utilized,
sold, provided or furnished by Parent or any Parent Subsidiary nor the conduct
of the business of Parent and the Parent Subsidiaries as currently conducted
violates, infringes or misappropriates any Intellectual Property of, or
violates any material Contract with, any third Person; (iii) to the Knowledge
of Parent, the manufacture, sale, offer for sale, use, or importation of any
Parent Product/Service, following any FDA approval or clearance of the same,
will not infringe or misappropriate any Intellectual Property of any third
Person; (iv) there is no pending or, to the Knowledge of Parent, threatened,
claim or litigation against Parent or any Parent Subsidiary, contesting the
validity, enforceability or ownership of the Parent Owned
Intellectual Property or right of Parent or any Parent Subsidiary to exercise
the rights therein; and (v) there is no claim or proceeding pending against
Parent, or to the Knowledge of Parent threatened, alleging that Parent or any
Parent Subsidiary by the use or sale of any Parent Product/Service have
infringed or misappropriated any Intellectual Property of any third party.

  



  

(c)  No employee, independent contractor, consultant or agent
of Parent or any Parent Subsidiary has misappropriated any Trade Secrets of
any other Person in the course of the performance of his or her duties as an
employee, independent contractor, consultant or agent of Parent or any Parent
Subsidiary.

  



  

(d)  Each employee of, or consultant to, Parent or any Parent
Subsidiary, that has performed services relevant to the Parent Owned
Intellectual Property for Parent or any Parent Subsidiary that is material to
Parent's or any Parent Subsidiary's operations has assigned to Parent or a
Parent Subsidiary any and all rights, title and interest in and to such
Intellectual Property.

  



  

(e)  To the Knowledge of Parent, Parent has taken reasonable
precautions customary in the territory and industry in which Parent operates
to protect the secrecy, confidentiality, and value of its material Trade
Secrets, that it intends to maintain as trade secrets under applicable Laws
and, to the Knowledge of Parent, such Trade Secrets have not been divulged to
any third party except pursuant to a properly executed standard
confidentiality and non-disclosure agreement or other similar written
obligations of confidentiality and, to the Knowledge of Parent, no Person has
breached such agreement.

  



  

(f)  No Parent Owned Intellectual Property right will terminate
or cease to be a valid right of Parent by reason of the execution and
delivery of this Agreement by Parent, the performance of Parent of its
obligations hereunder, or the consummation by Parent of the transactions
contemplated by this Agreement.

  



  

(g)  Except as would not, individually or in the aggregate,
reasonably be expected to have a Parent Material Adverse Effect, the Parent
Owned Intellectual Property was

  



  

   

37 
--- 

 


--- 

    



  



  

not developed using any federal or university funding, resources or staff and
no government entity or university has any rights to any of the Parent Owned
Intellectual Property.

  



  

3.12  Regulatory and Related Matters.

  



  

(a)  Each Parent Entity holds all Permits, variances,
registrations, exemptions, Orders and other governmental
authorizations, consents, approvals and clearances, including all
authorizations under the Federal Food, Drug and Cosmetic Act of 1938, the
Public Health Service Act of 1944, and the regulations of the FDA promulgated
thereunder, from any Governmental Entity that is concerned with the quality,
identity, strength, purity, safety, efficacy or manufacturing of Parent
Products/Services and that in any such case is material to the conduct of
their respective businesses as they are now being conducted (any such
Governmental Entity, a " _Parent Regulatory Agency_ ") necessary for the
lawful operating of the businesses of Parent or any of its Subsidiaries (the
" _Parent Permits_ "), and all such Parent Permits are valid, and in full
force and effect. Since January 1, 2012, there has not occurred any violation
of, default (with or without notice or lapse of time or both) under, or event
giving to others any right of termination, amendment or cancellation of, with
or without notice or lapse of time or both, any Parent Permit. Parent and
each of its Subsidiaries are in compliance in all material respects with the
terms of all Parent Permits, and no event has occurred that would reasonably
be expected to result in the revocation, cancellation, non-renewal or adverse
modification of any Parent Permit, except as would not be material to the
conduct of Parent's and each of its Subsidiaries' respective businesses.

  



  

(b)  Since January 1, 2013, all applications, submissions,
information and data utilized by Parent or Parent's Subsidiaries as the basis
for, or submitted by or, to the Knowledge of Parent, on behalf of Parent or
Parent's Subsidiaries in connection with, any and all requests for a Parent
Permit relating to Parent or any of its Subsidiaries, and its respective
business and Parent Products/Services, when submitted to the FDA or other
Parent Regulatory Agency, were true and correct in all material respects as
of the date of submission, and any updates, changes, corrections or
modification to such applications, submissions, information and data required
under applicable Laws have been submitted to the FDA or other Parent
Regulatory Agency.

  



  

(c)  Since January 1, 2012, neither Parent, nor any of its
Subsidiaries, has committed any act, made any statement or failed to make any
statement that would reasonably be expected to provide a basis for the FDA or
any other Parent Regulatory Agency to invoke its policy with respect to
"Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities",
or similar policies, set forth in any applicable Laws, except as would not,
individually or in the aggregate, reasonably be expected to be material to
Parent and the Parent Subsidiaries taken as a whole.

  



  

3.13   _Compliance with Laws_.

  



  

Since January 1, 2012, the Parent Entities have been and currently are in
compliance in all material respects with all Laws and all Orders, in each
case applicable to any Parent Entity. Since January 1, 2012, each Parent
Entity has held and currently holds all material Permits reasonably necessary
for the conduct of their respective businesses as they are now being

  



  

   

38 
--- 

 


--- 

    



  



  

conducted and such Permits are valid and in full force and effect. (i) No
revocation or cancellation of any such material Permit is pending, and (ii)
since January 1, 2012 no Parent Entity has received any written, or to the
Knowledge of the Parent, oral, notice from any Governmental Entity
threatening to revoke or cancel any such Permit or threatening any adverse
action with respect to any such Permit. Since January 1, 2012, each Parent
Entity is in compliance in all material respects with the terms of such
Permits.

  



  

3.14   _Material Contracts_.

  



  

No Parent Entity is a party to any Contract or amendment thereto that would
be required to be, and has not been, filed as an exhibit to a SEC Report
filed by Parent with the SEC as of the date of this Agreement. With respect to
any Contract or amendment thereto required to be filed as an exhibit to a SEC
Report filed by Parent with the SEC: (i) the Contract is in full force and
effect, except those which are cancelled, rescinded or terminated after the
date of this Agreement in accordance with their terms (and not as a result of
a Default by Parent) and subject to the Bankruptcy and Equity Exception; (ii)
no Parent Entity has failed to perform all of its material obligations
thereunder, (iii) no Parent Entity is in Default thereunder; and (iv) no other
party to any such Contract is, to the Knowledge of Parent, in Default in any
respect or has repudiated or waived any material provision thereunder.

  



  

3.15   _Tax and Regulatory Matters_.

  



  

No Parent Entity or, to the Knowledge of Parent, any Affiliate thereof has
taken or agreed to take any action, and Parent does not have any Knowledge of
any agreement, plan or other circumstance, that is reasonably likely to (i)
prevent the Merger from qualifying as a "reorganization" within the meaning
of Section 368(a) of the Code, or (ii) materially impede or delay receipt of
any of the Governmental Approvals.

  



  

3.16   _Litigation_.

  



  

As of the date hereof and at any time since January 1, 2012, except in each
case as would not, individually or in the aggregate, reasonably be expected
to be material to Parent and the Parent Subsidiaries taken as a whole, or as
set forth in _Section 3.16 _of the Parent Disclosure Schedule, (i) there is
no and has not been any Litigation instituted or pending, or, to the
Knowledge of Parent, threatened against Parent or its Assets and (ii) neither
Parent nor Sub nor any of their respective Assets is or has been subject, or,
to the Knowledge of Parent, threatened to be subject, to any outstanding
Order.

  



  

3.17   _Information Supplied_.

  



  

(a)  None of the information supplied or to be supplied by or
on behalf of Parent or Sub and included or incorporated by reference in the
Registration Statement to be filed by Parent with the SEC will, when the
Registration Statement becomes effective, contain an untrue statement of a
material fact, or omit to state any material fact necessary to make the
statements therein, in light of the circumstances under which they are made,
not misleading.

  



  

   

39 
--- 

 


--- 

    



  



  

(b)  None of the information supplied or to be supplied by or on
behalf of Parent or Sub and included or incorporated by reference in (i) the
Proxy Statement/Prospectus to be mailed to the Company's shareholders
including any amendment or supplement thereto or (ii) any other documents to
be filed by Parent or any of its Affiliates with the SEC or any other
Regulatory Authority in connection with the transactions contemplated hereby
(including the Required Filings) will, at the respective time such
documents are filed, and with respect to the Proxy Statement/Prospectus, when
first mailed, distributed or disseminated to the shareholders of the Company,
contain any untrue statement of a material fact, or omit to state any material
fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading, or, in the case of the Proxy Statement/Prospectus or any
amendment thereof or supplement thereto, at the time of the Company
Shareholders' Meeting to consider the Merger contain any untrue statement of
a material fact, or omit to state any material fact required to be stated
therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading.

  



  

(c)  All documents that Parent and its Affiliates are
responsible for filing with any Regulatory Authority in connection with the
transactions contemplated hereby will comply as to form in all material
respects with the provisions of applicable Law, including the provisions of
the Securities Act, the Exchange Act and the rules and regulations promulgated
by the SEC thereunder.

  



  

3.18   _Brokers and Finders_.

  



  

Except for J.P. Morgan Securities LLC, the fees of which will be paid by the
Parent, no broker, finder or investment banker is entitled to any brokerage,
finder's or other fee or commission from Parent or any Parent Subsidiary in
connection with this Agreement or the transactions contemplated hereby.

  



  

3.19   _Ownership and Operations of Sub_.

  



  

Parent, directly or indirectly, owns all of the outstanding capital stock of
Sub. Sub was formed solely for the purpose of engaging in the Merger and the
transactions contemplated hereby and has engaged in no other business
activities or conducted any other operations other than those relating to the
Merger and the transactions contemplated hereby.

  



  

3.20   _Ownership of Company Common Stock_.

  



  

Neither Parent, Sub nor any Affiliate of Parent or Sub, beneficially owns
(within the meaning of either Section 13 of the Exchange Act and the rules
and regulations promulgated thereunder or Section 14A:10A-3 of the NJBCA), or
will prior to the Effective Time beneficially own any shares of Company
Common Stock, or is, or will be prior to the Effective Time, a party to any
contract, arrangement or understanding (other than this Agreement and the
other agreements contemplated herein) for the purpose of acquiring,
holding, voting or disposing of any shares of Company Common Stock.

  



  

   

40 
--- 

 


--- 

    



  



  

Article 4 
  _Conduct of Business Pending Consummation_

  



  

4.1   _Affirmative Covenants of the Company_.

  



  

From the date of this Agreement until the earlier of the Effective Time, or
the termination of this Agreement in accordance with _Section 6.1_, except
as contemplated or permitted by this Agreement, as set forth on the Company
Disclosure Schedule, as required by applicable Law, or unless the prior
written consent of Parent shall have been obtained (which shall not be
unreasonably withheld, conditioned or delayed), the Company shall, and shall
cause each Company Subsidiary to: (a) operate its business in the ordinary
course consistent with past practice; (b) use its reasonable efforts to
preserve intact its business organization and material Assets and
maintain its rights and franchises and keep available the services of present
employees, consultants, independent contractors and executive officers of the
Company and the Company Subsidiaries; (c) notify Parent promptly after receipt
of any material communication (written or oral) between the Company or any of
the Company Subsidiaries, on the one hand, and any Healthcare Regulatory
Authority, on the other hand, and before giving any material submission to
any Healthcare Regulatory Authority; and (d) take no action that would
reasonably be likely to materially adversely affect the ability of any Party
to consummate the transactions contemplated hereby on the terms and subject
to the conditions set forth herein. The Company further agrees to consult with
Parent in connection with the implementation of any new or significantly
revised billing system by the Company or any Company Subsidiary.

  



  

4.2   _Negative Covenants of the Company_.

  



  

From the date of this Agreement until the earlier of the Effective Time or
the termination of this Agreement in accordance with _Section 6.1_, unless
the prior written consent of Parent shall have been obtained (which consent
shall not be unreasonably withheld, conditioned or delayed), except as set
forth in _Section 4.2_ of the Company Disclosure Schedule, except as
otherwise expressly contemplated herein, and except as required by applicable
Law, the Company covenants and agrees that it will not do or agree or commit
to do, or permit any of the Company Subsidiaries to do or agree or commit to
do, any of the following:

  



  

(a)  amend the Organizational Documents of any Company Entity;

  



  

(b)  incur any debt obligation or other obligation for borrowed
money (other than (i) indebtedness of one wholly owned Company Entity to the
Company or a wholly owned Company Entity, (ii) trade payables incurred in the
ordinary course of business consistent with past practice, (iii) borrowing in
the ordinary course of business consistent with past practice under the
Company's amended revolving note payable loan agreement in effect as of the
date hereof or (iv) capital leases for equipment entered into in the ordinary
course of business consistent with past practice not to exceed an aggregate
amount of $5,000,000), or impose, or suffer the imposition, on any material
Asset of any Company Entity of any Lien or permit any such Lien to exist
(other than in connection with Liens in effect as of the date hereof that are
disclosed in the Company Disclosure Schedule);

  



  

   

41 
--- 

 


--- 

    



  



  

(c)  repurchase, redeem, or otherwise acquire or exchange
(other than acquisitions or exchanges in the ordinary course consistent with
past practice under the Company Option Plan), directly or indirectly, any
shares, or any securities convertible into any shares, of the capital stock
of any Company Entity;

  



  

(d)  (i) except for this Agreement, issue, sell, pledge,
encumber, authorize the issuance of, enter into any Contract to issue, sell,
pledge, encumber, or authorize the issuance of, or otherwise permit to become
outstanding, any additional shares of Company Common Stock (other than the
issuance of Company Common Stock issued upon the exercise of Company Options
outstanding on the date hereof in accordance with the Company Option Plan or
in connection with the replacement of certificates evidencing Company Common
Stock, which certificates were lost or destroyed) or any other capital stock
of any Company Entity, or any stock appreciation rights, or any option,
warrant, or other Equity Right, (ii) except pursuant to _Section
1.8_, accelerate the exercisability of any share of restricted stock, option,
warrant or other right to purchase shares of Company Common Stock or any
other capital stock of any Company Entity or (iii) declare, set aside or pay
any dividend or distribution payable in cash, stock or property in respect of
the capital stock of any Company Entity (other than any dividend or
distribution payable by any Company Subsidiary to another Company Subsidiary
or to the Company);

  



  

(e)  adjust, split, combine or reclassify any capital stock of
any Company Entity or issue or authorize the issuance of any other securities
in respect of or in substitution for shares of Company Common Stock, or sell,
lease, mortgage or otherwise dispose of or otherwise encumber, (i) any shares
of capital stock of any Company Subsidiary (unless any such shares of stock
are sold or otherwise transferred to another wholly owned Company Entity and
other than encumbrances that are contemplated by subsections (i), (iv), (v),
(vii) and (ix) of the definition of Permitted Liens) or (ii) except in the
ordinary course of business consistent with past practice, any individual
Asset (that is not an intangible Asset) having a book value in excess of
$300,000 individually or $1,000,000 in the aggregate, except for like-kind
exchanges of, and capital leases for, equipment in the ordinary course
of business consistent with past practice;

  



  

(f)  (i) except for purchases of U.S. Treasury securities or
U.S. Government agency securities, which in either case have maturities of
three (3) years or less, purchase any securities or make any material
investment, whether by purchase of stock or securities, contributions to
capital, Asset transfers, loans or advances, or purchase of any Assets, in any
Person other than a wholly owned Company Subsidiary, or otherwise acquire
direct or indirect control over any Person or (ii) merge, consolidate or
adopt a plan of liquidation;

  



  

(g)  (i) enter into any new line of business or make or agree to
make any new capital expenditures that, in the aggregate, are in excess of
$16,000,000, (ii) dispose of, license, or permit to lapse any rights in any
material Owned Intellectual Property, in each case, in this clause (ii) other
than in the ordinary course of business consistent with past practice, or
(iii) disclose to any Person, except pursuant to confidentiality obligations
or requirements of Law,

  

   

  



  

   

42 
--- 

 


--- 

    



  



  

other than to Representatives of Parent, any material Trade Secret (provided
that disclosure that is not authorized by the Company or any Company
Subsidiary shall not constitute a breach of this Section 4.2(g)(iii);

  



  

(h)  (i) except as required by the terms of any Plan or Contract
(as in effect on the date hereof) or pursuant to requirements of Law, (A)
increase the benefits available to any current or former executive officer or
director; (B) increase the base salary, wages or bonus opportunity of any
current or former executive officer or director of the Company, except for
individual increases in base salary, wages or bonus opportunity of not more
than ten percent (10%); or (C) grant any severance, bonus, termination pay,
equity or equity-based awards to any current or former executive officer or
director of the Company other than as required by any employment agreement or
pursuant to any Plan established prior to the date of this Agreement; (ii)
establish, adopt, materially amend or terminate any plan, agreement, program,
policy, trust, fund or other arrangement that would be a Plan if it were in
existence as of the date of this Agreement, or any Plan, except as required to
comply with requirements of Law or in the ordinary course of business
consistent with past practice; (iii) hire or engage any employee or individual
independent contractor of the Company, except for any employee or contractor
(A) who does not have an M.D. or Ph.D. degree, or equivalent, and who has an
aggregate annual base compensation that is not in excess of $200,000, or (B)
who does have an M.D. or Ph.D. degree, or equivalent, and who is hired or
engaged in the ordinary course of business consistent with past practice; or
(iv) forgive or discharge in whole or in part any outstanding loans or
advances to any present or former director, officer, employee,
individual consultant or independent contractor of the Company;

  



  

(i)  (i) except in the ordinary course of business consistent
with past practice or as required by applicable Law, (i) make or change any
material Tax election, (ii) file any amended Tax Return related to a material
amount of Taxes, (iii) settle any Tax claim or assessment relating to the
Company Entities and relating to a material amount of Taxes, or (iv)
surrender any right to claim a refund relating to a material amount of Taxes;

  



  

(j)  make any material change in any accounting methods or
policies or systems of internal accounting controls, except as may be
required by statutory or regulatory accounting rules, GAAP or applicable laws,
or regulatory requirements or regulatory interpretations with respect thereto
(including pursuant to standards, guidelines and interpretations of the FASB
or any similar organization);

  



  

(k)  except to the extent expressly permitted by _Section 4.7_,
take any action that is intended or would reasonably be expected to result in
any of the conditions to the Merger set forth in _Article 5_ not being
satisfied;

  



  

(l)  except in the ordinary course of business consistent with
past practice or as otherwise permitted under this _Section 4.2_, enter
into, modify, amend or terminate any Company Material Contract or waive,
release, compromise or assign any material rights or claims with respect to
any Company Material Contract;

  



  

   

43 
--- 

 


--- 

    



  



  

(m)  settle, commence (which for the avoidance of doubt does not
include the commencement of counter claims or cross claims), or compromise
any pending or threatened Litigation except with respect to settlements or
agreements that involve only the payment of monetary damages not in excess of
$300,000 individually or $1,000,000 in the aggregate and, in each case,
related incidental provisions;

  



  

(n)  pay, discharge, or satisfy any material Liabilities, other
than the payment, discharge, or satisfaction of Liabilities (i) when
contractually scheduled to do so without acceleration and (ii) in the ordinary
course of business consistent with past practice;

  



  

(o)  terminate or modify in any material respect, or fail to
exercise renewal rights with respect to, any material insurance policy;

  



  

(p)  take any action, or knowingly fail to take any action,
which action or failure to act prevents or impedes, or would reasonably be
expected to prevent or impede, the Merger from qualifying as a
"reorganization" within the meaning of Section 368(a) of the Code; or

  



  

(q)  agree or commit to do any of the foregoing.

  



  

4.3   _Covenants of Parent_.

  



  

From the date of this Agreement until the earlier of the Effective Time or
the termination of this Agreement in accordance with _Section 6.1_, unless
the prior written consent of Company shall have been obtained (which consent
shall not be unreasonably withheld, conditioned or delayed), and except as
otherwise expressly contemplated herein or as set forth in Parent's Disclosure
Schedule, Parent covenants and agrees that it shall and shall cause each of
the Parent Subsidiaries to (x) operate its business only in the
ordinary course consistent with past practice, and (y) use its reasonable
efforts to preserve intact its business organization and Assets and maintain
its rights and franchises; provided, that the foregoing shall not prevent
any Parent Entity from acquiring, discontinuing or disposing of any of its
Assets or business if such action (A) would not, individually or in the
aggregate, reasonably be expected to have a Parent Material Adverse Effect,
and (B) is, in the judgment of Parent, desirable in the conduct of the
business of the Parent Entities. From the date of this Agreement until the
earlier of the Effective Time or the termination of this Agreement in
accordance with _Section 6.1_, Parent further covenants and agrees that it
will not do or agree or commit to do, or permit any of its Subsidiaries to do
or agree or commit to do, any of the following without the prior written
consent of Company, which consent shall not be unreasonably withheld, delayed
or conditioned, or as otherwise contemplated herein or in the Parent
Disclosure Schedule:

  



  

(a)  amend the Organizational Documents of Parent or any
Significant Subsidiaries (as defined in Regulation S-X promulgated by the
SEC) in a manner that would adversely affect the Company or the holders of
Company Common Stock relative to other holders of Parent Common Stock;

  



  

   

44 
--- 

 


--- 

    



  



  

(b)  repurchase, redeem, or otherwise acquire or exchange (other
than exchanges in the ordinary course consistent with past practice under all
"employee benefit plans" (as defined in ERISA) of any Parent Entity and other
than pursuant to the conversion of Parent's convertible notes governed by
that certain indenture dated as of January 30, 2013 between Parent and Wells
Fargo Bank, National Association, as trustee), directly or indirectly, more
than ten percent (10%) of the current outstanding shares, or any securities
convertible into any shares, of the capital stock of any Parent Entity, or
declare or pay any dividend or make any other distribution in respect of
Parent's capital stock;

  



  

(c)  adopt a plan of liquidation;

  



  

(d)  take any action, or knowingly fail to take any action,
which action or failure to act prevents or materially impedes, or would
reasonably be expected to prevent or materially impede, the Merger from
qualifying as a "reorganization" within the meaning of Section 368(a) of the
Code;

  



  

(e)  except for and excluding issuances contemplated by this
Agreement, agreements disclosed in the Parent SEC Reports or pursuant to the
exercise of stock options or other Equity Rights outstanding as of the date
hereof and pursuant to the terms thereof in existence on the date hereof,
issue, sell, pledge, encumber, authorize the issuance of, enter into any
Contract to issue, sell, pledge, encumber, or authorize the issuance of, or
otherwise permit to become outstanding shares or Equity Rights
representing more than twenty percent (20%) of the current outstanding shares
of Parent Common Stock, or any other capital stock of any Parent Entity (on
an as-converted basis) whether by sale, transfer, merger, tender offer, share
exchange, business combination, reorganization, recapitalization or
otherwise; provided, however, that this Section 4.3 shall not prohibit Parent
from issuing any securities (i) for cash or (ii) to acquire, directly or
indirectly, any Assets or another business;

  



  

(f)  take any action that would reasonably be expected to
result in any of the conditions to the merger set forth in _Article 5_ not
being satisfied; or

  



  

(g)  agree to take, make any commitment to take, or adopt any
resolutions of Parent's board of directors in support of, any of the actions
prohibited by this _Section 4.3_.

  



  

4.4   _Notification of Certain Matters_.

  



  

(a)  Each Party agrees to promptly notify the other Party upon
becoming aware of (i) any notice or other written communication from any
Person alleging that the consent of such Person may be required in connection
with the transactions contemplated by this Agreement, (ii) any notice or
other written communication from any Governmental Entity in connection with
the transactions contemplated by this Agreement, and (iii) any Litigation
instituted or threatened (or unasserted but considered probable of assertion
and which if asserted would have at least a reasonable possibility of an
unfavorable outcome) against such Party or any its directors, officers or
Affiliates, including by any stockholder of such Party, before any
Governmental Entity, relating to or involving or otherwise affecting such
Party or any of the Company Subsidiaries, which, if pending on the date of
this Agreement, would have been

  



  

   

45 
--- 

 


--- 

    



  



  

required to have been disclosed pursuant to this Agreement or relating to this
Agreement or the transactions contemplated hereby, or seeking damages or
discovery in connection with such transactions. Parent shall have the right to
be consulted with respect to the defense of any such Litigation; provided,
that subject to _Section 4.15_, the Company shall retain the sole right and
complete discretion to determine its own course of conduct with respect to any
such Litigation.

  



  

(b)  The Company agrees to promptly notify Parent upon becoming
aware of any final, nonappealable decision from a court, patent office, or
other regulatory agency rendering any Company Registered Intellectual Property
invalid or unenforceable or any facts or circumstances, that would, or would
reasonably be expected to, affect in any material respect the Company's use or
value of any Intellectual Property.

  



  

4.5   _No Control of Other Party 's Business; Other Actions_.

  



  

Nothing contained in this Agreement is intended to give Parent the right to
control or direct any of the Company Entities' operations prior to the
Effective Time. Prior to the Effective Time, the Company Entities shall
exercise, consistent with the terms and conditions of this Agreement,
complete control and supervision over their respective businesses, assets and
operations.

  



  

4.6   _Preparation of Proxy Statement/Prospectus and Registration
Statement; Company Shareholders ' Meeting_.

  



  

(a)  Subject to _Section 4.7_, as promptly as practicable
after the execution of this Agreement, the Company and Parent shall cooperate
in preparing, and the Company shall file with the SEC, the Proxy Statement
(when included in the Registration Statement as a prospectus, including any
amendments or supplements, the " _Proxy Statement/Prospectus_ ") and
Parent shall prepare, together with the Company, and file with the SEC the
Registration Statement. Each of the Company and Parent shall also prepare and
file with the SEC any other document, schedule or statement required to be
filed by such Party (a " _Required Filing_ "). Each of Parent and the Company
shall promptly provide to the other such information concerning its
business affairs and financial statements as is requested by the other party
and, in the reasonable judgment of the providing party or its counsel, may be
required or appropriate for inclusion in the Proxy Statement/Prospectus,
Registration Statement and any Required Filing pursuant to this _Section
4.6_, or in any amendments or supplements thereto, and shall cause its
counsel and auditors to cooperate with the other's counsel and auditors in
the preparation of the Proxy Statement/Prospectus, Registration Statement and
any Required Filing. Each of the Company and Parent shall use its reasonable
best efforts to cause the Proxy Statement/Prospectus and Registration
Statement, respectively, to be filed with the SEC not later than the date that
is sixty (60) calendar days after the date hereof. Parent and the Company
shall use their reasonable best efforts to cause the Registration Statement to
become effective under the Securities Act as soon after such filing as
practicable and to keep the Registration Statement effective as long as is
necessary to consummate the Merger and the transactions contemplated hereby.
The Company shall use its reasonable best efforts to cause the Proxy
Statement/Prospectus to be mailed to its shareholders as promptly as
practicable after the Registration Statement becomes effective. The Parties
shall promptly provide copies, consult with each other and cooperate in the
preparation of

  



  

   

46 
--- 

 


--- 

    



  



  

written responses with respect to any written comments received from the SEC
with respect to the Proxy Statement/Prospectus, the Registration Statement or
any Required Filing and promptly advise one another of any oral comments
received from the SEC. The Registration Statement, the Proxy
Statement/Prospectus and any Required Filing shall, at the time of the Company
Shareholders' Meeting comply as to form in all material respects with the
Securities Act and the Exchange Act and the rules and regulations promulgated
by the SEC thereunder. The Company shall retain a proxy solicitor on terms
reasonably acceptable to Parent in connection with the solicitation of the
Required Company Vote.

  



  

(b)  Parent and the Company shall make all required filings with
respect to the Merger and the transactions contemplated hereby under the
Securities Act and the Exchange Act, the rules of any stock exchange on which
Parent's securities or the Company's securities are listed, applicable state
securities and "blue sky" Laws and the rules and regulations thereunder
and any applicable foreign securities Laws or with any foreign securities
authorities. Each Party will advise the other, promptly (but in any event
within one (1) Business Day) after it receives notice thereof, of the time
when the Registration Statement has become effective or any supplement or
amendment has been filed, the issuance of any stop order, the suspension of
the qualification of the Parent Common Stock issuable in connection with the
Merger for offering or sale in any jurisdiction, any request by the SEC for
amendment of the Proxy Statement/Prospectus, the Registration Statement or any
Required Filing or comments thereon and responses thereto or requests by the
SEC for additional information. No amendment or supplement to the Proxy
Statement/Prospectus, the Registration Statement or any Required Filing shall
be filed without the approval of both Parent and the Company, which
approval shall not be unreasonably withheld or delayed; provided, that with
respect to documents filed by a Party which are incorporated by reference in
the Proxy Statement/Prospectus, the Registration Statement or any Required
Filing, this right of approval shall apply only with respect to information
relating to the other Party or its business, financial condition or results of
operation. If at any time prior to the Effective Time, any information
relating to Parent, Sub or the Company, or any of their
respective Affiliates, officers or directors, should be discovered by Parent
or the Company that should be set forth in an amendment or supplement to the
Proxy Statement/Prospectus, the Registration Statement or any Required Filing,
so that such documents would not include any misstatement of a material fact
or omit to state any material fact necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading, the
Party that discovers such information shall promptly (but in any event within
two (2) Business Days) notify the other Parties hereto and an appropriate
amendment or supplement describing such information shall be promptly filed
with the SEC and, to the extent required by Law, disseminated to the
shareholders of the Company.

  



  

(c)  The Company shall cause the Company Shareholders' Meeting
to be duly called and held as soon as reasonably practicable after the SEC
declares the Registration Statement effective for the purpose of obtaining the
Required Company Vote. In connection with such meeting, the Company will (i)
subject to the ability of the Board to make a Change in Recommendation or
Company Intervening Event Change in Recommendation pursuant to _Section
4.7_, make the Company Board Recommendation and include such recommendation
in the Proxy Statement/Prospectus, (ii) subject to the ability of the Board to
make a Change in

  



  

   

47 
--- 

 


--- 

    



  



  

Recommendation or Company Intervening Event Change in Recommendation pursuant
to _Section 4.7_, use its reasonable best efforts to obtain the Required
Company Vote and (iii) otherwise comply with all legal requirements applicable
to such meeting. In the event that during the five Business Days prior to the
date that the Company Shareholders' Meeting is then scheduled to be held, the
Company delivers to Parent a notice of an intent to make a Change in
Recommendation or a Company Intervening Event Change in Recommendation, or to
enter into a Company Acquisition Agreement, in each case, to the extent
permitted by _Section 4.7_  (including in connection with a change in terms
pursuant to the last sentence of _Section 4.7(d)(i)_ ), Parent may direct the
Company to postpone the Company Shareholders' Meeting for up to ten Business
Days and the Company shall promptly, and in any event no later than the next
Business Day, postpone the Company Shareholders' Meeting in accordance with
Parent's direction. Notwithstanding any Change in Recommendation or Company
Intervening Event Change in Recommendation, the Company shall nonetheless
submit this Agreement to the Company's shareholders to obtain the Required
Company Vote at the Company Shareholders' Meeting unless this Agreement is
terminated in accordance with _Article VI_ prior to the Company Shareholders'
Meeting. For the avoidance of doubt, unless this Agreement is terminated in
accordance with its terms, neither the commencement, proposal, public
disclosure or communication to the Company of any Company Acquisition Proposal
nor the making of any Change in Recommendation or Company Intervening Event
Change in Recommendation shall limit otherwise affect the obligation of the
Company to set a record date for, duly call, give notice of, convene and hold
the Company Shareholders' Meeting in accordance with this _Section 4.6_.

  



  

(d)  Each Party shall use its reasonable best efforts to ensure
that the information supplied or to be supplied by such Party specifically
for inclusion or incorporation in the Registration Statement, at the time the
Registration Statement is declared effective by the SEC, does not contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements
therein not misleading. Each Party shall use its reasonable best efforts to
ensure that the information supplied or to be supplied by such Party to the
Company specifically for inclusion in the Proxy Statement/Prospectus, on the
date the Proxy Statement/Prospectus is first mailed to the shareholders of the
Company, at the time of the Company Shareholders' Meeting and at the
Effective Time, does not contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under
which they were made, not misleading. Each Party shall use its reasonable best
efforts to ensure that the information supplied or to be supplied by such
Party specifically for inclusion or incorporation in any Required Filing, at
the time any such Required Filing is filed with the SEC, does not contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements
therein not misleading.

  



  

(e)  The Company and Parent shall cooperate with each other and
each shall use (and shall cause their respective Subsidiaries to use)
reasonable best efforts to take or cause to be taken all actions, and do or
cause to be done all things necessary, proper or advisable on its part under
this Agreement in connection with the Merger and the other transactions
contemplated

  



  

   

48 
--- 

 


--- 

    



  



  

hereby as soon as practicable, including, without limitation, preparing and
filing as soon as practicable all documentation to effect all necessary
notices, reports and other filings, and all other Consents, registrations,
approvals, permits and authorizations necessary or advisable to be obtained.

  



  

4.7   _No Solicitation_.

  



  

(a)  The Company shall not, nor shall it authorize or permit
any of its Affiliates to, and shall not authorize or permit its and its
Affiliates' respective Representatives to, directly or indirectly (i) solicit,
initiate or knowingly encourage or otherwise take any action to facilitate
any inquiries regarding, or the making of, any proposal or offer that
constitutes, or may reasonably be expected to lead to, the submission of any
Company Acquisition Proposal, or, (ii) subject to _Section 4.7(b)_, conduct
or engage in any discussions or negotiations with, disclose any non-public
information relating to the Company or any of its Subsidiaries to, or
knowingly assist, participate in, facilitate or encourage any effort by, any
third party that, to the Company's Knowledge is seeking to make, or has made,
any Company Acquisition Proposal, or (iii) subject to _Section
4.7(b)_, approve, endorse or recommend any Company Acquisition Proposal, or
(iv) subject to _Section 4.7(b)_, enter into any agreement in principle,
letter of intent, term sheet, acquisition agreement, merger agreement, option
agreement, joint venture agreement, partnership agreement or other similar
Contract (other than, for the avoidance of doubt, an Acceptable NDA to the
extent permitted by _Section 4.7(b)_) relating to any Company Acquisition
Proposal (each, a " _Company Acquisition Agreement_ "), or (v) subject to
_Section 4.7(b)_, grant any waiver, amendment or release under any standstill
or confidentiality agreement or any Anti-takeover Laws or otherwise fail to
enforce any of the foregoing (it being understood that the Company shall
immediately take all steps within its power necessary to terminate any waiver
that may have been heretofore granted, to any Person other than Parent or any
of Parent's Affiliates, under any such provisions), or (vi) resolve or agree
to do any of the foregoing. Subject to _Section 4.7(b)_, neither the Board
nor any committee thereof shall make, withdraw, amend, modify or materially
qualify, in a manner adverse to Parent or Sub, the Company Board
Recommendation, or recommend a Company Acquisition Proposal, fail to
recommend against acceptance of any tender offer or exchange offer for the
shares of Company Common Stock within ten (10) Business Days after the
commencement of such offer, or make any public statement inconsistent with the
Company Board Recommendation, or resolve or agree to take any of the
foregoing actions (any of the foregoing a " _Change in Recommendation_ "). The
Company shall, and shall cause its Affiliates to, cease immediately and cause
to be terminated, and shall not authorize or permit any of its or their
Representatives to continue, any and all existing activities, discussions or
negotiations, if any, with any third party conducted prior to the date hereof
with respect to any Company Acquisition Proposal and shall use its reasonable
best efforts to cause any such third party (or its agents or advisors) in
possession of non-public information in respect of the Company or any of its
Subsidiaries that was furnished by or on behalf of the Company and its
Affiliates to return or destroy (and confirm destruction of) all such
information, subject to _Section 4.7(b)_, and shall terminate access of all
Persons (other than Parent, the Company and their respective Affiliates and
Representatives) to any "data room" with respect to any Company Acquisition
Proposal.

  



  

   

49 
--- 

 


--- 

    



  



  

(b)  Notwithstanding the provisions of _Section 4.7(a)_, prior
to the receipt of the Required Company Vote, the Board, directly or
indirectly through any Representative, may, subject to _Section 4.7(c)_ and
provided that the Company has complied with _Section 4.7(a)_ with respect to
the applicable third party, (i) participate in negotiations or
discussions with such third party that has made a bona fide, unsolicited
Company Acquisition Proposal that the Board determines in good faith, after
consultation with the Company's outside legal counsel and financial advisors,
constitutes or could reasonably be expected to result in a Superior Proposal,
and the Company, its Affiliates and its and its Affiliates' Representatives
may enter into an Acceptable NDA with such third party, (ii) furnish to such
third party information relating to the Company or any of its Subsidiaries;
provided, that all material non-public information provided to such person has
previously been provided to Parent prior to or is provided to Parent
contemporaneously with the provision to such Person and (iii) grant a waiver
under a standstill agreement, but in each case referred to in the foregoing
clauses (i), (ii) and (iii), (A) only if the Board determines in good faith,
after consultation with the Company's outside legal counsel and financial
advisors, that the failure to take such action would be inconsistent with the
Board's fiduciary duties under applicable Law and (B) such third party
executes a confidentiality agreement that constitutes an Acceptable NDA.
Nothing contained in this _Section 4.7_ shall prevent the Board from
disclosing to the Company's shareholders a position contemplated by Rule 14d-9
and Rule 14e-2(a) promulgated under the Exchange Act with regard to a Company
Acquisition Proposal or any other disclosure required by applicable Law, if
the Board determines in good faith, after consultation with the Company's
outside legal counsel, that failure to disclose such position would result in
a violation of applicable Law. Any public disclosure by the Company relating
to a Company Acquisition Proposal (other than a "stop, look and listen" or
similar communication of the type contemplated by Rule 14d-9(f) under the
Exchange Act) shall be deemed to be a Change in Recommendation unless the
Board expressly publicly reaffirms its approval or recommendation of this
Agreement and the Merger in such disclosure, or in the case of a "stop, look
and listen" or similar communication, in a subsequent disclosure on or before
the earlier of (i) the last day of the ten (10) business day period under
Rule 14d-9(f) under the Exchange Act and (ii) two (2) Business Days before the
Company Shareholders' Meeting.

  



  

(c)  The Company shall notify Parent promptly (but in any event
within twenty-four (24) hours and prior to engaging in any of the actions
under _Section 4.7(b)_) of (i) any Company Acquisition Proposal, (ii) any
initial request for non-public information concerning the Company or any
Company Subsidiary related to, or from any Person or group who would
reasonably be expected to make a Company Acquisition Proposal, or (iii) any
initial request for discussions or negotiations related to any Company
Acquisition Proposal. In such notice, the Company shall identify the third
party making, and details of the material terms and conditions of, any such
Company Acquisition Proposal, request, or inquiry and provide copies of any
written proposals, draft agreements and all draft or executed financing
commitments and related material documentation. The Company shall keep Parent
promptly informed of the status of any such Company Acquisition Proposal,
including any material changes to the timing, amount or form of
consideration, conditionality or other material terms of (or any other
material developments with respect to) any Company Acquisition
Proposal, request, or inquiry including by promptly, and in any event no
later than forty-eight (48) hours after receipt by the Company or any of its
Representatives, providing to Parent copies of any additional or revised
written

  



  

   

50 
--- 

 


--- 

    



  



  

proposals, requests, inquiries, draft agreements and all draft or executed
financing commitments and related material documentation. The Company agrees
that it and its Representatives will not enter into any agreement with any
Person subsequent to the date hereof that prohibits the Company from
providing any information or materials to Parent in accordance with, or
otherwise complying with, this _Section 4.7_.

  



  

(d)  Except as set forth in this _Section 4.7(d)_, the Board
shall not make any Change in Recommendation or enter into (or permit any
Company Subsidiary to enter into) a Company Acquisition Agreement.

  



  

(i)  Notwithstanding anything to the contrary in this
Agreement but provided that the Company shall at all times be in
compliance with _Section 4.7(a)_ , at any time prior to the receipt of the
Required Company Vote, the Board may, in response to a Superior Proposal,
make a Change in Recommendation or enter into (or permit any Company
Subsidiary to enter into) a Company Acquisition Agreement if, (i) the Board,
prior to effecting the Change in Recommendation, provides Parent five (5)
Business Days prior written notice of its intention to take such action,
which notice shall include a description in reasonable detail of such Superior
Proposal, (ii) the Company is and remains in compliance with this _Section
4.7_ during the five (5) Business Days following such written notice, the
Board and, if requested by Parent, its Representatives have negotiated in good
faith with Parent regarding any revisions to the terms and conditions of the
transactions contemplated by this Agreement, including the Merger; and (iii)
at the end of the five (5) Business Day period described in the foregoing
clause (ii), the Board concludes in good faith, after consultation with the
Company's outside legal counsel and financial advisors (and taking into
account any adjustment or modification of the terms of this Agreement which
Parent has proposed), that such Company Acquisition Proposal (if any)
continues to constitute a Superior Proposal and the failure to make a Change
in Recommendation would be inconsistent with its fiduciary duties under
applicable Law. Any material change to the terms, facts and circumstances
relating to the Superior Proposal will be deemed to be a new
Superior Proposal, as applicable, for purposes of this _Section 4.7_ and the
Company shall be required to comply again with the requirements of this
_Section 4.7(d)_, except that references to "five (5) Business Days" shall be
deemed to be references to "two (2) Business Days."

  



  

(ii)  Notwithstanding anything to the contrary in this
Agreement, at any time prior to the receipt of the Required Company Vote, the
Board may make a Change in Recommendation in response to a Company Intervening
Event (a " _Company Intervening Event Change in Recommendation_ ") if the
Board determines in good faith, after consultation with the Company's
outside legal counsel and financial advisors, that the failure to make a
Company Intervening Event Change in Recommendation would be inconsistent with
the Board's fiduciary duties under applicable Law, provided, that: (A) Parent
shall have received written notice from the Company (a " _Company Notice of
Intervening Event Change in Recommendation_ ") of the Company's intention to
make a Company Intervening Event Change in Recommendation at least five (5)
Business Days prior to the taking of such action by the Company, which notice
shall specify the applicable Company Intervening Event in reasonable detail,
(B) during such period and prior to making a Company Intervening Event Change
in Recommendation, if requested by Parent, the Company and its
Representatives shall have negotiated in good faith with Parent and

  



  

   

51 
--- 

 


--- 

    



  



  

its Representatives regarding any revisions or adjustments proposed by
Parent to the terms and conditions of this Agreement as would enable the
Company to proceed with its recommendation of this Agreement and the Merger
and not make such Company Intervening Event Change in Recommendation and (C)
the Company may make a Company Intervening Event Change in Recommendation
only if the Board, after considering in good faith any revisions or
adjustments to the terms and conditions of this Agreement that Parent shall
have, prior to the expiration of the 5-Business Day period, offered in
writing in a manner that would form a binding contract if accepted by the
Company, continues to determine in good faith that such Company Intervening
Event exists and that the failure to make a Company Intervening Event Change
in Recommendation would, after consultation with the Company's outside legal
counsel and financial advisors, be inconsistent with its fiduciary duties
under applicable Law.

  



  

(iii)  For purposes of this Agreement, (A) " _Company Acquisition
Proposal_ " means any unsolicited offer or proposal made by a Person or group
at any time after the date hereof that would result in such Person or group
acquiring, directly or indirectly, beneficial ownership (with respect to
securities, within the meaning of Section 13(d) of the Exchange Act) of
at least fifteen percent (15%) (based on the fair market value thereof) of
the Assets of, equity interest in, or business of, the Company and the
Company Subsidiaries, taken as a whole, pursuant to a merger, reorganization,
recapitalization, consolidation, license, share exchange, business
combination, tender offer, sale of shares of capital stock, sale of assets or
other similar transaction, including any single or multi-step transaction or
series of related transactions, in each case other than the Merger, (B) "
_Superior Proposal_ " means any Company Acquisition Proposal that if
consummated would result in a Person or group owning, directly or indirectly,
(x) fifty percent (50%) or more of all classes of outstanding equity
securities of the Company or of the surviving entity in a merger involving
the Company or the resulting direct or indirect parent of the Company or such
surviving entity or (y) fifty percent (50%) or more (based on the fair market
value thereof) of the Assets of the Company and the Company Subsidiaries
(including capital stock of the Company Subsidiaries), taken as a whole, that
the Board determines in good faith (after consultation with its outside legal
counsel and financial advisors) is superior, from a financial point of view,
to this Agreement and the Merger, taking into account all financial, legal,
regulatory and other aspects of such proposal and of this Agreement
(including the relative risks of non-consummation and any changes to the terms
of this Agreement proposed by Parent to the Company), and (C) a " _Company
Intervening Event_ " shall mean any fact, circumstance, occurrence, event,
development, change or condition or combination thereof relating directly to
the Company, its Assets or its operations that was not known or reasonably
foreseeable to the Board as of the date of this Agreement (or if known, the
consequences or magnitude of which were not known or reasonably foreseeable)
other than (i) changes in the market price or trading volume of the shares of
Company Common Stock (however, the underlying reasons for such changes may
constitute a Company Intervening Event), (ii) the timing of any consents,
registrations, Permits or clearances required to be obtained prior to the
Effective Time by the Company or Parent or any of their respective
Subsidiaries from any Governmental Entity in connection with this Agreement
and the consummation of the Merger and the other transactions contemplated
hereby, (iii) a Company Acquisition Proposal, or an inquiry, proposal or
offer that could reasonably be expected to lead to a Company Acquisition
Proposal, or the consequences thereof, (iv) the fact that the Company

  



  

   

52 
--- 

 


--- 

    



  



  

exceeds any internal projections, budgets or forecasts or third-party revenue
or earnings predictions or other analyst expectations, projections, forecasts
or budgets for any period (however, the underlying reasons for such
events may constitute a Company Intervening Event), (v) matters set forth in
clauses ( _A)_ through ( _D)_ of the definition of Company Material Adverse
Effect and (vi) events set forth on _Section 4.7(d)(iii)_ of the Company
Disclosure Schedule.

  



  

4.8   _Access to Information_.

  



  

(a)  Upon reasonable notice, the Company shall (and shall cause
the Company Subsidiaries to), subject to applicable Law, afford to Parent and
its Representatives reasonable access during normal business hours, during the
period prior to the Effective Time, to all its officers, employees,
properties, offices, plants and other facilities and to all books and records,
including financial statements, other financial data and monthly financial
statements within the time such statements are customarily prepared,
and, during such period, the Company shall (and shall cause its Subsidiaries
to) furnish promptly to Parent and its Representatives, consistent with its
legal obligations, all other information concerning its business, properties
and personnel as such Person may reasonably request. Any investigation
pursuant to this _Section 4.8_ shall be conducted in such manner as not to
interfere unreasonably with the conduct of the business of the Company and the
Company Subsidiaries. No investigation conducted by any Party to this
Agreement shall in any way modify any representations or covenants made by the
Company or Parent.

  



  

(b)  Prior to the Effective Time and after any termination of
this Agreement, each Party hereto will hold and will cause
its Representatives to hold all information that is disclosed pursuant to
_Section 4.8(a)_ in accordance with the provisions of that certain
confidentiality agreement, dated May 1, 2015 (the " _Confidentiality
Agreement_ "), between the Company and Parent. No investigation by Parent
shall diminish, obviate or prevent Parent's reliance upon any of the
representations, warranties, covenants or agreements of the Company contained
in this Agreement.

  



  

4.9   _Antitrust Notification; Consents; Reasonable Best
Efforts_.

  



  

(a)  Each Party hereto shall file or cause to be filed with (i)
the Federal Trade Commission and the Department of Justice any notifications
required to be filed under the HSR Act and (ii) to the extent required, the
appropriate Governmental Entity all filings required to be filed under any
foreign Antitrust Law (" _Foreign Antitrust Filings_ "), in each case in
accordance with the applicable rules and regulations promulgated under the
relevant Law, with respect to the transactions contemplated hereby. Each
Party hereto will use reasonable best efforts to make the filing under the HSR
Act and any additional Foreign Antitrust Filings as promptly as reasonably
practicable after the date hereof. Each Party hereto will use reasonable best
efforts to respond on a timely basis to any requests (formal or informal) for
additional information made by any such agency. The administrative filing fee
payable under the HSR Act shall be borne fifty percent (50%) by Parent and
fifty percent (50%) by the Company.

  



  

(b)  The Company and Parent shall cooperate with each other and
each shall use (and shall cause their respective Subsidiaries to use)
reasonable best efforts to take or cause

  



  

   

53 
--- 

 


--- 

    



  



  

to be taken all actions, and do or cause to be done all things necessary,
proper or advisable on its part under this Agreement and applicable Laws to
consummate and make effective the Merger and the other
transactions contemplated hereby as soon as practicable, including, without
limitation, preparing and filing as soon as practicable all documentation to
effect all necessary undertakings, notices, reports and other filings and to
obtain as soon as practicable all Governmental Approvals, and all other
Consents, registrations, approvals, permits and authorizations necessary or
advisable to be obtained from any Governmental Entity or other third party in
order to consummate the Merger or any of the other transactions
contemplated hereby, including with or from any works council, labor union or
similar entity or governing body.

  



  

(c)  Without limiting _Section 4.9(b)_ , Parent and the Company
shall take all such actions as may be necessary in order to resolve any
objections or suits (or threatened suits) that may be asserted by a
Governmental Entity or other third party with respect to the Merger or the
other transactions contemplated hereby as violative of any Antitrust Law,
including selling, holding separate, divesting, or otherwise disposing of any
of its Assets and agreeing to conduct its business in a particular manner
(collectively, " _Divestitures_ "); provided that (A) any obligation to make
or agree to make a Divestiture by the Parent, Company or any of their
respective Subsidiaries may, at Parent's or the Company's option, as
applicable, be conditioned upon and effective as of the Effective Time and
shall not affect the other terms or conditions hereunder and (B) neither
Parent nor Sub shall be required to effect, and the Company and its
Subsidiaries shall not effect, any Divestitures with respect to Assets of the
Company and its Subsidiaries or Parent and its Subsidiaries that, in the
aggregate, generated or were reasonably necessary to service more than two
and one-half percent (2.5%) of the aggregate consolidated revenues, in their
respective most recently completed fiscal years, of the Company, the Company
Subsidiaries, Parent and the Parent Subsidiaries. Subject to applicable
Laws relating to the exchange of information and the preservation of any
applicable attorney-client privilege, work-product doctrine, self-audit
privilege or other similar privilege (collectively, " _Legal Privilege_ "),
Parent and the Company shall use reasonable best efforts to collaborate in
reviewing and commenting on in advance, and to consult the other on,
information relating to Parent or the Company, as the case may be, and any of
their respective Subsidiaries, that appears in (i) any filing made with, (ii)
written materials submitted to, or (iii) oral statements made to, any
Governmental Entity or other third party in connection with the Merger and
the other transactions contemplated hereby. In connection with such
collaboration, each of the Company and Parent shall act reasonably and as
promptly as practicable. Parent and the Company will communicate with any
governmental antitrust authority in respect of the transactions contemplated
by this Agreement (other than communications that are not material or relate
only to administrative matters) only after having consulted with the other's
advisors in advance and having taken into account any reasonable comments and
requests of the other Party and its advisors. Where permitted by the
governmental antitrust authority, Parent and Company will allow the other's
advisers to attend all meetings with any governmental antitrust authority or
participate in any telephone calls or other such communications (other than
meetings, telephone calls or communications that are not material or relate
only to administrative matters).

  



  

(d)  Subject to applicable Laws and the preservation of any
applicable Legal Privilege, the Company and Parent each shall, upon request
by the other, use reasonable best

  



  

   

54 
--- 

 


--- 

    



  



  

efforts to cooperate in obtaining, and furnish the other with all information
concerning itself, the Company Subsidiaries, directors, officers and
stockholders and such other matters as may be reasonably necessary
or advisable in connection with the Proxy Statement/Prospectus, the
Registration Statement, any Required Filing or any other statements, filings,
Governmental Approvals, notices or applications made by or on behalf of the
Company, Parent or any of their respective Subsidiaries to any Governmental
Entity or other third party in connection with the Merger and the other
transactions contemplated hereby.

  



  

(e)  Subject to any confidentiality obligations and the
preservation of any Legal Privilege, the Company and Parent each shall use
reasonable best efforts to keep the other apprised of the status of matters
relating to completion of the transactions contemplated hereby, including
promptly furnishing the other with copies of notices or other communications
received by Parent or the Company, as the case may be, or any of the Company
Subsidiaries, from any Governmental Entity or other third party with respect
to the Merger and the other transactions contemplated hereby.

  



  

(f)  Subject to the provisions of _Sections 4.7_ and _4.9(b)_
, in the event that any administrative or judicial action or proceeding is
instituted (or threatened to be instituted) by a Governmental Entity or
private party challenging any transaction contemplated by this Agreement, or
any other agreement contemplated hereby, each of Parent, Sub and the
Company shall cooperate with each other and use reasonable best efforts to
contest and resist any such action or proceeding and to have vacated, lifted,
reversed or overturned any decree, judgment, injunction or other order,
whether temporary, preliminary or permanent, that is in effect and that
prohibits, prevents or restricts consummation of the transactions contemplated
by this Agreement.

  



  

4.10   _Filing with State Office_.

  



  

Upon the terms and subject to the conditions of this Agreement, Sub and the
Company shall execute and file the Certificate of Merger with the office of
the Department of the Treasury of the State of New Jersey in connection with
the Closing.

  



  

4.11   _Directors ' and Officers' Indemnification and Insurance_.

  



  

(a)  For purposes of this _Section 4.11_, (i) " _Indemnified
Person_ " shall mean any person who was, is now, or has been at any time
prior to the Effective Time, an officer or director of the Company or any
Company Subsidiary or who was serving at the request of the Company or any
Company Subsidiary as an officer or director of another corporation,
joint venture or other enterprise, and (ii) " _Proceeding_ " shall mean any
claim, action, suit, proceeding or investigation, whether or not such claim,
proceeding or investigation results in a formal civil or criminal litigation
or regulatory action.

  



  

(b)  From and after the Effective Time, Parent and the Surviving
Corporation shall (i) indemnify and hold harmless against any costs or
expenses (including attorneys' fees), judgments, fines, losses, claims,
damages or liabilities incurred in connection with any Proceeding, and
provide advancement of expenses to, all Indemnified Persons to the fullest

  



  

   

55 
--- 

 


--- 

    



  



  

extent permitted under applicable Law and the Company Organizational
Documents, and (ii) honor the provisions regarding elimination of
liability of directors, indemnification of officers, directors and employees
and advancement of expenses contained in the Company Organizational Documents
immediately prior to the Effective Time and ensure that the certificate of
incorporation and bylaws of the Surviving Corporation shall contain
provisions no less favorable with respect to indemnification, advancement of
expenses and exculpation of present and former directors, officers, employees
and agents of the Company and the Company Subsidiaries than are presently set
forth in the Company Organizational Documents. Any right of indemnification of
an Indemnified Person pursuant to this _Section 4.11(b) _shall not be
amended, repealed or otherwise modified at any time until six (6) years from
the Effective Time in a manner that would adversely affect the rights of such
Indemnified Person as provided herein except as required by applicable Law.
Without limiting the foregoing, in any case in which approval by Parent or
the Surviving Corporation is required to effectuate any indemnification or
advancement of expenses, Parent or the Surviving Corporation, as applicable,
shall direct, at the election of the Indemnified Person, that the
determination of any such approval shall be made by independent counsel
mutually agreed upon between Parent and the Indemnified Person.

  



  

(c)  For a period of six (6) years from the Effective Time,
Parent shall maintain in effect the Company's current directors' and
officers' liability insurance policies in respect of acts or omissions
occurring at or prior to the Effective Time, covering each Indemnified Person
on terms with respect to such coverage and amounts no less favorable than
those of such policies in effect on the date of this Agreement; provided,
that Parent may substitute therefor policies of a reputable and
financially sound insurance company with the same or better credit rating as
the Parent's current insurance company, containing terms, conditions,
retentions and limits of liabilities, including with respect to coverage and
amounts, no less favorable to any Indemnified Person; provided further, that
in satisfying their obligation under this _Section 4.11(c)_, Parent shall not
be obligated to pay for coverage for any 12-month period with aggregate
premiums for insurance in excess of 300% of the amount (the " _Annual Amount_
") payable by the Company for 12 months of coverage under its existing
directors' and officers' liability insurance policies, it being understood
and agreed that Parent shall nevertheless be obligated to provide such
coverage as may be obtained for 300% of the Annual Amount. Parent will cause
such policies to be maintained in full force and effect for their full term,
and cause all obligations thereunder to be honored by the Surviving
Corporation. In lieu of maintaining such policies, the Surviving Corporation
may purchase, at the Effective Time, tail policies, from a reputable and
financially sound insurance company with the same or better credit rating as
the Company's current insurance company, to the current directors' and
officers' liability insurance policies maintained at such time by the Company,
which tail policies (i) will be effective for a period from the Effective
Time through and including the date six (6) years after the Effective Time
with respect to claims arising from facts or events that existed or occurred
prior to or at the Effective Time, and (ii) will contain coverage that is at
least as protective to such directors and officers as the coverage provided by
such existing policies; provided, that the Surviving Corporation shall not be
obligated to pay for coverage for any 12-month period with aggregate premiums
for insurance in excess of 300% of the Annual Amount, it being understood and
agreed that the Surviving Corporation shall nevertheless be obligated to
provide such coverage as may be obtained for 300% of the Annual Amount.

  



  

   

56 
--- 

 


--- 

    



  



  

(d)  Subject to applicable Law, the rights of any Indemnified
Person under this _Section 4.11_ shall be in addition to any other rights
such Indemnified Person may have under the certificate of incorporation or
bylaws of the Surviving Corporation or any of the Company Subsidiaries under
the NJBCA or otherwise. The provisions of this _Section 4.11_ shall
survive the consummation of the Merger for a period of six (6) years and are
expressly intended to benefit, and to be enforceable by, each of the
Indemnified Persons and their respective heirs and personal representatives;
provided, that in the event that any claim or claims for indemnification set
forth in _Section 4.11_ are asserted or made within such six (6) year
period, all rights to indemnification in respect of any such claim or claims
shall continue until disposition of any and all such claims.

  



  

(e)  If Parent and/or Surviving Corporation, or any of their
respective successors or assigns, transfers or conveys all or
substantially all of their properties and assets to any other Person, then,
in each such case, to the extent necessary, proper provision shall be made so
that the successors and assigns of Parent and/or Surviving Corporation, as the
case may be, shall assume the obligations of Parent and Surviving Corporation
set forth in this _Section 4.11_.

  



  

4.12   _Press Releases_.

  



  

The initial press release concerning the Agreement and the Merger shall be a
joint release and, thereafter, so long as this Agreement is in effect, none
of Parent, Sub or the Company will disseminate any press release or other
public disclosure materially related to this Agreement, the Merger or any
other transaction contemplated hereby (except for public disclosure permitted
under _Section 4.7_), without the prior consent of the other Parties hereto
provided, that nothing in this _Section 4.12_ shall be deemed to prohibit
any Party from making any disclosure that its outside legal counsel deems
required by Law or the rules or regulations of any applicable securities
exchange or Governmental Entity to which the relevant Party is subject or
submits, wherever situated, in which case the Party required to make the
release or announcement shall use its reasonable best efforts to allow each
other Party reasonable time to comment on such release or announcement in
advance of such issuance; provided, further, that each of Parent and the
Company may make any public statement in response to specific questions by the
press, without obtaining the consent of or consulting with the other Parties
hereto, analysts, investors or those attending industry conferences or
financial analyst conference calls (without obtaining the consent of or
consulting with the other Parties hereto), so long as any such statements are
not inconsistent with previous press releases, public disclosures or public
statements made jointly by Parent and the Company and do not reveal material,
non-public information regarding the other Parties.

  



  

4.13   _State Takeover Laws; Charter Provisions; No Rights Plan_.

  



  

(a)  Parent, Sub, the Company and the Board shall take all
actions as may be necessary to ensure that no Anti-takeover Law is or becomes
applicable to this Agreement, the Merger or any of the other transactions
contemplated by this Agreement.

  



  

(b)  The Company shall take all necessary action to ensure that
the entering into of this Agreement and the consummation of the Merger and
the other transactions

  



  

   

57 
--- 

 


--- 

    



  



  

contemplated hereby do not and will not result in the grant of any rights to
any Person under the Company Organizational Documents or restrict or impair
the ability of Parent or any of its Subsidiaries to vote, or otherwise to
exercise the rights of a shareholder with respect to, shares of the Company
that may be directly or indirectly acquired or controlled by them.

  



  

(c)  From the date hereof through the earlier of termination of
this Agreement and the Effective Time, the Company will not adopt, approve or
agree to adopt, a rights plan, "poison-pill" or other similar agreement or
arrangement or any anti-takeover provision in the Company Organizational
Documents that is, or at the Effective Time shall be, applicable to the
Company, the Company Common Stock, the Merger or the other transactions
contemplated by this Agreement.

  



  

4.14   _Employee Benefits and Contracts_.

  



  

(a)  For the period from the Effective Time until December 31,
2016, Parent shall provide, and cause the Surviving Corporation to provide
each employee of the Company and any Company subsidiary, base salary or wage
rate, bonus opportunity, commission opportunity, incentive compensation,
pension, welfare and fringe benefits (other than defined benefit pension
benefits and retiree medical benefits) no less favorable than the base salary
or wage rate, bonus opportunity, commission opportunity, incentive
compensation, pension, welfare and fringe benefits (other than defined
benefit pension benefits and retiree medical benefits) that are provided to
each employee pursuant to Plans on the date of this Agreement. Except to the
extent set forth in Section 4.14(d) of this Agreement, nothing herein shall
require Parent to continue any particular Plan or benefit or prevent the
Parent from terminating (or causing the termination of) the employment of any
employee of the Company or any Company Subsidiary at any time after
the Closing Date for any reason (or no reason). The provisions of this
Section 4.14 are for the sole benefit of the parties to this Agreement and
nothing herein, express or implied, is intended or shall be construed to
constitute an amendment to any Plan or create any right or cause of action in
or on behalf of any Person (including, for the avoidance of doubt, any current
or former employees, officers, directors or consultants of the Company or any
of the Company Subsidiaries), other than the parties hereto.

  



  

(b)  With respect to any employee benefit plan maintained by
Parent or its Affiliates in which any employee of the Company or any Company
Subsidiary becomes or is a participant, for purposes of determining
eligibility to participate, vesting, vacation, paid time-off and severance
and other benefit plan accruals (other than benefit accrual under a defined
benefit pension plan), each such employee's service with the Company or any
Company Subsidiary (as well as service with any predecessor employer, to the
extent service with the predecessor employer is recognized by the Company or
Company Subsidiary) shall be treated as service with Parent and its
Affiliates; provided, however, that such service need not be recognized to the
extent that such recognition would result in any duplication of benefits.

  



  

(c)  With respect to any welfare plan maintained by Parent or
any of its Subsidiaries, including the Surviving Corporation, in which any
employee of the Company or any Company Subsidiary becomes or is eligible to
participate after the Effective Time, Parent shall, or shall cause its
Subsidiaries to, (i) waive all limitations as to preexisting conditions and

  



  

   

58 
--- 

 


--- 

    



  



  

exclusions with respect to participation and coverage requirements applicable
to such employees to the extent such conditions and exclusions were
satisfied or did not apply to such employees under welfare plans of the
Company or its Subsidiaries prior to the Effective Time and (ii) provide each
such employee with credit for any co-payments and deductibles paid and for
out-of-pocket maximums incurred prior to the Effective Time in satisfying any
analogous deductible or out-of-pocket requirements to the extent applicable
under such plan.

  



  

(d)  Parent shall, and shall cause its Subsidiaries, including
the Surviving Corporation, to honor, in accordance with its terms, each
employment agreement listed on _Section 2.13(a)_ of the Company Disclosure
Schedule and all obligations thereunder, including any rights or benefits
arising as a result of the transactions contemplated hereby (either alone or
in combination with any other event, including termination of employment).

  



  

(e)  Upon the Effective Time, the compensation committee of the
board of directors of Parent (or such other body that shall administer the
Parent Stock Plan or any other plan that Parent may from time to time adopt),
shall grant stock options to purchase Parent Common Stock under the Parent
Stock Plan or any other plan that Parent may from time to time adopt, with an
exercise price equal to the Fair Market Value (as such term is defined in the
Parent Stock Plan or any other plan that Parent may from time to time adopt)
of a share of Parent Common Stock on the Closing Date, (i) to those employees
of the Company and Company Subsidiaries, (ii) in such amounts and (iii) in
accordance with the vesting schedule, in each case, as set forth on _Schedule
4.14(e)_  attached hereto as such schedule may be updated by the Company
prior to the Effective Time to reallocate such stock options among employees
of the Company and Company Subsidiaries; provided, however, that the total
number of such stock options shall not be increased above the number set
forth in such schedule at the time that this Agreement is executed.

  



  

(f)  This _Section 4.14_ shall be binding upon and inure
solely to the benefit of each of the parties to this Agreement, and nothing
in this _Section 4.14_, express or implied, shall confer upon any other
Person any rights or remedies of any nature whatsoever under or by reason of
this _Section 4.14_. Nothing contained herein, express or implied (i) shall
be construed to establish, amend or modify any benefit plan, program,
agreement or arrangement or (ii) shall alter or limit the ability of the
Surviving Corporation, Parent or any of their respective Affiliates to
amend, modify or terminate any benefit plan, program, agreement or
arrangement at any time assumed, established, sponsored or maintained by any
of them. The parties hereto acknowledge and agree that the terms set forth in
this _Section 4.14_ shall not create any right in any employee of the
Company or any Company Subsidiary or any other Person to any continued
employment with the Surviving Corporation, Parent or any of their respective
Subsidiaries or compensation or benefits of any nature or kind whatsoever.

  



  

4.15   _Shareholder Litigation_.

  



  

Each of the Company and Parent shall keep the other Party hereto informed of,
and cooperate with such Party in connection with, any shareholder litigation
or claim against such Party and/or its directors or officers relating to the
Merger or the other transactions contemplated by this Agreement; provided,
that, notwithstanding any contrary provision of _Section 4.3_, no

  



  

   

59 
--- 

 


--- 

    



  



  

settlement in connection with such shareholder litigation shall be agreed to
without Parent's prior written consent (which consent shall not be
unreasonably withheld, conditioned or delayed).

  



  

4.16   _NASDAQ; Post-Closing SEC Reports_.

  



  

Prior to the Effective Time, the Company shall cooperate with Parent and use
reasonable efforts to take, or cause to be taken, all actions, and do or
cause to be done all things, reasonably necessary, proper or advisable on its
part under applicable Laws and rules and policies of the NASDAQ to enable the
delisting by the Surviving Corporation of the Company Common Stock from the
NASDAQ and the deregistration of the Company Common Stock under the Exchange
Act, in each case, promptly after the Effective Time. Parent will use
reasonable efforts to cause the Surviving Corporation to file with the SEC (a)
a Form 25 on the Closing Date, or as soon as reasonably practicable
thereafter, following the Closing and (b) a Form 15 on the first business day
that is at least ten (10) days after the date the Form 25 is filed (such
period between the Form 25 filing date and the Form 15 filing date, the "
_Delisting Period_ "). If the Surviving Corporation is reasonably likely to
be required to file any reports pursuant to the Exchange Act during the
Delisting Period, the Company will deliver to Parent at least five (5)
business days prior to the Closing a substantially final draft of any such
reports reasonably likely to be required to be filed during the Delisting
Period (" _Post-Closing SEC Reports_ "). The Post-Closing SEC Reports
provided by the Company pursuant to this _Section 4.16_ will (i) not contain
any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements
made therein, in the light of the circumstances under which they were made,
not misleading and (ii) comply in all material respects with the provisions
of applicable Laws.

  



  

4.17   _FIRPTA Company Certificate_.

  



  

Prior to the Effective Time, the Company shall execute and deliver to Parent
and Sub a certificate (in a form reasonably acceptable to Parent and Sub)
conforming to the requirements of Treasury Regulations Sections 1.1445-2(c)(3)
and 1.897-2(h).

  



  

4.18   _Conduct of Parent and Sub_.

  



  

Subject to applicable Law, neither Parent nor Sub will take any action that,
or fail to take any reasonable action, for which the failure to take such
action, is intended to, or would reasonably be expected to, individually or in
the aggregate, result in any condition to the Merger not being satisfied or
prevent, delay or impede the ability of Parent and Sub or the Company to
consummate the Merger or the other transactions contemplated by this
Agreement.

  



  

4.19   _Section 16 Matters_.

  



  

The Board or a committee of non-employee directors thereof (as such term is
defined for purposes of Rule 16b-3(d) under the Exchange Act) shall adopt a
resolution in advance of the Effective Time providing that the disposition by
the officers and directors of the Company of Company Common Stock, Company
Options or other equity securities of the Company pursuant to the Merger or
the other transactions contemplated by this Agreement is intended to be
exempt

  



  

   

60 
--- 

 


--- 

    



  



  

from liability pursuant to Rule 16b-3 under the Exchange Act and shall take
all such reasonable steps as may be required to cause such dispositions to be
so exempt. The board of directors of Parent or a committee of non-employee
directors thereof (as such term is defined for purposes of Rule 16b-3(d) under
the Exchange Act) shall adopt a resolution in advance of the Effective Time
providing that the receipt by the Company Insiders (as defined below) of
Parent Common Stock or other equity securities of Parent pursuant to the
Merger or the other transactions contemplated by this Agreement (to the
extent such equity securities are listed in the Section 16 Information, as
defined below) is intended to be exempt from liability pursuant to Rule 16b-3
under the Exchange Act. For purposes of this _Section 4.19_, the term "
_Company Insiders_ " means those officers and directors of the Company who are
currently subject to or will become subject to the reporting requirements of
Section 16(a) of the Exchange Act as insiders of Parent in conjunction with
the Merger, and the term " _Section 16 Information_ " means information
provided by Company that is accurate in all respects regarding Company
Insiders and the number of shares of Parent Common Stock or other Parent
equity securities to be acquired by each such Company Insider in connection
with the Merger and other transactions contemplated by this Agreement.

  



  

4.20   _Governance Matters_.

  



  

The Company shall take all reasonable action to cause, effective at the
Effective Time, if requested by Parent, the resignations of such directors
and officers of the Company and/or the Company Subsidiaries as Parent may
request.

  



  

4.21   _SEC Reports_.

  



  

During the period prior to the Effective Time, the Company and Parent shall
each continue to timely file or furnish all forms, reports, statements,
schedules and other materials with the SEC required to be filed or furnished
pursuant to the Exchange Act or other federal or applicable foreign
securities Laws.

  



  

4.22   _Post-Closing Restructuring_.

  



  

As promptly as practicable after the Effective Time, the Surviving
Corporation shall merge with and into a Delaware limited liability company
wholly owned by Parent (the " _LLC_ "), in accordance with the provisions of
the NJBCA and the Delaware Limited Liability Act, as amended (the " _DELLC
Act_ "), and with the effects provided in the NJBCA and the DELLC Act. At the
effective time of such merger, the separate corporate existence of the
Surviving Corporation shall cease, and the LLC shall continue as the
surviving entity in such merger (the " _Surviving Entity_ ") and shall be a
wholly owned Subsidiary of Parent and shall governed by the Laws of the State
of Delaware. From and after the effective time of such merger, the Surviving
Entity shall possess all properties, rights, privileges, powers and franchises
of the Surviving Corporation, and all of the claims, obligations,
liabilities, debts and duties of the Surviving Corporation and the LLC shall
become the claims, obligations, liabilities, debts and duties of the
Surviving Entity.

  



  

   

61 
--- 

 


--- 

    



  



  

Article 5 
  _Conditions Precedent to Obligations to Consummate_

  



  

5.1   _Conditions to Obligations of Each Party_.

  



  

The obligations of the Company, Parent and Sub to effect the Merger and the
other transactions contemplated hereby are subject to the satisfaction or
waiver (other than the Required Company Vote, which may not be waived in any
circumstance) on or prior to the Closing of the following conditions:

  



  

(a)   _Company Shareholder Approval_. The Company shall have
obtained the Required Company Vote in connection with the approval and
adoption of this Agreement, the Merger and the other transactions contemplated
by this Agreement.

  



  

(b)   _No Injunctions or Restraints, Illegality_. No statute,
rule, regulation, executive order, decree or ruling, shall have been adopted
or promulgated, and no temporary restraining order, preliminary or permanent
injunction or other order issued by a court or other U.S. Governmental Entity
of competent jurisdiction shall be in effect, having the effect of making the
Merger or the other transactions contemplated hereby illegal or otherwise
prohibiting consummation of the Merger or the other transactions contemplated
hereby; provided, that the provisions of this _Section 5.1(b)_ shall not be
available to any Party whose failure to fulfill its obligations pursuant to
_Section 4.9_ shall have been the cause of, or shall have resulted in, such
order or injunction.

  



  

(c)   _Antitrust and Competition Laws_. The waiting period (and
any extension thereof) applicable to the Merger and the other transactions
contemplated pursuant to this Agreement under the HSR Act shall have been
terminated or shall have expired, and all waiting period expirations or
terminations, consents, clearances, waivers, licenses, orders, registrations,
approvals, permits, and authorizations necessary under the Antitrust Laws of
the jurisdictions set forth in _Section 5.1(c)_ of the Company Disclosure
Schedule and _Section 5.1(c)_ of the Parent Disclosure Schedule, shall have
been obtained.

  



  

(d)   _Consents and Approvals_. All consents, waivers,
authorizations and approvals of any Governmental Entity or any third party
required in connection with the execution, delivery and performance of this
Agreement and the other transactions contemplated hereby set forth in
_Section 5.1(d)_ of the Company Disclosure Schedule and _Section 5.1(d)_
of the Parent Disclosure Schedule shall have been duly obtained and shall be
in full force and effect on the Closing Date.

  



  

(e)   _Listing_. The Parent Common Stock to be issued in the
Merger shall have been approved for quotation or listing, as the case may be,
on the New York Stock Exchange (or any successor inter-dealer quotation system
or stock exchange thereto) subject to official notice of issuance.

  



  

(f)   _Effectiveness of the Registration Statement_. The
Registration Statement shall have been declared effective by the SEC under
the Securities Act. No stop order

  



  

   

62 
--- 

 


--- 

    



  



  

suspending the effectiveness of the Registration Statement shall have been
issued by the SEC and no proceedings for that purpose and no similar
proceeding in respect of the Proxy Statement/Prospectus shall have been
initiated or threatened by the SEC.

  



  

5.2   _Conditions to Obligations of Parent and Sub_.

  



  

The obligations of Parent and Sub to effect the Merger and the other
transactions contemplated hereby are subject to the satisfaction, or waiver
by Parent, on or prior to the Closing, of the following additional conditions:

  



  

(a)   _Representations and Warranties_. The representations and
warranties of the Company set forth in _Article 2 _ of this Agreement shall
be true and correct with such exceptions as would not, individually or in the
aggregate, reasonably be expected to have a Company Material Adverse Effect
(without giving effect to any limitation indicated therein by the
words "Company Material Adverse Effect," "in all material respects," "in any
material respect," "material" or "materially" used with respect to the
Company (each, a " _Company Materiality Qualifier_ ")) when made and as of
the Closing Date, as if made at and as of such date (except those
representations and warranties that address matters only as of a particular
date, which shall be true and correct in all respects only as of such date),
provided, that the representations and warranties of the Company set forth
(i) in _Sections 2.3_ (other than the last sentence of _2.3(b)_ ),  _2.4(a)_
, _2.4(b)(i)_ , _2.4(c)(ii)_ , _2.4(d)_ , _2.23_ , _2.25_ and the first
sentence of _Sections 2.1(a)_ and _2.1(b)_ , shall be true and correct in all
respects (without giving effect to any Company Materiality Qualifier therein)
other than inaccuracies that are de minimis in the context of a transaction of
this magnitude, and (ii) in _Section 2.7(b)_ shall be true and correct in all
respects, in each of the foregoing cases, when made and as of the Closing
Date, as if made at and as of such date (except those representations and
warranties that address matters only as of a particular date, which shall be
true and correct in all respects only as of that date). Parent shall have
received a certificate of an executive officer of the Company to such effect.
For purposes of this _Section 5.2(a)_ , "de minimis" with respect to
inaccuracies in _Section 2.3_ shall mean inaccuracies involving, in the
aggregate, an amount of shares of Company Common Stock not in excess of
69,510.

  



  

(b)   _Performance of Obligations of the Company_. The Company
shall have performed in all material respects and complied in all material
respects with all agreements and covenants required to be performed or
complied with by it under this Agreement at or prior to the Closing Date;
provided that the failure to notify Parent in accordance with _Sections
4.1(c)_ , _4.4(a) _ and _4.4(b)_ shall not be deemed to be a failure to
perform or comply with such agreements and covenants unless such notice was
with respect to a fact, change, event, effect or occurrence that has had or
that would reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect. Parent shall have received a certificate of
an executive officer of the Company to such effect.

  



  

(c)   _Parent Tax Opinion_. Parent shall have received a
written opinion of counsel from Greenberg Traurig, P.A., in form reasonably
satisfactory to Parent (the " _Parent Tax Opinion_ " and together with the
Company Tax Opinion, the " _Tax Opinions_ "), dated as of the Closing Date,
to the effect that the Merger will qualify as a "reorganization" within the
meaning of Section 368(a) of the Code. In rendering such Parent Tax Opinion,
such counsel shall be

  



  

   

63 
--- 

 


--- 

    



  



  

entitled to rely upon representations of officers of Company and Parent
reasonably satisfactory in form and substance to such counsel. If Greenberg
Traurig, P.A. does not render such opinion, this condition may be satisfied if
a nationally-recognized law firm (other than Davis Polk and Wardwell LLP)
renders such opinion, relying upon representations of officers of the Company
and Parent reasonably satisfactory in form and substance to such firm.

  



  

5.3   _Conditions to Obligations of the Company_.

  



  

The obligations of the Company to effect the Merger and the other
transactions contemplated hereby are subject to the satisfaction of, or
waiver by the Company, on or prior to the Closing of the following additional
conditions:

  



  

(a)   _Representations and Warranties_. The representations and
warranties of Parent and Sub set forth in _Article 3_ of this Agreement shall
be true and correct with such exceptions as would not, individually or in the
aggregate, reasonably be expected to have a Parent Material Adverse Effect
(without giving effect to any limitation indicated therein by the words
"Parent Material Adverse Effect," "in all material respects," "in any
material respect," "material" or "materially" used with respect to Parent or
Sub (each, a " _Parent Materiality Qualifier_ ")) when made and as of the
Closing Date, as if made at and as of such date (except those representations
and warranties that address matters only as of a particular date, which shall
be true and correct in all respects only as of such date), provided, that the
representations and warranties of Parent and Sub set forth in (i) _Sections
3.2(a)_ , _3.2(b)(i)_ , _3.4_ , _3.18_ and _3.19_ , and the first sentence of
_Sections 3.1(a)_ and _3.1(b)_ shall be true and correct in all respects
(without giving effect to any Parent Materiality Qualifier therein) other
than inaccuracies that are de minimis in the context of a transaction of
this magnitude, and (ii) _Section 3.8(a)_ shall be true and correct in all
respects, in each of the foregoing cases, when made and as of the Closing
Date, as if made at and as of such date (except those representations and
warranties that address matters only as of a particular date, which shall be
true and correct in all respects only as of that date). The Company shall have
received a certificate of an executive officer of Parent and Sub to such
effect. For purposes of this _Section 5.3(a)_ , "de minimis" with respect to
inaccuracies in _Section 3.4(a)_ shall mean inaccuracies involving, in the
aggregate, an amount of shares of Parent Common Stock not in excess of
1,158,229.

  



  

(b)   _Performance of Obligations of Parent_. Parent shall have
performed in all material respects and complied in all material respects with
all agreements and covenants required to be performed or complied with by it
under this Agreement at or prior to the Closing Date; provided that the
failure to notify the Company in accordance with _Section 4.4(a)_ shall not be
deemed to be a failure to perform or comply with such agreements and
covenants unless such notice was with respect to a fact, change, event,
effect or occurrence that has had or that would reasonably be expected to
have, individually or in the aggregate, a Parent Material Adverse Effect. The
Company shall have received a certificate of an executive officer of Parent to
such effect.

  



  

(c)   _Company Tax Opinion_. Company shall have received a
written opinion of counsel from Davis Polk and Wardwell LLP, in form reasonably
satisfactory to Company (the " _Company Tax Opinion_ "), dated as of the
Closing Date, to the effect that the Merger will qualify

  



  

   

64 
--- 

 


--- 

    



  



  

as a "reorganization" within the meaning of Section 368(a) of the Code.
In rendering such Company Tax Opinion, such counsel shall be entitled to rely
upon representations of officers of the Company and Parent reasonably
satisfactory in form and substance to such counsel. If Davis Polk and Wardwell
LLP does not render such opinion, this condition may be satisfied if a
nationally-recognized law firm (other than Greenberg Traurig, P.A.) renders
such opinion, relying upon representations of officers of the Company and
Parent reasonably satisfactory in form and substance to such firm.

  



  

Article 6 
  _Termination_

  



  

6.1   _Termination_.

  



  

This Agreement may be terminated at any time prior to the Effective Time,
whether before or after receipt of the Required Company Vote (except as
otherwise expressly noted):

  



  

(a)  by mutual written consent of Parent and the Company, by
action of their respective boards of directors;

  



  

(b)  by either the Company or Parent if:

  



  

(i)  the Effective Time shall not have occurred on or before
December 2, 2015 (the " _Termination Date_ "); provided that the Termination
Date shall be automatically extended for a period of ninety (90) days in the
event that the failure of the Closing to have occurred by the initial
Termination Date results primarily by the failure of any of the conditions set
forth in  _Sections 5.1(c)_, _5.1(d)_ , _5.1(e)_ or _5.1(f)_ ; and provided
further, that the right to terminate this Agreement under this _Section
6.1(b)(i)_ shall not be available to any Party whose failure to fulfill any
obligation under this Agreement has been the principal cause of the failure of
the Effective Time to occur on or before the Termination Date and such action
or failure to perform constitutes a breach of this Agreement;

  



  

(ii)  if any Governmental Entity of competent jurisdiction shall
have issued an order, decree or ruling or taken any other action permanently
restraining, enjoining or otherwise prohibiting or making illegal the
transactions contemplated by this Agreement, and such order, decree, ruling
or other action shall be in effect and shall have become final and
nonappealable; provided that the Party seeking to terminate this Agreement
pursuant to _Section 6.1(b)(ii)_ shall have used its reasonable best efforts
to resist, remove or resolve such restraint or prohibition as required by this
Agreement; and provided, further, that the right to terminate this Agreement
pursuant to this _Section 6.1(b)(ii)_ shall not be available to any
Party whose material breach of any provision of this Agreement results in the
imposition of such order, decree or ruling or the failure of such order,
decree or ruling to be resisted, resolved or lifted; or

  



  

(iii)  if the Company Shareholders' Meeting shall have been
conducted and the Required Company Vote shall not have been obtained.

  



  

(c)  by Parent, if:

  



  

   

65 
--- 

 


--- 

    



  



  

(i)  the Company shall have breached or failed to perform in
any respect any of its representations, warranties, covenants or agreements
contained in this Agreement, which breach or failure to perform (A) is not
capable of being, or is not, cured by the Company within ninety (90) days
following receipt by the Company of written notice of such breach or failure
to perform from Parent (or, if earlier, the Termination Date), and (B) would
result in a failure of any condition set forth in _Sections  5.1_ or _5.2_ ;
provided that Parent's right to terminate this Agreement pursuant to this
_Section 6.1(c)(i) _shall not be available if Parent or Sub is then in
material breach of any of its representations, warranties, covenants
or agreements hereunder that would result in the conditions to Closing set
forth in _Sections 5.1_ or _5.3_ not being satisfied;

  



  

(ii)  (A)(i) the Board fails to include the Company Board
Recommendation in the Proxy Statement/Prospectus or (ii) a Change in
Recommendation or a Company Intervening Event Change in Recommendation shall
have occurred; (B) there has been a publicly announced Company Acquisition
Proposal that is not with respect to a tender offer or exchange offer, and the
Board shall have failed to publicly reaffirm the Company Board Recommendation
within five (5) Business Days after Parent so requests in writing; (C)
the Company enters into a written agreement with respect to a Company
Acquisition Agreement; or (D) the Company or the Board shall have publicly
announced its intention to do any of the foregoing; or

  



  

(d)  by the Company if

  



  

(i)  Parent or Sub shall have breached or failed to perform in
any respect any of their respective representations, warranties, covenants or
agreements contained in this Agreement, which breach or failure to perform (A)
is not capable of being, or is not, cured by Parent within ninety (90) days
following receipt by Parent of written notice of such breach or failure to
perform from the Company (or, if earlier, the Termination Date), and (B)
would result in a failure of any condition set forth in  _Sections 5.1_ or
_5.3_ ; provided, that the Company's right to terminate this Agreement
pursuant to this _Section 6.1(d)(i)_ shall not be available if the Company
is then in material breach of any of its representations, warranties,
covenants or agreements hereunder that would result in the conditions to
Closing set forth in _Sections 5.1 _or _5.2_ not being satisfied;

  



  

(ii)  there is a Change in Recommendation (for the avoidance of
doubt, but not a Company Intervening Event Change in Recommendation) after
complying with _Section 4.7_; or

  



  

(iii)  the Company enters into a Company Acquisition Agreement
with respect to a Superior Proposal after complying with the requirements of
_Section 4.7_ and concurrently with such termination the Company pays to
Parent the Company Termination Fee pursuant to _Section 6.2(b)_.

  



  

   

66 
--- 

 


--- 

    



  



  

6.2   _Effect of Termination_.

  



  

(a)  Except as provided in this _Section 6.2_, in the event of
termination of this Agreement by either the Company or Parent as provided in
_Section 6.1_, this Agreement (other than _Section 4.8(b)_, _4.12_ ,  _6.2_
, _6.3_ and _Article 7_ ) shall forthwith become void and there shall be no
liability or obligation on the part of Parent, Sub or the Company or their
respective Representatives; provided, that the termination of this
Agreement shall not relieve any Party from any liability or damage (which the
parties acknowledge and agree shall not be limited to the reimbursement of
expenses or out-of-pocket costs, and may include to the extent proven the
benefit of the bargain lost by a party's stockholders (taking into
consideration relevant matters including other combination opportunities and
the time value of money), which shall be deemed in such event to be damages
of such party) as a result of any fraud or intentional and material breach
of this Agreement by any party.

  



  

(b)  If (x) Parent shall terminate this Agreement pursuant to
_Sections 6.1(c)(i) _or _6.1(c)(ii)(B)_  or (y) Parent or the Company shall
terminate this Agreement pursuant to _Sections 6.1(b)(i)_ (provided that the
Company Shareholders' Meeting has not yet been held) or _6.1(b)(iii)_ , and,
in either case (x) or (y), at any time after the date of this Agreement and
prior to the termination of this Agreement a Company Acquisition Proposal
shall have been publicly disclosed and not publicly withdrawn, then (A) the
Company shall pay Parent the Expense Reimbursement within one (1)
Business Day after Parent's demand therefor and (B) if within twelve (12)
months after such termination, the Company enters into a Company Acquisition
Agreement or consummates a Company Acquisition Proposal, then the Company
shall pay to Parent an amount equal to $54,000,000 (the " _Company
Termination Fee_ ") by wire transfer of same day funds on the earlier of
the date of entry into the Company Acquisition Agreement and such
consummation.

  



  

(c)  If (x) Parent shall terminate this Agreement pursuant to
_Sections 6.1(c)(ii)(A)_, _(C)_ or _(D) _ or (y) the Company shall terminate
this Agreement pursuant to _Section 6.1(d)(ii)_ then, in either case,
the Company shall pay to Parent (1), not later than two (2) Business Days
following such termination, an amount equal to the Company Termination Fee
and (2) the Expense Reimbursement within one (1) Business Day after Parent's
demand therefor; provided, however, that if a termination under _Section
6.1(c)(ii)(A)_ is pursuant to clause (ii) thereof because a Company
Intervening Event Change in Recommendation has occurred, then in lieu of the
Company Termination Fee, the Company shall pay to Parent an amount equal to
$40,500,000 (the " _Company Intervening Event Termination Fee_ ") (and, for
the avoidance of doubt, the Expense Reimbursement). In addition, if Parent
shall terminate this Agreement in a situation where it receives the Company
Intervening Event Termination Fee and within twelve (12) months after such
termination, the Company enters into a Company Acquisition Agreement or
consummates a Company Acquisition Proposal, then the Company shall pay to
Parent an amount equal to $13,500,000 on the earlier of the date of entry
into the Company Acquisition Agreement and such consummation. For the
elimination of doubt, this amount shall be in addition to the Company
Intervening Event Termination Fee and the Expense Reimbursement that the
Company shall pay to Parent pursuant to this _Section 6.2(c)_.

  



  

   

67 
--- 

 


--- 

    



  



  

(d)  If the Company shall terminate this Agreement pursuant to
_Section 6.1(d)(iii)_, then the Company shall pay to Parent the Company
Termination Fee concurrently with such termination and the Expense
Reimbursement within one (1) Business Day after Parent's demand therefor.

  



  

(e)  For purposes of this _Section 6.2_, (A) the term "
_Company Acquisition Proposal_ " shall have the meaning assigned to such term
in _Section 4.7(d)(ii)_, except that the reference to "fifteen
percent (15%)" in the definition of " _Company Acquisition Proposal_ " shall
be deemed to be a reference to "fifty percent (50%)" and (B) the term "
_Expense Reimbursement_ " shall mean Parent's documented out-of-
pocket expenses incurred in connection with investigating, negotiating,
documenting and implementing this Agreement and the transactions contemplated
hereby not in excess of an aggregate of $3,000,000.

  



  

(f)  All payments under this _Section 6.2_ shall be made by
wire transfer of immediately available funds to an account or accounts
designated by Parent.

  



  

(g)  The Company acknowledges that the agreements contained in
this _Section 6.2_ are an integral part of the transactions contemplated by
this Agreement and are not a penalty, and that, without these agreements,
Parent and Sub would not enter into this Agreement. Nothing contained in this
_Section 6.2_ shall constitute or shall be deemed to constitute liquidated
damages for the intentional breach by the Company of the terms of this
Agreement or otherwise limit the rights of Parent. If the Company fails to
pay promptly any fees or expenses due pursuant to this _Section 6.2_, the
Company will also pay to Parent Parent's reasonable costs and expenses
(including legal fees and expenses) in connection with any action, including
the filing of any lawsuit or other legal action, taken to collect payment,
together with interest on the amount of the unpaid fees or expenses under
this _Section 6.2_, accruing from its due date, at an interest rate per annum
equal to two (2) percentage points in excess of the prime commercial lending
rate quoted by The Wall Street Journal. Any change in the interest rate
hereunder resulting from a change in such prime rate will be effective at the
beginning of the date of such change in such prime rate. Under no
circumstances shall the Company be obligated to pay more than one (1) Company
Termination Fee. If Parent receives the Company Termination Fee pursuant to
_Sections 6.2(b)_, _6.2(c)_ , or _6.2(d)_ , the collection of such fee will
be the sole and exclusive remedy (other than receipt of the Expense
Reimbursement) of Parent and Sub in respect of (i) any breach of, or
inaccuracy contained in the Company's covenants, agreements, representations
or warranties in this Agreement, (ii) any loss suffered as a result of the
failure of the Merger to be consummated and (iii) any other losses, damages,
obligations or liabilities suffered as a result of or under this Agreement and
the transactions contemplated hereby. Upon payment of the Company Termination
Fee in accordance with this _Section 6.2_, none of the Company, or any of
its shareholders, directors, Affiliates, officers or agents shall have any
further liability or obligation relating to or arising under this Agreement
or the transactions contemplated hereby (other than with respect to the
payment of the Expense Reimbursement, if such Expense Reimbursement has not
yet been paid).

  



  

6.3   _Expenses_. Except as otherwise provided herein, including
as set forth in _Section 6.2_, all Expenses shall be borne by the Party
incurring such Expenses, it being understood and agreed that the fee payable
under the HSR Act shall be borne equally by Parent

  



  

   

68 
--- 

 


--- 

    



  



  

and the Company and each of the Company and Parent shall pay half of any
administrative filing fees required to be paid in connection with any filing
made under any Foreign Antitrust Filing in connection with the
transactions contemplated hereby.

  



  

Article 7 
  _Miscellaneous_

  



  

7.1   _Definitions_.

  



  

(a)  Except as otherwise provided herein, the capitalized terms
set forth below shall have the following meanings:

  



  

" _Acceptable NDA_ " means a confidentiality agreement containing terms at
least as restrictive with respect to such Person as the terms contained in
the Confidentiality Agreement are with respect to Parent (provided that such
confidentiality agreement may provide that any standstill provisions shall
terminate if there is a public announcement that a third party other than
Parent has entered into an agreement with the Company with respect to a
Company Acquisition Proposal or such third party has publicly announced
that it intends to commence a tender offer with respect to the Company's
equity securities), subject, however, to the last sentence of _Section
4.7(c)_.

  



  

" _Affiliate_ " of a Person means (x) any other Person directly, or
indirectly through one or more intermediaries, controlling, controlled by or
under common control with such Person and (y) for purposes of Section 4.7 any
officer or director of such Person.

  



  

" _Antitrust Laws_ " mean the Sherman Act, as amended, the Clayton Act, as
amended, the HSR Act, the Federal Trade Commission Act, as amended, and all
other state, foreign, national, multinational, and supra-national Laws, if
any, that are designed or intended to control mergers and acquisitions or to
prohibit, restrict or regulate actions having the purpose or effect of
monopolization or restraint of trade or lessening of competition through
merger or acquisition.

  



  

" _Assets_ " of a Person means all of the assets, properties, businesses and
rights of such Person of every kind, nature, character and
description, whether tangible or intangible, accrued or contingent, or
otherwise relating to or utilized in such Person's business, directly or
indirectly, in whole or in part, whether or not carried on the books and
records of such Person, and whether or not owned in the name of such Person
or any Affiliate of such Person and wherever located.

  



  

" _Audit_ " means any audit, investigation, claim, assessment of Taxes,
deficiency action, other examination by any Governmental Entity, or any
administrative or judicial proceeding or appeal of such proceeding relating to
Taxes.

  



  

" _Business Day_ " means a day except a Saturday, a Sunday or other day on
which the SEC or banks in the City of New York are authorized or required by
Law to be closed.

  



  

" _CLIA_ " means the Clinical Laboratory Improvement Amendments of 1988, 42
U.S.C.  263a _et seq_. and its implementing regulations at 42 C.F.R. pts.
493 and 498.

  



  

   

69 
--- 

 


--- 

    



  



  

" _CMS_ " means the Centers for Medicare and Medicaid Services, a non-
independent agency within the United States Department of Health and Human
Services

  



  

" _Company Common Stock_ " means the common stock, par value $0.01 per share,
of the Company.

  



  

" _Company Disclosure Schedule_ " means the written information set forth in
a disclosure letter delivered as of the date of this Agreement to Parent and
attached hereto describing in reasonable detail the matters contained therein
and, with respect to each disclosure made therein, referencing each Section
of this Agreement under which such disclosure is being made. Unless
reasonably apparent from its face, information disclosed with respect to one
Section shall not be deemed to be disclosed for purposes of any other Section
not specifically referenced with respect thereto.

  



  

" _Company Entities_ " means, collectively, the Company and the Company
Subsidiaries.

  



  

" _Company Material Adverse Effect_ " means any state of facts, event,
change, circumstance, development, effect or occurrence which, individually
or together with any other state of facts, event, change, circumstance,
development, effect or occurrence, has or would reasonably be expected to
have a material adverse effect on (i) the assets, properties, capitalization,
condition (financial or otherwise), financial position, business or results
of operations of the Company Entities, taken as a whole; provided, that "
_Company Material Adverse Effect_ " shall be deemed to exclude the impact of
(A) changes after the date hereof in Laws (or interpretations thereof) of
general applicability or interpretations thereof by Governmental Entities, (B)
changes or modifications after the date hereof in GAAP or regulatory
accounting requirements (or regulatory interpretations thereof), (C) actions
and omissions of any Company Entity taken with the prior written consent of
Parent or expressly permitted pursuant to this Agreement, (D) the public
announcement of this Agreement, including, without limitation, any shareholder
litigation related to this Agreement, (E) changes in the market price or
trading volume of Company Common Stock (it being understood that any cause of
any such change may be taken into consideration when determining whether a
Company Material Adverse Effect has occurred or would reasonably be expected
to occur, unless such cause is otherwise excluded), (F) general national or
international economic, financial, political or business conditions including
the engagement by the United States in hostilities, whether or not pursuant
to a declaration of a national emergency or war, or the occurrence of any
military or terrorist attack upon the United States or any of its
territories, possession or diplomatic or consular offices or upon any military
installation, equipment or personnel of the United States, or (G) any failure
by the Company to meet internal projections, budgets or forecasts or third-
party revenue or earnings predictions or other analyst expectations,
projections, forecasts or budgets for any period (it being understood that
any cause of any such failure may be taken into consideration when determining
whether a Company Material Adverse Effect has occurred or would reasonably be
expected to occur, unless such cause is otherwise excluded); provided, that
state of facts, events, changes, circumstances, developments, effects or
occurrences referred to in clauses (A), (B) and (F) above shall be considered
for purposes of determining whether there has been or would

  



  

   

70 
--- 

 


--- 

    



  



  

reasonably be expected to be a Company Material Adverse Effect if and to the
extent such state of facts, events, changes, circumstances, developments,
effects or occurrences has had or would reasonably be expected to have a
disproportionate adverse effect on the Company and the Company
Subsidiaries, as compared to other companies operating in the industry or
territory in which the Company and the Company Subsidiaries operate; or (ii)
the ability of the Company to perform its obligations under this Agreement or
to consummate the Merger or the other transactions contemplated by this
Agreement.

  



  

" _Company Material Contract_ " means any Contract that is binding upon the
Company or any Company Subsidiary and that: (i) would be required to be filed
by the Company as a "material contract" pursuant to Item 601(b)(10) of
Regulation S-K under the Securities Act; (ii) contains covenants that limit
the ability of the Company or any Company Subsidiary (or which, following the
consummation of the Merger, could restrict or purport to restrict the ability
of the Surviving Corporation or Parent or any of their Affiliates) to compete
in any business or with any Person or in any geographic area; (iii) is
required to be set forth in _Section 2.15(c)_ of the Company Disclosure
Schedule; (iv) involves the payment to or from any Company Entity of $250,000
or more; (v) relates to indebtedness for borrowed money or any third-party
financial guaranty, in each case in excess of $1,000,000; (vi) any Lease that
is required to be set forth in _Section 2.17_ of the Company Disclosure
Schedule; (vii) involves any exchange traded or over the counter swap,
forward, future, option, cap, floor or collar financial Contract, or
other derivative Contract, or any other interest rate or foreign currency
protection Contract, not entered into in the ordinary course of business
consistent with past practice; (viii) involves the acquisition or disposition,
directly or indirectly (by merger or otherwise), of a business or capital
stock or other equity interest of another Person outside of the ordinary
course of business consistent with past practice, which acquisition or
disposition has yet to be consummated; or (ix) contains a "standstill" or
similar provision that restricts the ability of the Company, the Company
Subsidiaries or any of their respective Affiliates to acquire any of the
securities or assets of a third party or such third party's Affiliates.

  



  

" _Company Option Plan_ " means, either individually or collectively, the
Company's 2000 Employee Incentive Stock Option Plan and 2003 Employee
Incentive Stock Option Plan.

  



  

" _Company Preferred Stock_ " means the preferred stock, par value $0.10 per
share, of the Company.

  



  

" _Company SEC Documents_ " means the SEC Documents of the Company.

  



  

" _Company Services_ " means all commercial services provided by the Company
including testing of human specimens for any purpose.

  



  

" _Company Shareholders ' Meeting_" means the meeting of the shareholders of
the Company to approve and adopt this Agreement, the Merger and the
transactions contemplated hereby, including any adjournment or adjournments
thereof.

  



  

" _Company Subsidiaries_ " means the Subsidiaries of the Company, which shall
include any corporation, limited liability company, limited partnership,
limited liability partnership or other organization acquired as a Subsidiary
of the Company in the future and held as a Subsidiary by the Company at the
Effective Time.

  



  

   

71 
--- 

 


--- 

    



  



  

" _Consent_ " means any consent, approval, authorization, clearance,
exemption, waiver, or similar affirmation by any Person pursuant to
any Contract, Law, Lease, Order or Permit.

  



  

" _Contract_ " means any written or oral agreement, arrangement,
authorization, commitment, contract, indenture, instrument, license,
obligation, plan, practice, restriction, promise, understanding, or
undertaking of any kind or character, or other document to which any
Person is a party or that is binding on any Person or its capital stock,
Assets or business (but specifically excluding the Leases).

  



  

" _Default_ " means (i) any breach or violation of, default under,
contravention of, or conflict with, any Contract, Lease, Law, Order, or
Permit; (ii) any occurrence of any event that with the passage of time or the
giving of notice or both would constitute a breach or violation of, default
under, contravention of, or conflict with, any Contract, Lease, Law, Order, or
Permit; or (iii) any occurrence of any event that with or without the passage
of time or the giving of notice would give rise to a right of any Person to
exercise any remedy or obtain any relief under, terminate or revoke, suspend,
cancel, or modify or change the current terms of, or renegotiate, or to
accelerate the maturity or performance of, or to increase or impose any
Liability under, any Contract, Lease, Law, Order, or Permit.

  



  

" _Environmental Laws_ " means all foreign, federal, state, or local
statutes, regulations, ordinances, orders, judgments, codes, decrees or other
legal requirements protecting the environment, including the ambient air,
soil, surface water or groundwater or natural resources, pollution or human
exposure to Materials of Environmental Concern.

  



  

" _Environmental Permits_ " means all permits, licenses, registrations, and
other authorizations of Governmental Entities required under applicable
Environmental Laws.

  



  

" _Equity Rights_ " means all binding arrangements, calls, commitments,
Contracts, options, rights to subscribe to, scrip, warrants, or other binding
obligations of any character whatsoever in each case by which a Person is or
may be bound to issue additional shares of its capital stock or other Equity
Rights, including securities or rights convertible into or exchangeable for
shares of the capital stock of that Person.

  



  

" _Exchange Act_ " means the Securities Exchange Act of 1934, as amended.

  



  

" _Exhibit_ " means the Exhibits so marked, copies of which are attached to
this Agreement. Such Exhibits are hereby incorporated by reference herein and
made a part hereof, and may be referred to in this Agreement and any other
related instrument or document without being attached hereto or thereto.

  



  

" _Expenses_ " of a Person means all fees and expenses, including all out-of-
pocket expenses (including all fees and expenses of counsel,
accountants, investment bankers, experts and consultants to a Party hereto
and its Affiliates), incurred by or on behalf of such Person in connection
with or related to the authorization, preparation, negotiation, execution and
performance of this Agreement, the Confidentiality Agreement and the
transactions contemplated hereby and thereby, including the preparation,
printing, filing and mailing, as the

  



  

   

72 
--- 

 


--- 

    



  



  

case may be, of the Proxy Statement/Prospectus, the Registration Statement and
the other Required Filings and any amendments or supplements thereto, and the
solicitation of shareholder approval and all other matters related to the
transactions contemplated hereby.

  



  

" _FDA_ " means the United States Food and Drug Administration.

  



  

" _GAAP_ " means United States generally accepted accounting principles.

  



  

" _Governmental Entity_ " shall mean any foreign, multinational, supra-
national, or domestic arbitrator, court, nation, governmental or quasi-
governmental agency, government, any state or other political subdivision
thereof and any entity exercising executive, legislative, judicial regulatory
or administrative functions of, or pertaining to, government.

  



  

" _Healthcare Regulatory Authorizations_ " means all approvals, clearances,
authorizations, registrations, certifications, licenses and permits granted
by any Healthcare Regulatory Authority, including participation agreements
with governmental third-party payors, including by way of example, Medicare,
Medicare Advantage, Medicaid, Tricare, FEHBP and any "federal health care
program," as that term is defined in Social Security Act  1128B(f), and
certificates of compliance and certificates of accreditation issued pursuant
to CLIA.

  



  

" _HSR Act_ " means Section 7A of the Clayton Act, as added by Title II of
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the
rules and regulations promulgated thereunder.

  



  

" _IRS_ " means the United States Internal Revenue Service.

  



  

" _Knowledge_ " as used with respect to a Person (including references to
such Person being aware of a particular matter) means, except as
otherwise specifically provided herein, the personal knowledge after
reasonable inquiry of the chairman, chief executive officer, president, chief
financial officer, chief accounting officer, chief operating officer, or
general counsel of such Person.

  



  

" _Law_ " means any foreign, federal, state or local law, statute, code,
ordinance, rule, regulation or other requirement.

  



  

" _Leases_ " means all leases, subleases, licenses, concessions and other
agreements (written or oral) pursuant to which the Company or any Company
Subsidiary holds any Leased Real Property, including the right to all security
deposits and other amounts and instruments deposited by or on behalf of the
Company or any Company Subsidiary thereunder.

  



  

" _Leased Real Property_ " means all material leasehold or subleasehold
estates and other rights to use or occupy any land, buildings, structures,
improvements, fixtures or other interest in real property held by the Company
or any Company Subsidiary.

  



  

" _Liability_ " means any direct or indirect, primary or secondary,
liability, indebtedness, obligation, penalty, cost or expense (including
costs of investigation, collection and defense), claim, deficiency, guaranty
or endorsement of or by any Person (other than endorsements of

  



  

   

73 
--- 

 


--- 

    



  



  

notes, bills, checks and drafts presented for collection or deposit in the
ordinary course of business) of any type, whether accrued, absolute or
contingent, liquidated or unliquidated, matured or unmatured, or otherwise.

  



  

" _Lien_ " means any conditional sale agreement, default of title, easement,
encroachment, encumbrance, hypothecation, lien, mortgage,
pledge, reservation, restriction, security interest, title retention or other
security arrangement, or any charge of any nature whatsoever of, on, or with
respect to any property or property interest, other than (i) liens reflected
(or with respect to liabilities reflected) in the most recent audited
financial statements of the Company or any Company Subsidiary or Parent or any
of its Subsidiaries, as applicable; (ii) mechanics', materialmen's, workmen's
or similar liens; (iii) easements, rights of way or similar encumbrances that
do not materially interfere with the operations of the business of the Company
Entities or the Parent Entities, as applicable, as presently conducted; (iv)
liens for Taxes and all water, sewer, utility, trash and other similar
charges, in each case that are not yet due and payable or are being contested
in good faith; (v) with respect to _Article 4_  hereof, all matters created
or caused by or on behalf of, or with the written consent of, Parent; (vi)
licenses to Intellectual Property granted in the ordinary course of business
consistent with past practice; (vii) restrictions on transfers arising
under applicable securities Laws; (viii) liens that would be set forth in a
title policy, title report or survey with respect to the applicable real
property; and (A) are not substantial in character, amount or extent in
relation to the applicable real property and (B) do not materially and
adversely impact the Company's current or contemplated use, utility or value
of the applicable real property or otherwise materially and adversely impair
the Company's present or contemplated business operations at such location,
(ix) liens with respect to the Company's amended revolving note payable loan
agreement and (x) liens with respect to capital leases for equipment entered
into in the ordinary course of business consistent with past practice ((i)
through (x), collectively, " _Permitted Liens_ ").

  



  

" _Litigation_ " means any action, arbitration, cause of action, lawsuit,
claim, complaint, criminal prosecution, governmental or other examination or
investigation, audit (other than regular audits of financial statements by
outside auditors and review or examination of a patent or patent application
by a patent office), compliance review, inspection, hearing, administrative or
other proceeding relating to or affecting a Party, its business, its records,
its policies, its practices, its compliance with Law, its actions, its
Assets (including Contracts related to it), or the transactions contemplated
by this Agreement.

  



  

" _made available_ ", with respect to a particular document, means that such
document was included in the virtual data room assembled by the Company and
its Representatives and made accessible to Parent and its Representatives and
included in such virtual data room prior to the date hereof and was
accessible to Parent and its Representatives and included therein as of 5:00
p.m., New York City time, on the date that is two Business Days prior to the
date hereof.

  



  

" _Material_ " or " _material_ " for purposes of this Agreement shall be
determined in light of the facts and circumstances of the matter in question;
provided that any specific monetary amount stated in this Agreement shall
determine materiality in that instance.

  



  

   

74 
--- 

 


--- 

    



  



  

" _Materials of Environmental Concern_ " means any pollutants or contaminants
or any hazardous, acutely hazardous, radioactive or toxic substance, material
or medical or other waste defined and regulated as such under Environmental
Laws.

  



  

" _Medicare_ " means the federal health insurance program administered by CMS
pursuant to titles II, XI and XVIII of the Social Security Act, and includes
Medicare Advantage as set forth in 42 C.F.R. pt. 422.

  



  

" _Medicaid_ " means the federal-state health program for the categorically
and medically needy administered by the states pursuant to state plans with
CMS pursuant to XI and XIX of the Social Security Act.

  



  

" _NASDAQ_ " means the NASDAQ Global Select Market.

  



  

" _OIG_ " means the office with the United States Department of Health and
Human Services charged with, among other things, combatting fraud, waste and
abuse in federal health care programs.

  



  

" _Order_ " means any administrative award, settlement, decree, injunction,
judgment, quasi-judicial decision or award, ruling or writ of any
Governmental Entity.

  



  

" _Organizational Documents_ " means with respect to any entity, the
certificate or articles of incorporation and bylaws of such entity or any
similar charter or other organizational documents of such entity.

  



  

" _Owned Intellectual Property_ " means all Intellectual Property that is
owned by the Company or any Company Subsidiary (whether solely or jointly
with a third party).

  



  

" _Owned Real Property_ " means all land, together with all buildings,
structures, improvements and fixtures located thereon, and all easements and
other rights and interests appurtenant thereto, owned by the Company or any
Company Subsidiary.

  



  

" _Parent Common Stock_ " means the common stock, par value $0.01 per share,
of the Parent.

  



  

" _Parent Disclosure Schedule_ " means the written information set forth in
the disclosure letter delivered as of the date of this Agreement by Parent to
the Company.

  



  

" _Parent Entities_ " means, collectively, Parent and all Parent
Subsidiaries.

  



  

" _Parent Financial Statements_ " means the consolidated balance sheets
(including related notes and schedules, if any) of Parent as of December 31,
2014 and the related statements of operations, changes in stockholders'
equity, and cash flows (including related notes and schedules, if any) for
each of the three fiscal years ended December 31, 2014, 2013 and 2012, as
filed by Parent in SEC Documents.

  



  

   

75 
--- 

 


--- 

    



  



  

" _Parent Material Adverse Effect_ " means any state of facts, event, change,
circumstance, development, effect or occurrence which, individually or
together with any other state of facts, event, change, circumstance,
development, effect or occurrence, has or would reasonably be expected to
have a material adverse effect on (i) the assets, properties, capitalization,
condition (financial or otherwise), financial position, business or results
of operations of the Parent Entities, taken as a whole; provided, that "
_Parent Material Adverse Effect_ " shall be deemed to exclude the impact of
(A) changes after the date hereof in Laws (or interpretations thereof) of
general applicability or interpretations thereof by Governmental Entities, (B)
changes or modifications after the date hereof in GAAP or regulatory
accounting requirements (or regulatory interpretations thereof), (C) actions
and omissions of Parent or any of its Subsidiaries taken with the prior
written consent of the Company, (D) the public announcement of this
Agreement, including, without limitation, any shareholder litigation related
to this Agreement, (E) changes in the market price or trading volume of
Parent Common Stock (it being understood that any cause of any such change may
be taken into consideration when determining whether a Parent Material
Adverse Effect has occurred or would reasonably be expected to occur, unless
such cause is otherwise excluded), (F) general national or international
economic, financial, political or business conditions including the
engagement by the United States in hostilities, whether or not pursuant to a
declaration of a national emergency or war, or the occurrence of any military
or terrorist attack upon the United States or any of its territories,
possession or diplomatic or consular offices or upon any military
installation, equipment or personnel of the United States, or (G) any
failure by Parent to meet internal projections, budgets or forecasts or
third-party revenue or earnings predictions or other analyst
expectations, projections, forecasts or budgets for any period (it being
understood that any cause of any such failure may be taken into
consideration when determining whether a Parent Material Adverse Effect has
occurred or would reasonably be expected to occur, unless such cause is
otherwise excluded); provided, that state of facts, events, changes,
circumstances, developments, effects or occurrences referred to in clauses
(A), (B) and (F) above shall be considered for purposes of determining whether
there has been or would reasonably be expected to be a Parent Material
Adverse Effect if and to the extent such state of facts, events, changes,
circumstances, developments, effects or occurrences has had or would
reasonably be expected to have a disproportionate adverse effect on the Parent
Entities, as compared to other companies operating in the industry or
territory in which the Parent Entities operate; or (ii) the ability of Parent
to perform its obligations under this Agreement or to consummate the Merger or
the other transactions contemplated by this Agreement.

  



  

" _Parent Option_ " means an option to purchase one share of Parent Common
Stock granted by Parent.

  



  

" _Parent Owned Intellectual Property_ " means all Intellectual Property that
is owned by Parent or any Parent Subsidiary (whether solely or jointly with a
third party).

  



  

" _Parent Products/Services_ " means (i) all commercial services provided by
Parent or any Parent Subsidiary and (ii) all marketed products, and all
compounds or devices and Product Candidates that are being evaluated or are
under development, current, active or otherwise, or consideration by Parent
or any Parent Subsidiary or any of their respective licensees, whether in
clinical trials as to which Parent or any Parent Subsidiary holds the
applicable investigational

  



  

   

76 
--- 

 


--- 

    



  



  

new drug applications, or in earlier stages of development, or otherwise.
Parent Products includes LDTs.

  



  

" _Parent Registered Intellectual Property_ " means all trademarks,
Copyrights, and Patents that are the subject of an application for
registration or a registration issued, filed with or recorded by any
Governmental Entity and included in the Parent Owned Intellectual Property.

  



  

" _Parent SEC Documents_ " means the SEC Documents of Parent.

  



  

" _Parent Stock Plan_ " means the OPKO Health, Inc. 2007 Equity Incentive
Plan, as amended.

  



  

" _Parent Subsidiaries_ " means the Subsidiaries of Parent, which shall
include any corporation, limited liability company, limited partnership,
limited liability partnership or other organization acquired as a Subsidiary
of Parent in the future and held as a Subsidiary by Parent at the Effective
Time.

  



  

" _Parent Warrant_ " means a warrant to purchase one share of Parent Common
Stock granted by Parent.

  



  

" _Party_ " means any of Parent, Sub or the Company, and " _Parties_ " means
Parent, Sub and the Company.

  



  

" _Permit_ " means any federal, state, local and foreign governmental
approval, authorization, certificate, easement, filing, franchise,
license, notice, permit or right to which any Person is a party or that is or
may be binding upon or inure to the benefit of any Person or its securities,
Assets, or business.

  



  

" _Person_ " means a natural person or any legal, commercial or governmental
entity, such as, but not limited to, a corporation, general
partnership, joint venture, limited partnership, limited liability company,
limited liability partnership, trust, business association, group acting in
concert, or any person acting in a representative capacity.

  



  

" _Proxy Statement_ " means the proxy statement on Schedule 14A to be
prepared and filed with the SEC by the Company relating to the approval and
adoption by the Company's shareholders of this Agreement, the Merger and the
other transactions contemplated by this Agreement.

  



  

" _Registration Statement_ " means the registration statement on Form S-4,
and any amendment or supplement thereto, pursuant to which the Parent Common
Stock issuable in the Merger will be registered with the SEC, in which the
Proxy Statement will be included as a prospectus.

  



  

" _Regulatory Authorities_ " means, collectively, the SEC, the New York Stock
Exchange, NASDAQ, the Federal Trade Commission, the Department of Justice,
any Healthcare Regulatory Authority and all other foreign, federal, state,
county, local or other governmental or regulatory agencies, authorities
(including taxing and self-regulatory authorities), instrumentalities (whether
domestic or foreign) having jurisdiction over the Parties and their
respective Subsidiaries.

  



  

   

77 
--- 

 


--- 

    



  



  

" _Release_ " means any release, spill, emission, leaking, pumping,
injection, deposit, disposal, discharge, dispersal, leaching or
migration into the indoor or outdoor environment, including movement through
air, soil, surface water, groundwater or real property.

  



  

" _Representative_ " means any director, officer, employee, Affiliate,
investment banker, financial advisor, attorney, accountant, consultant or
other representative or agent engaged by a Person.

  



  

" _Required Company Vote_ " means the affirmative vote at an annual or
special meeting of the shareholders of the Company, at which a quorum is
present in accordance with the NJBCA and the bylaws of the Company, of holders
of the Company Common Stock representing at least a majority of the votes
cast at such meeting.

  



  

" _SEC_ " means the United States Securities and Exchange Commission.

  



  

" _SEC Documents_ " means all reports, forms, schedules, agreements (oral or
written), registration statements, proxy statements and other documents (in
each case including all exhibits and schedules thereto and documents
incorporated by reference therein) filed, or required to be filed, by a Party
with the SEC pursuant to the Securities Laws.

  



  

" _Securities Act_ " means the Securities Act of 1933, as amended.

  



  

" _Securities Laws_ " means the Securities Act, the Exchange Act, the
Investment Company Act of 1940, as amended, the Investment Advisors Act of
1940, as amended, the Trust Indenture Act of 1939, as amended, and the rules
and regulations of any Regulatory Authority promulgated thereunder.

  



  

" _Sub Common Stock_ " means the common stock, par value $0.01 per share, of
Sub.

  



  

" _Subsidiaries_ " means all those corporations, associations or other
business entities of which the entity in question either (i) owns or
controls fifty percent (50%) or more of the outstanding equity securities
either directly or through an unbroken chain of entities as to each of which
fifty percent (50%) or more of the outstanding equity securities is owned
directly or indirectly by its parent (provided, that there shall not be
included any such entity the equity securities of which are owned or
controlled in a fiduciary capacity); (ii) in the case of partnerships, serves
as a general partner; (iii) in the case of a limited liability company, serves
as a manager or a managing member; (iv) otherwise has the ability to elect a
majority of the directors, trustees, managers, or managing members thereof;
or (v) under GAAP consolidates in its financial statements.

  



  

" _Surviving Corporation_ " means the Company as the surviving corporation in
the Merger.

  



  

" _Tax_ " or " _Taxes_ " means any federal, state, county, local, or foreign
taxes, charges, fees, levies, imposts, duties or other assessments,
including, without limitation, income, gross receipts, excise, employment,
sales, use, transfer, recording license, payroll, franchise, severance,
documentary, stamp, occupation, windfall profits, environmental, federal
highway use,

  



  

   

78 
--- 

 


--- 

    



  



  

commercial rent, customs duties, capital stock, paid-up capital, profits,
withholding, Social Security, single business and unemployment, disability,
real property, personal property, registration, ad valorem, value added,
alternative or add-on minimum, estimated or other tax or governmental fee of
any kind whatsoever, imposed or required to be withheld by the United States
or any state, county, local or foreign government or subdivision or agency
thereof, whether imposed directly or through withholding, whether disputed or
not, and including any interest, penalties and additions imposed thereon or
with respect thereto, and any Liability for payment of any amounts described
in above, whether as a result of transferee Liability, of being a member of an
affiliated, consolidated, combined, unitary or similar group, as a result of
any Tax sharing, Tax indemnity or Tax allocation Contract or any other
express or implied agreement to indemnify or otherwise succeed to, assume, or
bear responsibility for the Taxes of any other Person, as a withholding agent
or collection agent, or otherwise through operation of Law.

  



  

" _Tax Laws_ " means any Laws relating to Taxes.

  



  

" _Tax Liability_ " means any Liability in respect of Taxes.

  



  

" _Tax Return_ " means any report, return, information return or other
information required to be supplied to a Regulatory Authority in connection
with Taxes, including any return of an affiliated or combined or unitary group
that includes a Party or the Company Subsidiaries, and any schedule,
attachment or amendment to any Tax Return.

  



  

The terms set forth below shall have the meanings ascribed thereto on the
referenced pages:

  



  

  

  

  

     Term  | Page 
---|--- 
   Agreement  | 1 
   Annual Amount  | 56 
   Anti-takeover Laws  | 30 
   Balance Sheet Date  | 15 
   Bankruptcy and Equity Exception  | 11 
   Board  | 1 
   Book-Entry Share  | 4 
   Certificate of Merger  | 2 
   Change in Recommendation  | 49 
   Closing  | 2 
   Closing Date  | 2 
   Code  | 1 
   Committee  | 59 
   Company  | 1 
   Company Acquisition Agreement  | 49 
   Company Acquisition Proposal  | 52 
   Company Board Recommendation  | 12 
   Company Certificate  | 4 
    

     Term  | Page 
---|--- 
   Company Financial Advisor  | 30 
   Company Insiders  | 60 
   Company Intellectual Property  | 23 
   Company Intervening Event  | 52 
   Company Intervening Event Change in Recommendation  | 51 
   Company Intervening Event Termination Fee  | 67 
   Company Materiality Qualifier  | 63 
   Company Notice of Intervening Event Change in Recommendation  | 52 
   Company CEO  | 59 
   Company Options  | 4 
   Company Organizational Documents  | 9 
   Company Plan Option  | 4 
   Company Registered Intellectual Property  | 23 
   Company Securities  | 10 
   Company Tax Opinion  | 64 
   Company Termination Fee  | 67 
   Confidentiality Agreement  | 53 
  
   

  



  

  

     
--- 
   



   

79 
--- 

 


--- 

    



  

  

     Converted Shares  | 3 
---|--- 
   Copyrights  | 23 
   DEA  | 25 
   Divestitures  | 54 
   Effective Time  | 3 
   ERISA  | 20 
   ERISA Affiliate  | 20 
   Exchange Agent  | 6 
   Exchange Ratio  | 4 
   Expense Reimbursement  | 67 
   Filed Company SEC Documents  | 9 
   Foreign Antitrust Filings  | 53 
   Governmental Approvals  | 12 
   Grant Date  | 10 
   Healthcare Regulatory Authority  | 12 
   Indemnified Person  | 55 
   Intellectual Property  | 23 
   Legal Privilege  | 54 
   Merger  | 2 
   Merger Consideration  | 4 
   Multiemployer Plan  | 20 
    

  

  

     NJBCA  | 2 
---|--- 
   Option Pool  | 59 
   Parent  | 1 
   Parent Materiality Qualifier  | 64 
   Parent Notes  | 32 
   Parent Permits  | 38 
   Parent Regulatory Agency  | 38 
   Parent Securities  | 34 
   Parent Stock Option  | 59 
   Parent Tax Opinion  | 57 
   Patents  | 23 
   Plans  | 20 
   Proceeding  | 55 
   Proxy Statement/Prospectus  | 46 
   Sarbanes-Oxley Act  | 13 
   Section 16 Information  | 60 
   Sub  | 1 
   Subsidiary Securities  | 11 
   Superior Proposal  | 52 
   Tax Opinions  | 63 
   Trade Secrets  | 23 
 

  



  

  

     
--- 
   

  

  

  



  



  



  



  



  



  



  



  



  



  



  



  



  



  



  



  



  

Any singular term in this Agreement shall be deemed to include the plural,
and any plural term the singular. Whenever the words "include," "includes" or
"including" are used in this Agreement, they shall be deemed followed by the
words "but not limited to." The word "or" is not exclusive. References to
"written" or "in writing" include in visual electronic form. Words of one
gender shall be construed to apply to each gender. The words
"hereof", "herein" and "hereunder" and words of like import used in this
Agreement shall refer to this Agreement as a whole and not to any particular
provision of this Agreement. Any capitalized terms used in any Exhibit or
Schedule but not otherwise defined therein, shall have the meaning as defined
in this Agreement. References to any statute shall be deemed to refer to such
statute as amended from time to time and to any rules or regulations
promulgated thereunder (except if expressly stated otherwise). References to
any agreement or contract are to that agreement or contract as amended,
modified or supplemented from time to time in accordance with the terms
hereof and thereof. References to any Person include the successors and
permitted assigns of that Person. References from or through any date mean,
unless otherwise specified, from and including or through and
including, respectively.

   

  



  

7.2   _Non-Survival of Representations, Warranties and
Agreements_.

  



  

None of the representations, warranties, covenants and other agreements in
this Agreement or in any instrument delivered pursuant to this Agreement
shall survive the Effective Time, except for _Section 4.11_ and those other
covenants and agreements contained herein and therein that by their terms
apply or are to be performed in whole or in part after the Effective Time
and this _Article 7_.

  



  

   

80 
--- 

 


--- 

    



  



  

7.3   _Disclosure Schedules_.

  



  

The inclusion of any information in the disclosure schedules accompanying
this Agreement will not be deemed an admission or acknowledgment, in and of
itself, solely by virtue of the inclusion of such information in such
disclosure schedules, that such information is required to be listed in such
disclosure schedules or that such information is material to any party or the
conduct of the business of any party.

  



  

7.4   _Governing Law; Jurisdiction_.

  



  

This Agreement shall be governed by and construed in accordance with the Laws
of the State of Delaware, regardless of the Laws that might otherwise govern
under applicable principles of conflicts of laws thereof, except to the extent
that mandatory provisions of federal law apply or mandatory principles of law
require the application of the NJBCA. Each of the Parties hereto hereby
irrevocably and unconditionally submits, for itself and its property, to the
exclusive jurisdiction of the courts of the State of Delaware and any
appellate court thereof and any United States District Court for the State of
Delaware and any appellate court thereof, in any action or proceeding arising
out of or relating to this Agreement or the agreements delivered in connection
herewith or the transactions contemplated hereby or thereby or for
recognition or enforcement of any judgment relating thereto, and each of the
Parties hereby irrevocably and unconditionally (a) agrees not to commence any
such action except in such courts, (b) agrees that any claim in respect of
any such action or proceeding may be heard and determined in such courts, (c)
waives, to the fullest extent it may legally and effectively do so, any
objection which it may now or hereafter have to venue of any such action or
proceeding in any such courts, and (d) waives, to the fullest extent
permitted by Law, the defense of any inconvenient forum to the maintenance of
such action or proceeding in any such courts. Each of the Parties hereto
agrees that a final judgment in any such action or proceeding shall be
conclusive and may be enforced in other jurisdictions by suit on the judgment
or in any other manner provided by Law. Each of the Parties irrevocably
consents to service of process in any such action or proceeding in the manner
provided for notices in _Section 7.13_ of this Agreement; provided, that
nothing in this Agreement shall affect the right of any Party to this
Agreement to serve process in any other manner permitted by Law.

  



  

7.5   _WAIVER OF JURY TRIAL_. EACH OF THE PARTIES HEREBY WAIVES
TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY, IN ANY MATTERS
(WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF,
RELATED TO, OR CONNECTED WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY.

  



  

7.6   _Severability; Construction_.

  



  

If any term, provision, covenant or restriction of this Agreement is held by
a court of competent jurisdiction or other authority to be invalid, void or
unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Agreement shall remain in full force and effect and
shall in no way be affected, impaired or invalidated so long as the economic
or legal substance of the transactions contemplated hereby is not affected in
any manner materially

  



  

   

81 
--- 

 


--- 

    



  



  

adverse to any Party. Upon such a determination, the Parties shall negotiate
in good faith to modify this Agreement so as to effect the original intent of
the Parties as closely as possible in an acceptable manner in order that the
transactions contemplated hereby be consummated as originally contemplated to
the fullest extent possible.

  



  

7.7   _Specific Performance_.

  



  

The Parties agree that irreparable damage would occur for which monetary
damages would not be an adequate remedy in the event that the Parties do not
perform their obligations under the provisions of this Agreement in accordance
with their specific terms or otherwise breach such obligations. Accordingly,
the Parties agree that, if for any reason any of Parent, Sub or the Company
shall have failed to perform its obligations under this Agreement or
otherwise breached this Agreement, then the Party seeking to enforce this
Agreement against such nonperforming Party shall be entitled to seek specific
performance and the issuance of immediate injunctive and other equitable
relief to prevent breaches of this Agreement and to enforce specifically the
terms and provisions hereof, without the necessity of proving the inadequacy
of money damages as a remedy, and the Parties further agree to waive any
requirement for the securing or posting of any bond in connection with the
obtaining of any such injunctive or other equitable relief, this being in
addition to and not in limitation of any other remedy to which they are
entitled at Law or in equity. The Parties agree that (a) by seeking the
remedies provided for in this _Section 7.7_, a Party shall not in any respect
waive its right to seek any other form of relief that may be available to a
Party under the terms of this Agreement in the event that the remedies
provided for in this _Section 7.7_ are not available or otherwise are not
granted and (b) nothing contained in this _Section 7.7_ shall require any
Party to institute any proceeding for (or limit any Party's right to
institute any proceeding for) specific performance under this _Section 7.7_
before exercising any termination right under _Article 6_ (and, if
applicable, pursuing damages after such termination) nor shall the
commencement of any action pursuant to this _Section 7.7_ or anything
contained in this _Section 7.7_ restrict or limit any Party's right to
terminate this Agreement in accordance with the terms of _Article 6_ or pursue
any other remedies under this Agreement that may be available then or
thereafter.

  



  

7.8   _Entire Agreement_.

  



  

This Agreement and the Confidentiality Agreement contain the entire
understanding among the Parties hereto with respect to the
transactions contemplated hereby and supersede and replace all prior and
contemporaneous agreements and understandings, oral or written, with regard
to such transactions. All Exhibits and Schedules hereto and any documents and
instruments delivered pursuant to any provision hereof are expressly made a
part of this Agreement as fully as though completely set forth herein.

  



  

7.9   _Amendments_.

  



  

This Agreement may be amended by the Parties, by action taken or authorized
by their respective boards of directors, at any time before or after receipt
of the Required Company Vote, but, after any such approval, no amendment shall
be made which by Law requires further approval by such shareholders without
such further

  



  

   

82 
--- 

 


--- 

    



  



  

approval. This Agreement may not be amended except by an instrument in
writing signed on behalf of each of the Parties hereto.

  



  

7.10   _Extension; Waivers_.

  



  

At any time prior to the Effective Time, the Parties, by action taken or
authorized by their respective boards of directors, may, to the extent
legally allowed, (a) extend the time for the performance of any of the
obligations or other acts of the other parties hereto, (b) waive any
inaccuracies in the representations and warranties contained herein or in any
document delivered pursuant hereto and (c) waive compliance with any of the
agreements or conditions contained herein. Any agreement on the part of a
Party to any such extension or waiver shall be valid only if set forth in a
written instrument signed on behalf of such Party. The failure of any Party
to assert any of its rights under this Agreement or otherwise shall not
constitute a waiver of those rights.

  



  

7.11   _Parties in Interest_.

  



  

Except for (i) the rights of the Company shareholders to receive the Merger
Consideration following the Effective Time in accordance with the terms of
this Agreement (of which the shareholders are the intended beneficiaries
following the Effective Time) and (ii) the rights to continued
indemnification and insurance pursuant to _Section 4.11_ hereof (of which the
Persons entitled to indemnification or insurance, as the case may be, are the
intended beneficiaries following the Effective Time), nothing in this
Agreement is intended to confer any rights or remedies under or by reason of
this Agreement on any Persons other than the parties hereto and their
respective successors and permitted assigns. Nothing in this Agreement is
intended to relieve or discharge the obligations or liability of any third
Persons to the Company or Parent.

  



  

7.12   _Assignment_.

  



  

Except as expressly contemplated hereby, neither this Agreement nor any of
the rights, interests or obligations hereunder may be assigned by any Party
hereto (whether by operation of Law or otherwise) without the prior written
consent of the other Parties. Subject to the preceding sentence, this
Agreement will be binding upon, inure to the benefit of and be enforceable by
the Parties and their respective successors and permitted assigns.

  



  

7.13   _Notices_.

  



  

All notices, requests, demands and other communications in connection with
this Agreement shall be in writing and shall be deemed given if (a) delivered
personally, on the date of such delivery, (b) upon non-automated confirmation
of receipt when transmitted via electronic mail or upon automated or non-
automated confirmation when transmitted via facsimile (but only, in the case
of electronic mail and facsimile, if followed by transmittal by nationally
recognized overnight courier or by hand for delivery on the next Business
Day), or (c) on receipt (or refusal to accept delivery) after dispatch by
registered or certified mail (return receipt requested),

  



  



   

83 
--- 

 


--- 

    

  



  

 postage prepaid, or by a nationally recognized overnight courier (with
confirmation), addressed, in each case, as follows:

  



  

  

     If to the Company prior to the Effective Time:  |  

481 Edward H. Ross Drive

 

Elmwood Park, New Jersey 07407 

---|--- 
       | Attention:  | Marc D. Grodman M.D. 
---|---|--- 
     | Richard L. Faherty 
     | Facsimile:  | 201-791-1941 
     | Email:  | mgrodman@bioreference.com 
     | _rfaherty@bioreference.com_ 
       | 
---|--- 
     with a copy to (which shall not constitute notice):  |  

Davis Polk and Wardwell LLP

 

450 Lexington Avenue

 

New York, NY 10017 

---|--- 
       | Attention:  | David L. Caplan 
---|---|--- 
     | John H. Butler 
     | Facsimile:  | 212-701-5156 
     | Email:  | _david.caplan@davispolk.com_ 
     | _john.butler@davispolk.com_ 
   



    If to Parent or Sub or, from and after the Effective Time, the
Company:  |  

4400 Biscayne Boulevard

 

Miami, Florida 33137 

---|--- 
         | Attention:  | Kate Inman 
---|---|--- 
     | Facsimile:  | 305-575-4140 
     | Email:  | _KInman@opko.com_ 
   



    with a copy to (which shall not constitute notice):  |  

Greenberg Traurig, P.A.

 

333 Avenue of the Americas

 

(333 S.E. 2nd Ave)

 

Miami, Florida 33131 

---|--- 
       | Attention:  | Robert L. Grossman 
---|---|--- 
     | Ira N. Rosner 
     | Facsimile:  | 305-961-5756 
     | Email:  | _GrossmanB@gtlaw.com_ 
     | _rosneri@gtlaw.com_ 
    

  



  

  

7.14   _Counterparts_.

  



  

This Agreement may be executed in two or more counterparts (including by
facsimile or by an electronic scan delivered by electronic mail), each of
which shall be deemed to be an original, but all of which together shall
constitute one and the same instrument.

  



  

7.15   _Captions; Articles and Sections_.

  



  

The captions contained in this Agreement are for reference purposes only and
are not part of this Agreement. Unless otherwise indicated, all references to
particular Articles, Sections, Exhibits and Schedules shall mean and refer to
the referenced Articles, Sections,

  



  

   

84 
--- 

 


--- 

    



  



  

Exhibits and Schedules of this Agreement.

  



  

7.16   _Interpretations_.

  



  

Neither this Agreement nor any uncertainty or ambiguity herein shall be
construed or resolved against any Party, whether under any rule of
construction or otherwise. No Party to this Agreement shall be considered the
drafter. The Parties acknowledge and agree that this Agreement has been
reviewed, negotiated and accepted by all Parties and their attorneys and shall
be construed and interpreted according to the ordinary meaning of the words
used so as fairly to accomplish the purposes and intentions of all Parties
hereto. This Agreement shall be interpreted and applied in a manner which is
consistent with the classification of the Merger as a reorganization under
Code section 368(a). If there shall be any conflict between this Agreement and
the plan of merger executed and filed with the Certificate of Merger, then
this Agreement shall govern.

  



  



  

[Signature Page Follows]

  



    

85 
--- 

 


--- 

    



  

IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be
executed on its behalf by its duly authorized officers as of the day and year
first above written.

  



  



       | OPKO HEALTH, INC. 
---|--- 
     | 
     | 
     | By:   | /s/ Adam Logal 
     |   | Name: Adam Logal 
Title: SVP, CFO, CAO and  Treasurer 
   



  



  

       | BAMBOO ACQUISITION, INC. 
---|--- 
     | 
     | By:   | /s/ Adam Logal 
     |   | Name: Adam Logal 
Title: VP and Treasurer 
   



  



  

       | BIO-REFERENCE LABORATORIES, INC. 
---|--- 
     | 
     | 
     | By:   | /s/ Marc D. Grodman 
     |   | Name: Marc D. Grodman, M.D. 
Title: Chairman,  President and Chief Executive Officer 
   



  



    



  



     



      '

